Surgical
- Autoimmune disease
- Gene therapy
- General studies
- Imaging
- Immunology
- Oncology
- Surgical
- Transplantation
- Tumor cell growth
- Tumor growth
Autoimmune disease
Kalliokoski, S., Caja, S., Frias, R., Laurila, K., Koskinen, O., Niemela, O., . . . Lindfors, K. (2015), Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease., Journal of Molecular Medicine (Berlin, Germany), 93(1), 51-62. doi:10.1007/s00109-014-1204-8 [doi]
Gene therapy
Qiu M, Li G, Wang P, Li X, Lai F, Luo R, Liu B, Lin J., aarF domain containing kinase 5 gene promotes invasion and migration of lung cancer cells through ADCK5-SOX9-PTTG1 pathway, Exp Cell Res. 2020 Jul 1;392(1):112002. doi: 10.1016/j.yexcr.2020.112002. Epub 2020 Apr 8.
Lampe, J., Bossow, S., Weiland, T., Smirnow, I., Lehmann, R., Neubert, W., . . . Lauer, U. M. (2013)., An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis., Gene Therapy, 20(11), 1033-1041. doi:10.1038/gt.2013.28 [doi]
Tiwari A, Iida M, Kosnopfel C, Abbariki M, Menegakis A, Fehrenbacher B, Maier J, Schaller M, Brucker SY, Wheeler DL, Harari PM, Rothbauer U, Schittek B, Zips D, Toulany M., Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers, Cancers (Basel). 2020 Sep 29;12(10):2795. doi: 10.3390/cancers12102795.
Feichtinger, G. A., Hacobian, A., Hofmann, A. T., Wassermann, K., Zimmermann, A., van Griensven, M., & Redl, H. (2014)., Constitutive and inducible co-expression systems for non-viral osteoinductive gene therapy., European Cells & Materials, 27, 166-84; discussion 184. doi:vol027a13 [pii]
McCarthy GA, Di Niro R, Finan JM, Jain A, Guo Y, Wyatt CR, Guimaraes AR, Waugh TA, Keith D, Morgan TK, Sears RC, Brody JR., Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity., NAR Cancer. 2023 Apr 19;5(2):zcad016. doi: 10.1093/narcan/zcad016. eCollection 2023 Jun.
Gentschev, I., Muller, M., Adelfinger, M., Weibel, S., Grummt, F., Zimmermann, M., . . . Szalay, A. A. (2011)., Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68., PloS One, 6(7), e22069. doi:10.1371/journal.pone.0022069 [doi]
Arruabarrena-Aristorena A, Maag JLV, Kittane S, Cai Y, Karthaus WR, Ladewig E, Park J, Kannan S, Ferrando L, Cocco E, Ho SY, Tan DS, Sallaku M, Wu F, Acevedo B, Selenica P, Ross DS, Witkin M, Sawyers CL, Reis-Filho JS, Verma CS, Jauch R, Koche R, Baselga J, Razavi P, Toska E, Scaltriti M., FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer, Cancer Cell. 2020 Oct 12;38(4):534-550.e9. doi: 10.1016/j.ccell.2020.08.003. Epub 2020 Sep 3.
Yu, L., Liang, Y., Cao, X., Wang, X., Gao, H., Lin, S. Y., . . . Li, K. (2017), Identification of MYST3 as a novel epigenetic activator of ERalpha frequently amplified in breast cancer., Oncogene, 36(20), 2910-2918. doi:10.1038/onc.2016.433 [doi]
Unzu, C., Melero, I., Morales-Kastresana, A., Sampedro, A., Serrano-Mendioroz, I., Azpilikueta, A., . . . Fontanellas, A. (2014), Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus, PloS One, 9(1), e85432. doi:10.1371/journal.pone.0085432 [doi]
Dowaidar, M., Abdelhamid, H. N., Hallbrink, M., Freimann, K., Kurrikoff, K., Zou, X., & Langel, U. (2017)., Magnetic nanoparticle assisted self-assembly of cell penetrating peptides-oligonucleotides complexes for gene delivery, Scientific Reports, 7(1), 9159-017-09803-z. doi:10.1038/s41598-017-09803-z [doi]
Dinami R, Pompili L, Petti E, Porru M, D'Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, Serra V, Mano M, Giacca M, Leonetti C, Ciliberto G, Tarsounas M, Stoppacciaro A, Schoeftner S, Biroccio A., MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer., EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25.
Kim SS, Doherty C, Moghe M, Rait A, Pirollo KF, Harford JB, Chang EH., Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity, Cancers (Basel). 2022 Oct 18;14(20):5092. doi: 10.3390/cancers14205092.
Ady, J. W., Johnsen, C., Mojica, K., Heffner, J., Love, D., Pugalenthi, A., . . . Fong, Y. (2015)., Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma., Surgery, 158(2), 331-338. doi:10.1016/j.surg.2015.03.044 [doi]
Veiman, K. L., Kunnapuu, K., Lehto, T., Kiisholts, K., Parn, K., Langel, U., & Kurrikoff, K. (2015)., PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo., Journal of Controlled Release : Official Journal of the Controlled Release Society, 209, 238-247. doi:10.1016/j.jconrel.2015.04.038 [doi]
Croessmann, S., Wong, H. Y., Zabransky, D. J., Chu, D., Rosen, D. M., Cidado, J., . . . Park, B. H. (2017)., PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity., Breast Cancer Research and Treatment, 162(3), 451-464. doi:10.1007/s10549-017-4147-2 [doi]
Hollevoet, K., De Smidt, E., Geukens, N., & Declerck, P. (2018), Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies, Oncotarget, 9(17), 13623-13636. doi:10.18632/oncotarget.24426 [doi]
Kaliberov, S. A., Kaliberova, L. N., Yan, H., Kapoor, V., & Hallahan, D. E. (2016)., Retargeted adenoviruses for radiation-guided gene delivery., Cancer Gene Therapy, 23(9), 303-314. doi:10.1038/cgt.2016.32 [doi]
Shapira, S., Shapira, A., Kazanov, D., Hevroni, G., Kraus, S., & Arber, N. (2017)., Selective eradication of cancer cells by delivery of adenovirus-based toxins., Oncotarget, 8(24), 38581-38591. doi:10.18632/oncotarget.16934 [doi]
Anders, N. M., Liu, J., Wanjiku, T., Giovinazzo, H., Zhou, J., Vaghasia, A., . . . Rudek, M. A. (2016)., Simultaneous quantitative determination of 5-aza-2'-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors, Journal of Chromatography.B, Analytical Technologies in the Biomedical and Life Sciences, 1022, 38-45. doi:S1570-0232(16)30178-7 [pii]
Feichtinger, G. A., Hofmann, A. T., Slezak, P., Schuetzenberger, S., Kaipel, M., Schwartz, E., . . . Redl, H. (2014)., Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery., Human Gene Therapy Methods, 25(1), 57-71. doi:10.1089/hgtb.2013.113 [doi]
Abel, T., El Filali, E., Waern, J., Schneider, I. C., Yuan, Q., Munch, R. C., . . . Buchholz, C. J. (2013)., Specific gene delivery to liver sinusoidal and artery endothelial cells, Blood, 122(12), 2030-2038. doi:10.1182/blood-2012-11-468579 [doi]
Hou R, Yu Y, Sluter MN, Li L, Hao J, Fang J, Yang J, Jiang J., Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma, Cell Rep. 2022 Jun 21;39(12):111000. doi: 10.1016/j.celrep.2022.111000.
Chatterjee S, Naidu GS, Hazan-Halevy I, Grobe H, Ezra A, Sharma P, Goldsmith M, Ramishetti S, Sprinzak D, Zaidel-Bar R, Peer D., Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells., Sci Adv. 2023 Apr 5;9(14):eade4800. doi: 10.1126/sciadv.ade4800. Epub 2023 Apr 5.
Presutti, D., Ceccarelli, M., Micheli, L., Papoff, G., Santini, S., Samperna, S., . . . Tirone, F. (2018)., Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model., PloS One, 13(3), e0194206. doi:10.1371/journal.pone.0194206 [doi]
Nomikou, N., Feichtinger, G. A., Saha, S., Nuernberger, S., Heimel, P., Redl, H., & McHale, A. P. (2018)., Ultrasound-responsive gene-activated matrices for osteogenic gene therapy using matrix-assisted sonoporation., Journal of Tissue Engineering and Regenerative Medicine, 12(1), e250-e260. doi:10.1002/term.2406 [doi]
Zhao P, Zhu Y, Kim M, Zhao G, Wang Y, Collins CP, Mei O, Zhang Y, Duan C, Zhong J, Zhang H, You W, Shen G, Luo C, Wu X, Li J, Shu Y, Luu HH, Haydon RC, Lee MJ, Shi LL, Huang W, Fan J, Sun C, Wen L, Ameer GA, He TC, Reid RR., Effective Bone Tissue Fabrication Using 3D-Printed Citrate-Based Nanocomposite Scaffolds Laden with BMP9-Stimulated Human Urine Stem Cells, ACS Appl Mater Interfaces - 10.1021/acsami.4c13246
General studies
Choi YH, Zhang C, Liu Z, Tu MJ, Yu AX, Yu AM., A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism, J Pharmacol Exp Ther. 2021 Jun;377(3):305-315. doi: 10.1124/jpet.121.000584. Epub 2021 Mar 12.
Landgraf, L., Christner, C., Storck, W., Schick, I., Krumbein, I., Dahring, H., . . . Hilger, I. (2015), A plasma protein corona enhances the biocompatibility of Au@Fe3O4 janus particles, Biomaterials, 68, 77-88. doi:10.1016/j.biomaterials.2015.07.049 [doi]
Cook Sangar ML, Girard EJ, Hopping G, Yin C, Pakiam F, Brusniak MY, Nguyen E, Ruff R, Gewe MM, Byrnes-Blake K, Nairn NW, Miller DM, Mehlin C, Strand AD, Mhyre AJ, Correnti CE, Strong RK, Simon JA, Olson JM., A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure, Sci Transl Med. 2020 Mar 4;12(533):eaay1041. doi: 10.1126/scitranslmed.aay1041.
Crook ZR, Girard E, Sevilla GP, Merrill M, Friend D, Rupert PB, Pakiam F, Nguyen E, Yin C, Ruff RO, Hopping G, Strand AD, Finton KAK, Coxon M, Mhyre AJ, Strong RK, Olson JM., A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules, J Mol Biol. 2020 Jun 26;432(14):3989-4009. doi: 10.1016/j.jmb.2020.04.002. Epub 2020 Apr 15.
Joshi S, Montes de Oca I, Maghrabi A, Lopez-Yang C, Quiroz-Olvera J, Garcia CA, Jarajapu YPR., ACE2 gene transfer ameliorates vasoreparative dysfunction in CD34+ cells derived from diabetic older adults, Clin Sci (Lond). 2021 Jan 29;135(2):367-385. doi: 10.1042/CS20201133.
Crum RJ, Capella-Monsonís H, Chang J, Dewey MJ, Kolich BD, Hall KT, El-Mossier SO, Nascari DG, Hussey GS, Badylak SF., Biocompatibility and biodistribution of matrix-bound nanovesicles in vitro and in vivo, Acta Biomater. 2023 Jan 1;155:113-122. doi: 10.1016/j.actbio.2022.11.026. Epub 2022 Nov 22.
Talele S, Zhang W, Chen J, Gupta SK, Burgenske DM, Sarkaria JN, Elmquist WF., Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors, J Pharmacol Exp Ther. 2022 Oct;383(1):91-102. doi: 10.1124/jpet.122.001230. Epub 2022 Aug 5.
Das, S., Haedicke, K., & Grimm, J. (2018)., Cerenkov-activated sticky tag for in vivo fluorescence imaging., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(1), 58-65. doi:10.2967/jnumed.117.198549 [doi]
Gaffron F, Tilch A, Grüttner C, Kowalski A, Kramer M, Teichgräber U, Hilger AI., Challenges in Tracking of Fluorochrome-Labelled Nanoparticles in Mice via Whole Body NIRF Imaging, Nanomaterials (Basel). 2020 Mar 24;10(3):596. doi: 10.3390/nano10030596.
Rahman, C. V., Ben-David, D., Dhillon, A., Kuhn, G., Gould, T. W., Muller, R., . . . Livne, E. (2014)., Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model., Journal of Tissue Engineering and Regenerative Medicine, 8(1), 59-66. doi:10.1002/term.1497 [doi]
Deng H, Qiao H, Dai Q, Ma C., Deep learning in photoacoustic imaging: a review, J Biomed Opt. 2021 Apr;26(4):040901. doi: 10.1117/1.JBO.26.4.040901.
Andleeb F, Katta N, Gruslova A, Muralidharan B, Estrada A, McElroy AB, Ullah H, Brenner AJ, Milner TE., Differentiation of Brain Tumor Microvasculature From Normal Vessels Using Optical Coherence Angiography, Lasers Surg Med. 2021 Jun 15. doi: 10.1002/lsm.23446. Online ahead of print.
Altshuler A, Amitai-Lange A, Tarazi N, Dey S, Strinkovsky L, Hadad-Porat S, Bhattacharya S, Nasser W, Imeri J, Ben-David G, Abboud-Jarrous G, Tiosano B, Berkowitz E, Karin N, Savir Y, Shalom-Feuerstein R., Discrete limbal epithelial stem cell populations mediate corneal homeostasis and wound healing, Cell Stem Cell. 2021 Jul 1;28(7):1248-1261.e8. doi: 10.1016/j.stem.2021.04.003. Epub 2021 May 12.
Netser S, Meyer A, Magalnik H, Zylbertal A, de la Zerda SH, Briller M, Bizer A, Grinevich V, Wagner S., Distinct dynamics of social motivation drive differential social behavior in laboratory rat and mouse strains, Nat Commun. 2020 Nov 20;11(1):5908. doi: 10.1038/s41467-020-19569-0.
Manuel R, Lima MS, Dilly S, Daunay S, Abbe P, Pramil E, Solier S, Guillaumond F, Tubiana SS, Escargueil A, Pęgas Henriques JA, Ferrand N, Erdelmeier I, Boucher JL, Bertho G, Agranat I, Rocchi S, Sabbah M, Slama Schwok A., Distinction between 2'- and 3'-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration, Antioxidants (Basel). 2021 May 4;10(5):723. doi: 10.3390/antiox10050723.
Robin J, Ozbek A, Reiss M, Dean-Ben XL, Razansky D., Dual-Mode Volumetric Photoacoustic and Contrast Enhanced Ultrasound Imaging with Spherical Matrix Arrays, IEEE Trans Med Imaging. 2021 Nov 4;PP. doi: 10.1109/TMI.2021.3125398. Online ahead of print.
Kim, H. J., Park, S. S., Oh, S. Y., Kim, H., Kweon, O. K., Woo, H. M., & Kim, W. H. (2012), Effect of acellular dermal matrix as a delivery carrier of adipose-derived mesenchymal stem cells on bone regeneration., Journal of Biomedical Materials Research.Part B, Applied Biomaterials, 100(6), 1645-1653. doi:10.1002/jbm.b.32733 [doi]
Frees, S., Bidnur, S., Metcalfe, M., Raven, P., Chavez-Munoz, C., Moskalev, I., . . . So, A. (2016), Effect of contrast media on urinary cytopathology specimens., Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada, 10(7-8), 228-233. doi:10.5489/cuaj.3874 [doi]
Floyd RJ, Ricart Arbona RJ, Carrasco SE, Lipman NS., Examination of Horizontal Transmission of Nippostrongylus brasiliensis in Mice to Assess Biosecurity Risks., J Am Assoc Lab Anim Sci. 2023 May 1;62(3):243-253. doi: 10.30802/AALAS-JAALAS-23-000004. Epub 2023 May 1.
Luengo Y, Díaz-Riascos ZV, García-Soriano D, Teran FJ, Artés-Ibáñez EJ, Ibarrola O, Somoza Á, Miranda R, Schwartz S Jr, Abasolo I, Salas G., Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation, Pharmaceutics. 2022 Jul 22;14(8):1526. doi: 10.3390/pharmaceutics14081526.
Muñoz, Juan J; Tobajas, Esther; Juara, Sonia; Montero, Sara; Zapata, Agustín G;, FoxN1 mediates thymic cortex-medulla differentiation through modifying a developmental pattern based on epithelial tubulogenesis. Histochemistry and cell biology Vol.152, 2019, Histochemistry and cell biology Vol.152, 2019
van Rijn, S., Nilsson, J., Noske, D. P., Vandertop, W. P., Tannous, B. A., & Wurdinger, T. (2013), Functional multiplex reporter assay using tagged gaussia luciferase., Scientific Reports, 3, 1046. doi:10.1038/srep01046 [doi]
Klufa, Jörg; Bauer, Thomas; Hanson, Buck; Herbold, Craig; Starkl, Philipp; Lichtenberger, Beate; Srutkova, Dagmar; Schulz, Daniel; Vujic, Igor; Mohr, Thomas; Rappersberger, Klemens; Bodenmiller, Bernd; Kozakova, Hana; Knapp, Sylvia; Loy, Alexander; Sibilia, Maria;, Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy, Science translational medicine Vol.11, 2019
Leporq, B., Lambert, S. A., Ronot, M., Boucenna, I., Colinart, P., Cauchy, F., . . . Van Beers, B. E. (2016)., Hepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI., Quantification with 7.0T MRI. Magnetic Resonance in Medicine, 76(2), 510-518. doi:10.1002/mrm.25895 [doi]
Cheng Z, Li C, Khadria A, Zhang Y, Wang LV., High-gain and high-speed wavefront shaping through scattering media., Nat Photonics. 2023 Apr;17(4):299-305. doi: 10.1038/s41566-022-01142-4. Epub 2023 Jan 23.
Hernandez-Gonzalez F, Prats N, Ramponi V, López-DomÃnguez JA, Meyer K, Aguilera M, Muñoz MartÃn MI, MartÃnez D, Agusti A, Faner R, Sellarés J, Pietrocola F, Serrano M., Human senescent fibroblasts trigger progressive lung fibrosis in mice., Aging (Albany NY). 2023 Jul 1;15(14):6641-6657. doi: 10.18632/aging.204825. Epub 2023 Jul 1.
Ramis JM, Blasco-Ferrer M, Calvo J, Villa O, Cladera MM, Corbillo C, GayĂ A, Monjo M., Improved physical and osteoinductive properties of demineralized bone matrix by gelatin methacryloyl formulation, J Tissue Eng Regen Med. 2020 Mar;14(3):475-485. doi: 10.1002/term.3012. Epub 2020 Feb 8.
Keyaerts, M., Remory, I., Caveliers, V., Breckpot, K., Bos, T. J., Poelaert, J., . . . Lahoutte, T. (2012)., Inhibition of firefly luciferase by general anesthetics: Effect on in vitro and in vivo bioluminescence imaging., PloS One, 7(1), e30061. doi:10.1371/journal.pone.0030061 [doi]
Li, R., Phillips, E., Wang, P., Goergen, C. J., & Cheng, J. X. (2015)., Label-free in vivo imaging of peripheral nerve by multispectral photoacoustic tomography., Journal of Biophotonics, 9999(9999), 10.1002/jbio.201500004. doi:10.1002/jbio.201500004 [doi]
Guduric-Fuchs J, Pedrini E, Lechner J, Chambers SEJ, O'Neill CL, Mendes Lopes de Melo J, Pathak V, Church RH, McKeown S, Bojdo J, Mcloughlin KJ, Stitt AW, Medina RJ., miR-130a activates the VEGFR2/STAT3/HIF1? axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia, Mol Ther Nucleic Acids. 2021 Jan 20;23:968-981. doi: 10.1016/j.omtn.2021.01.015. eCollection 2021 Mar 5.
Mc Larney B, Hutter MA, Degtyaruk O, Deán-Ben XL, Razansky D., Monitoring of Stimulus Evoked Murine Somatosensory Cortex Hemodynamic Activity With Volumetric Multi-Spectral Optoacoustic Tomography, Front Neurosci. 2020 Jun 3;14:536. doi: 10.3389/fnins.2020.00536. eCollection 2020.
Kuehner F, Wong M, Straub E, Doorbar J, Iftner T, Roden RBS, Stubenrauch F., Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation in vivo., mBio. 2023 Aug 31;14(4):e0069623. doi: 10.1128/mbio.00696-23. Epub 2023 Jun 29.
Zhang M, Ye J, Xie Z, Yan Y, Wang J, Chen X., Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands, Bioconjug Chem. 2021 Sep 15;32(9):2108-2116. doi: 10.1021/acs.bioconjchem.1c00392. Epub 2021 Sep 6.
Domenici G, Eduardo R, Castillo-Ecija H, Orive G, Montero Carcaboso Á, Brito C., PDX-Derived Ewing's Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures, Cancers (Basel). 2021 Feb 19;13(4):879. doi: 10.3390/cancers13040879.
Chen, Z., Dean-Ben, X. L., Gottschalk, S., & Razansky, D. (2018), Performance of optoacoustic and fluorescence imaging in detecting deep-seated fluorescent agents, Biomedical Optics Express, 9(5), 2229-2239. doi:10.1364/BOE.9.002229 [doi]
Khadria A, Paavola CD, Maslov K, Brown-Augsburger PL, Grealish PF, Lozano E, Blankenship RL, Cao R, Shi J, Beals JM, Oladipupo SS, Wang LV., Photoacoustic imaging of the dynamics of a dye-labeled IgG4 monoclonal antibody in subcutaneous tissue reveals a transient decrease in murine blood oxygenation under anesthesia., J Biomed Opt. 2023 Nov;28(11):116002. doi: 10.1117/1.JBO.28.11.116002. Epub 2023 Nov 30.
Lenz SM, Collins JH, Ray NA, Hagge DA, Lahiri R, Adams LB., Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy, PLoS Negl Trop Dis. 2020 Sep 16;14(9):e0008583. doi: 10.1371/journal.pntd.0008583. eCollection 2020 Sep.
Bernardelli C, Chiaramonte E, Ancona S, Sirchia SM, Cerri A, Lesma E., Primary TSC2(-/meth) Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model, Int J Mol Sci. 2022 Aug 26;23(17):9713. doi: 10.3390/ijms23179713.
Houweling M, Abdul UK, Brahm C, Lagerweij T, Heukelom S, Koken PW, Honeywell R, Wedekind LE, Peters GJ, Verheul H, Sminia P, Noske D, Wurdinger T, Westerman BA., Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo, J Cancer Res Clin Oncol. 2022 Dec 1. doi: 10.1007/s00432-022-04483-3. Online ahead of print.
Basu, Sankha S; Regan, Michael S; Randall, Elizabeth C; Abdelmoula, Walid M; Clark, Amanda R; Gimenez-Cassina Lopez, BegoĂąa; Cornett, Dale S; Haase, Andreas; Santagata, Sandro; Agar, Nathalie Y R;, Rapid MALDI mass spectrometry imaging for surgical pathology., NPJ precision oncology Vol.3, 2019
LoCoco PM, Boyd JT, Espitia Olaya CM, Furr AR, Garcia DK, Weldon KS, Zou Y, Locke E, Tobon A, Lai Z, Ruparel SB, Ruparel NB, Hargreaves KM., Reliable approaches to extract high-integrity RNA from skin and other pertinent tissues used in pain research, Pain Rep. 2020 Mar 27;5(2):e818. doi: 10.1097/PR9.0000000000000818. eCollection 2020 Mar-Apr.
Peterson NC, Berlin AA., Risk Assessment for Use of a Porcine Circovirus-Contaminated Reagent in a Barrier Maintained Rodent Colony, J Am Assoc Lab Anim Sci. 2020 Sep 1;59(5):575-579. doi: 10.30802/AALAS-JAALAS-20-000012. Epub 2020 Jun 30.
Zhang Y, Hu P, Li L, Cao R, Khadria A, Maslov K, Tong X, Zeng Y, Jiang L, Zhou Q, Wang LV., Single-shot 3D photoacoustic tomography using a single-element detector for ultrafast imaging of hemodynamics., bioRxiv. 2023 Mar 15. pii: 2023.03.14.532661. doi: 10.1101/2023.03.14.532661. Update in: Nat Biomed Eng. 2023 Nov 30;:.
Maloney R, Buuh ZY, Zhao Y, Wang RE., Site-specific antibody fragment conjugates for targeted imaging, Methods Enzymol. 2020;638:295-320. doi: 10.1016/bs.mie.2020.02.023. Epub 2020 Mar 31.
Haedicke, K., Brand, C., Omar, M., Ntziachristos, V., Reiner, T., & Grimm, J. (2017)., Sonophore labeled RGD: A targeted contrast agent for optoacoustic imaging., Photoacoustics, 6, 1-8. doi:10.1016/j.pacs.2017.03.001 [doi]
Foubert, P., Squiban, C., Holler, V., Buard, V., Dean, C., Levy, B. I., . . . Tamarat, R. (2015)., Strategies to enhance the efficiency of endothelial progenitor cell therapy by ephrin B2 pretreatment and coadministration with smooth muscle progenitor cells on vascular function during the wound-healing process in irradiated or nonirradiated condition., Cell Transplantation, 24(7), 1343-1361. doi:10.3727/096368913X672064 [doi]
Grasso V, Willumeit-Rӧmer R, Jose J., Superpixel spectral unmixing framework for the volumetric assessment of tissue chromophores: A photoacoustic data-driven approach, Photoacoustics. 2022 May 11;26:100367. doi: 10.1016/j.pacs.2022.100367. eCollection 2022 Jun.
Manuel, C. A., Pugazhenthi, U., & Leszczynski, J. K. (2016)., Surveillance of a ventilated rack system for corynebacterium bovis by sampling exhaust-air manifolds, Journal of the American Association for Laboratory Animal Science : JAALAS, 55(1), 58-65.
Antunes IF, Dost RJ, Hoving HD, van Waarde A, Dierckx RAJO, Samplonius DF, Helfrich W, Elsinga PH, de Vries EFJ, de Jong IJ., Synthesis and Evaluation of (18)F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16?-(18)F-Fluoro-5?-Dihydrotestosterone, J Nucl Med. 2021 Aug 1;62(8):1140-1145. doi: 10.2967/jnumed.120.253641. Epub 2021 Jan 30.
King RE, Rademacher J, Ward-Shaw ET, Hu R, Bilger A, Blaine-Sauer S, Spurgeon ME, Thibeault SL, Lambert PF., The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice., Laryngoscope. 2023 Dec 12. doi: 10.1002/lary.31228. [Epub ahead of print]
Zhou Q, Chen Z, Liu YH, El Amki M, Glück C, Droux J, Reiss M, Weber B, Wegener S, Razansky D., Three-dimensional wide-field fluorescence microscopy for transcranial mapping of cortical microcirculation, Nat Commun. 2022 Dec 28;13(1):7969. doi: 10.1038/s41467-022-35733-0.
Dean-Ben, X., Fehm, T. F., & Razansky, D. (2014)., Universal hand-held three-dimensional optoacoustic imaging probe for deep tissue human angiography and functional preclinical studies in real time., . Journal of Visualized Experiments : JoVE, (93):e51864. doi(93), e51864. doi:10.3791/51864 [doi]
Luo AC, Wang J, Wang K, Zhu Y, Gong L, Lee U, Li X, Tremmel DM, Lin RZ, Ingber DE, Gorman J, Melero-Martin JM., A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation, Angiogenesis - 10.1007/s10456-024-09937-5
Lee U, Zhang Y, Zhu Y, Luo AC, Gong L, Tremmel DM, Kim Y, Villarreal VS, Wang X, Lin RZ, Cui M, Ma M, Yuan K, Wang K, Chen K, Melero-Martin JM., Robust differentiation of human pluripotent stem cells into mural progenitor cells via transient activation of NKX3.1, Nat Commun - 10.1038/s41467-024-52678-8
Gaskill BN, Boykin C, Zuniga I, Maynard K, Scorrano F., Evaluation of Thermal Support during Anesthesia Induction on Body Temperature in C57BL/6 and Nude Mice, J Am Assoc Lab Anim Sci - 10.30802/AALAS-JAALAS-23-000085
Imaging
Ayers GD, Cohen AS, Bae SW, Wen X, Pollard A, Sharma S, Claus T, Payne A, Geng L, Zhao P, Tantawy MN, Gammon ST, Manning HC., Reproducibility and repeatability of 18F-(2S, 4R)-4-fluoroglutamine PET imaging in preclinical oncology models, PLoS One - 10.1371/journal.pone.0313123
Kulkarni MB, Reed MS, Cao X, García HA, Ochoa MI, Jiang S, Hasan T, Doyley MM, Pogue BW., Combined dual-channel fluorescence depth sensing of indocyanine green and protoporphyrin IX kinetics in subcutaneous murine tumors, J Biomed Opt - 10.1117/1.JBO.30.S1.S13709
Tang L, Nozdriukhin D, Kalva SK, Zhou Q, Özsoy Ç, Lyu S, Reiss M, Vidal A, Torres A, Deán-Ben XL, Razansky D., Scalable Copper Sulfide Formulations for Super-Resolution Optoacoustic Brain Imaging in the Second Near-Infrared Window, Small Methods - 10.1002/smtd.202400927
Li X, Song W, Engle JW, Mixdorf JC, Barnhart TE, Sun Y, Zhu Y, Cai W., Immuno-PET Imaging of CD93 Expression with (64)Cu-Radiolabeled NOTA-mCD93 ([(64)Cu]Cu-NOTA-mCD93) and Insulin-Like Growth Factor Binding Protein 7 ([(64)Cu]Cu-NOTA-IGFBP7), Mol Pharm - 10.1021/acs.molpharmaceut.4c00983
Zhang Y, Hu P, Li L, Cao R, Khadria A, Maslov K, Tong X, Zeng Y, Jiang L, Zhou Q, Wang LV., Ultrafast longitudinal imaging of haemodynamics via single-shot volumetric photoacoustic tomography with a single-element detector, Nat Biomed Eng - 10.1038/s41551-023-01149-4
Malih S, Lin W, Tang Z, DeLuca MC, Engle JW, Alirezapour B, Cai W, Rasaee MJ., Noninvasive PET imaging of tumor PD-L1 expression with (64)Cu-labeled Durvalumab, Am J Nucl Med Mol Imaging - 10.62347/HUQD8000
Singhania M, Zaher A, Pulliam CF, Bayanbold K, Searby CC, Schoenfeld JD, Mapuskar KA, Fath MA, Allen BG, Spitz DR, Petronek MS., Quantitative MRI Evaluation of Ferritin Overexpression in Non-Small-Cell Lung Cancer, Int J Mol Sci - 10.3390/ijms25042398
Immunology
Sanz-Ortega, Laura; Rojas, José M; Marcos, Ana; Portilla, Yadileiny; Stein, Jens V; Barber, Domingo F;, T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field., Journal of nanobiotechnology Vol.17, 2019
Rhoden, J. J., Dyas, G. L., & Wroblewski, V. J. (2016)., A modeling and experimental investigation of the effects of antigen density, binding affinity, and antigen expression ratio on bispecific antibody binding to cell surface targets, The Journal of Biological Chemistry, 291(21), 11337-11347. doi:10.1074/jbc.M116.714287 [doi]
O'Leary, M. P., Warner, S. G., Kim, S. I., Chaurasiya, S., Lu, J., Choi, A. H., . . . Chen, N. G. (2018)., A novel oncolytic chimeric orthopoxvirus encoding luciferase enables real-time view of colorectal cancer cell infection., Molecular Therapy Oncolytics, 9, 13-21. doi:10.1016/j.omto.2018.03.001 [doi]
Di Pompo G, Errani C, Gillies R, Mercatali L, Ibrahim T, Tamanti J, Baldini N, Avnet S., Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis, Front Cell Dev Biol. 2021 May 28;9:678532. doi: 10.3389/fcell.2021.678532. eCollection 2021.
Rios-Doria, J., Harper, J., Rothstein, R., Wetzel, L., Chesebrough, J., Marrero, A., . . . Hollingsworth, R. (2017)., Antibody-drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads are immunomodulatory and synergize with multiple immunotherapies., Cancer Research, 77(10), 2686-2698. doi:10.1158/0008-5472.CAN-16-2854 [doi]
Zhang S, Zhao L, Guo M, Liu P, Li S, Xie W, Tian AL, Pol JG, Chen H, Pan H, Mao M, Li Y, Zitvogel L, Jin Y, Kepp O, Kroemer G., Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses., J Immunother Cancer. 2023 Jul;11(7). pii: e006785. doi: 10.1136/jitc-2023-006785.
Fusciello, Manlio; Fontana, Flavia; Tähtinen, Siri; Capasso, Cristian; Feola, Sara; Martins, Beatriz; Chiaro, Jacopo; Peltonen, Karita; YlÜsmäki, Leena; YlÜsmäki, Erkko; Hamdan, Firas; Kari, Otto K; Ndika, Joseph; Alenius, Harri; Urtti, Arto; Hirvonen, Jouni T; Santos, HÊlder A; Cerullo, Vincenzo;, Artificially cloaked viral nanovaccine for cancer immunotherapy., Nature communications Vol.10, 2019
Rogovskyy, A. S., & Bankhead, T. (2014)., Bacterial heterogeneity is a requirement for host superinfection by the lyme disease spirochete., Infection and Immunity, 82(11), 4542-4552. doi:10.1128/IAI.01817-14 [doi]
Crum RJ, Capella-MonsonÃs H, Chang J, Dewey MJ, Kolich BD, Hall KT, El-Mossier SO, Nascari DG, Hussey GS, Badylak SF., Biocompatibility and biodistribution of matrix-bound nanovesicles in vitro and in vivo., Acta Biomater. 2023 Jan 1;155:113-122. doi: 10.1016/j.actbio.2022.11.026. Epub 2022 Nov 22.
Puigdelloses M, Garcia-Moure M, Labiano S, Laspidea V, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, De la Nava D, Ausejo I, Hervás-Stubbs S, Herrador G, Chen Z, Hambardzumyan D, Patino Garcia A, Jiang H, Gomez-Manzano C, Fueyo J, Gállego Pérez-Larraya J, Alonso M., CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models, J Immunother Cancer. 2021 Jul;9(7):e002644. doi: 10.1136/jitc-2021-002644.
Wedekind MF, Miller KE, Chen CY, Wang PY, Hutzen BJ, Currier MA, Nartker B, Roberts RD, Boon L, Conner J, LaHaye S, Kelly BJ, Gordon D, White P, Mardis ER, Cripe TP., Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma, iScience. 2021 Jun 19;24(7):102759. doi: 10.1016/j.isci.2021.102759. eCollection 2021 Jul 23.
Verma B, Wesa A., Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents, Curr Protoc Pharmacol. 2020 Jun;89(1):e77. doi: 10.1002/cpph.77.
Alvero AB, Fox A, Madina BR, Krady MM, Gogoi R, Chehade H, Nakaar V, Almassian B, Yarovinsky TO, Rutherford T, Mor G., Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory., Cancer Immunol Res. 2023 Dec 11. doi: 10.1158/2326-6066.CIR-23-0127. [Epub ahead of print]
Ahmed MSU, Lord BD, Adu Addai B, Singhal SK, Gardner K, Salam AB, Ghebremedhin A, White J, Mahmud I, Martini R, Bedi D, Lin H, Jones JD, Karanam B, Dean-Colomb W, Grizzle W, Wang H, Davis M, Yates CC., Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling., Cancers (Basel). 2023 Apr 13;15(8). pii: 2282. doi: 10.3390/cancers15082282.
Li M, Wei W, Barnhart TE, Jiang D, Cao T, Fan K, Engle JW, Liu J, Chen W, Cai W., ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma, Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2737-2748. doi: 10.1007/s00259-021-05216-3. Epub 2021 Feb 3.
Landau S, Newman A, Edri S, Michael I, Ben-Shaul S, Shandalov Y, Ben-Arye T, Kaur P, Zheng MH, Levenberg S., Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networks, Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):e2101931118. doi: 10.1073/pnas.2101931118.
James, T. C., & Bond, U. (2012)., Molecular mimics of the tumour antigen MUC1., PloS One, 7(11), e49728. doi:10.1371/journal.pone.0049728 [doi]
Nair, Vidhya R; Malladi, Srinivas;, Mouse Models to Study Natural Killer Cell-Mediated Immunosurveillance and Metastatic Latency., Methods in molecular biology (Clifton, N.J.) Vol.1884, 2019
Hedberg J, Studebaker A, Smith L, Chen CY, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE., Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution., Mol Ther Oncolytics. 2023 Jul 19;30:39-55. doi: 10.1016/j.omto.2023.07.006. eCollection 2023 Sep 21.
Jacobson, O., Li, Q., Chen, H., Niu, G., Kiesewetter, D. O., Xu, L., . . . Chen, X. (2017)., PET-guided evaluation and optimization of internalized antibody-drug conjugates targeting erythropoietin-producing hepatoma A2 receptor., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 58(11), 1838-1844. doi:10.2967/jnumed.117.192245 [doi]
Rega, A., Terlizzi, M., Luciano, A., Forte, G., Crother, T. R., Arra, C., . . . Sorrentino, R. (2013)., Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing mice., Journal of Immunology (Baltimore, Md.: 1950), 190(5), 2391-2402. doi:10.4049/jimmunol.1202086 [doi]
Hsiao, H. C., Fan, X., Jordan, R. E., Zhang, N., & An, Z. (2018)., Proteolytic single hinge cleavage of pertuzumab impairs its fc effector function and antitumor activity in vitro and in vivo, Breast Cancer Research : BCR, 20(1), 43-018-0972-4. doi:10.1186/s13058-018-0972-4 [doi]
Hutzen, B., Chen, C. Y., Wang, P. Y., Sprague, L., Swain, H. M., Love, J., . . . Cripe, T. P. (2017)., TGF-beta inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma, Molecular Therapy Oncolytics, 7, 17-26. doi:10.1016/j.omto.2017.09.001 [doi]
Gruffaz, M., Vasan, K., Tan, B., Ramos da Silva, S., & Gao, S. J. (2017)., TLR4-mediated inflammation promotes KSHV-induced cellular transformation and tumorigenesis by activating the STAT3 pathway., Cancer Research, 77(24), 7094-7108. doi:10.1158/0008-5472.CAN-17-2321 [doi]
Maitra, R., Augustine, T., Dayan, Y., Chandy, C., Coffey, M., & Goel, S. (2017)., Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer, Oncotarget, 8(21), 35138-35153. doi:10.18632/oncotarget.16812 [doi]
Rogovskyy, A. S., & Bankhead, T. (2013)., Variable VlsE is critical for host reinfection by the lyme disease spirochete, PloS One, 8(4), e61226. doi:10.1371/journal.pone.0061226 [doi]
Valvo VM, Zhang Q, Jiang L, Holcomb EA, Pearson AN, Edmunds AG, Faulkner HG, James JG, Tate A, Huber AK, Wang Z, Guo Y, Karnak D, Parsels LA, Parsels JD, Lei YL, Rehemtulla A, Lin H, Carpenter ES, Wahl DR, Sahai V, Lawrence TS, Green MD, Morgan MA., Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer, Mol Cancer Ther - 10.1158/1535-7163.MCT-24-0210
Brendle SA, Li J, Sun D, Zhu J, Henderson-Redmond AN, Morgan DJ, Balogh KK, Covington D, Shearer DA, Hu J., Intraperitoneal delivery of cannabidiol (CBD) and Δ(9)-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice, Tumour Virus Res - 10.1016/j.tvr.2024.200307
Hjálmsdóttir Á, Hasler F, Waeckerle-Men Y, Duda A, López-Deber MP, Pihlgren M, Vukicevic M, Kündig TM, Johansen P., T cell independent antibody responses with class switch and memory using peptides anchored on liposomes, NPJ Vaccines - 10.1038/s41541-024-00902-3
King RE, Rademacher J, Ward-Shaw ET, Hu R, Bilger A, Blaine-Sauer S, Spurgeon ME, Thibeault SL, Lambert PF., The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice, Laryngoscope - 10.1002/lary.31228
Oncology
Siddique AB, Kilgore PCSR, Tajmim A, Singh SS, Meyer SA, Jois SD, Cvek U, Trutschl M, Sayed KAE., (-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer, Nutrients. 2020 Jun 11;12(6):1749. doi: 10.3390/nu12061749.
Jiménez-Mora E, Gallego B, Díaz-Gago S, Lasa M, Baquero P, Chiloeches A., (V600E)BRAF Inhibition Induces Cytoprotective Autophagy through AMPK in Thyroid Cancer Cells, Int J Mol Sci. 2021 Jun 3;22(11):6033. doi: 10.3390/ijms22116033.
Masoodi, K. Z., Ramos Garcia, R., Pascal, L. E., Wang, Y., Ma, H. M., O'Malley, K., . . . Wang, Z. (2013)., 5alpha-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models., Endocrinology, 154(7), 2296-2307. doi:10.1210/en.2012-2077 [doi]
Yang, Hailing; Shu, Zhang; Jiang, Yongying; Mao, Weiqun; Pang, Lan; Redwood, Abena; Jeter-Jones, Sabrina L; Jennings, Nicholas B; Ornelas, Argentina; Zhou, Jinhua; Rodriguez-Aguayo, Cristian; Bartholomeusz, Geoffrey; Iles, LaKesla R; Zacharias, Niki M; Millward, Steven W; Lopez-Berestein, Gabriel; Le, Xiao-Feng; Ahmed, Ahmed A; Piwnica-Worms, Helen; Sood, Anil K; Bast, Robert C; Lu, Zhen, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers, Clinical cancer research : an official journal of the American Association for Cancer Research Vol.25, 2019
Marayati R, Bownes LV, Stafman LL, Williams AP, Quinn CH, Atigadda V, Aye JM, Stewart JE, Yoon KJ, Beierle EA., 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts, Transl Oncol. 2021 Jan;14(1):100893. doi: 10.1016/j.tranon.2020.100893. Epub 2020 Sep 30.
Deng, Y., Wang, Z., Zhang, F., Qiao, M., Yan, Z., Wei, Q., . . . Zhang, J. (2016), A blockade of IGF signaling sensitizes human ovarian cancer cells to the anthelmintic niclosamide-induced anti-proliferative and anticancer activities, Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 39(3), 871-888. doi:10.1159/000447797 [doi]
Kuznik NC, Solozobova V, Lee II, Jung N, Yang L, Nienhaus K, Ntim EA, Rottenberg JT, Muhle-Goll C, Kumar AR, Peravali R, Gräßle S, Gourain V, Deville C, Cato L, Neeb A, Dilger M, Cramer von Clausbruch CA, Weiss C, Kieffer B, Nienhaus GU, Brown M, Bräse S, Cato ACB., A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway, iScience. 2022 Mar 31;25(5):104175. doi: 10.1016/j.isci.2022.104175. eCollection 2022 May 20.
Zhao Y, Wang C, Goel A., A combined treatment with melatonin and andrographis promotes autophagy and anticancer activity in colorectal cancer, Carcinogenesis. 2022 Apr 25;43(3):217-230. doi: 10.1093/carcin/bgac008.
Luderer, M. J., Muz, B., de la Puente, P., Chavalmane, S., Kapoor, V., Marcelo, R., . . . Azab, A. K. (2016), A hypoxia-targeted boron neutron capture therapy agent for the treatment of glioma., Pharmaceutical Research, 33(10), 2530-2539. doi:10.1007/s11095-016-1977-2 [doi]
Tian Q, Zhang P, Wang Y, Si Y, Yin D, Weber CR, Fishel ML, Pollok KE, Qiu B, Xiao F, Chong AS., A novel triptolide analog downregulates NF-kB and induces mitochondrial apoptosis pathways in human pancreatic cancer., Elife. 2023 Oct 25;12. pii: e85862. doi: 10.7554/eLife.85862. [Epub ahead of print]
Shivange G, Mondal T, Lyerly E, Bhatnagar S, Landen CN, Reddy S, Kim J, Doan B, Riddle P, Tushir-Singh J., A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors, Cell Rep. 2021 Nov 2;37(5):109953. doi: 10.1016/j.celrep.2021.109953.
Hight, M. R., Cheung, Y. Y., Nickels, M. L., Dawson, E. S., Zhao, P., Saleh, S., . . . Manning, H. C. (2014)., A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 20(8), 2126-2135. doi:10.1158/1078-0432.CCR-13-2444 [doi]
Dey, J., Kerwin, W. S., Grenley, M. O., Casalini, J. R., Tretyak, I., Ditzler, S. H., . . . Klinghoffer, R. A. (2016), A platform for rapid, quantitative assessment of multiple drug combinations simultaneously in solid tumors in vivo., PloS One, 11(6), e0158617. doi:10.1371/journal.pone.0158617 [doi]
Green, D. J., Orgun, N. N., Jones, J. C., Hylarides, M. D., Pagel, J. M., Hamlin, D. K., . . . Press, O. W. (2014), A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies., Cancer Research, 74(4), 1179-1189. doi:10.1158/0008-5472.CAN-13-1589 [doi]
Yang, Lu; Li, Yun; Bhattacharya, Arup; Zhang, Yuesheng;, A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer., Science translational medicine Vol.11, 2019
Neiveyans, Madeline; Melhem, Rana; Arnoult, Christophe; Bourquard, Thomas; Jarlier, Marta; Busson, Muriel; Laroche, Adrien; Cerutti, Martine; Pugnière, Martine; Ternant, David; Gaborit, Nadège; Chardès, Thierry; Poupon, Anne; Gouilleux-Gruart, ValÊrie; Pèlegrin, Andre; Poul, Marie-Alix;, A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions, mAbs Vol.11, 2019
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Burnes Vargas D, Malik AA, Guo HF, Zanzonico PB, Monette S, Michel AO, Rudin CM, Larson SM, Cheung NK., A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy, Clin Cancer Res. 2021 Jan 15;27(2):532-541. doi: 10.1158/1078-0432.CCR-20-2150. Epub 2020 Sep 21.
Pattarawat P, Hunt JT, Poloway J, Archibald CJ, Wang HR., A triple combination gemcitabine?+?romidepsin?+?cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis, Cancer Chemother Pharmacol. 2021 Sep;88(3):415-425. doi: 10.1007/s00280-021-04298-y. Epub 2021 May 27.
Roy, L. D., Dillon, L. M., Zhou, R., Moore, L. J., Livasy, C., El-Khoury, J. M., . . . Mukherjee, P. (2017)., A tumor specific antibody to aid breast cancer screening in women with dense breast tissue., Genes & Cancer, 8(3-4), 536-549. doi:10.18632/genesandcancer.134 [doi]
Kim, S. S., Rait, A., Kim, E., Pirollo, K. F., & Chang, E. H. (2015)., A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme., Nanomedicine : Nanotechnology, Biology, and Medicine, 11(2), 301-311. doi:10.1016/j.nano.2014.09.005 [doi]
Formisano, Luigi; Lu, Yao; Servetto, Alberto; Hanker, Ariella B; Jansen, Valerie M; Bauer, Joshua A; Sudhan, Dhivya R; Guerrero-Zotano, Angel L; Croessmann, Sarah; Guo, Yan; Ericsson, Paula Gonzalez; Lee, Kyung-Min; Nixon, Mellissa J; Schwarz, Luis J; Sanders, Melinda E; Dugger, Teresa C; Cruz, Marcelo Rocha; Behdad, Amir; Cristofanilli, Massimo; Bardia, Aditya; OShaughnessy, Joyce; Nagy, Rebecca J; Lanman, Richard B; Solovieff, Nadia; He, Wei; Miller, Michelle; Su, Fei; Shyr, Yu; Mayer, Ingrid A; Balko, Justin M; Arteaga, Carlos L;, Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer., Nature communications Vol.10, 2019
Li M, Li J, Guo X, Pan H, Zhou Q., Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress, Cancers (Basel). 2020 Jun 11;12(6):1538. doi: 10.3390/cancers12061538.
Tansi, F. L., Ruger, R., Bohm, C., Steiniger, F., Kontermann, R. E., Teichgraeber, U. K., . . . Hilger, I. (2017)., Activatable bispecific liposomes bearing fibroblast activation protein directed single chain fragment/Trastuzumab deliver encapsulated cargo into the nuclei of tumor cells and the tumor microenvironment simultaneously., Acta Biomaterialia, 54, 281-293. doi:S1742-7061(17)30203-9 [pii]
Young, N. R., Soneru, C., Liu, J., Grushko, T. A., Hardeman, A., Olopade, O. I., . . . Cohen, E. E. (2015)., Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo., Targeted Oncology, 10(4), 501-508. doi:10.1007/s11523-014-0353-6 [doi]
Ziegler, J., Bastian, A., Lerner, M., Bailey-Downs, L., Saunders, D., Smith, N., . . . Towner, R. A. (2017)., AG488 as a therapy against gliomas., Oncotarget, 8(42), 71833-71844. doi:10.18632/oncotarget.18284 [doi]
Gomes AP, Ilter D, Low V, Endress JE, Fernández-García J, Rosenzweig A, Schild T, Broekaert D, Ahmed A, Planque M, Elia I, Han J, Kinzig C, Mullarky E, Mutvei AP, Asara J, de Cabo R, Cantley LC, Dephoure N, Fendt SM, Blenis J., Age-induced accumulation of methylmalonic acid promotes tumour progression, Nature. 2020 Sep;585(7824):283-287. doi: 10.1038/s41586-020-2630-0. Epub 2020 Aug 19.
Dunn S, Eberlein C, Yu J, Gris-Oliver A, Ong SH, Yelland U, Cureton N, Staniszewska A, McEwen R, Fox M, Pilling J, Hopcroft P, Coker EA, Jaaks P, Garnett MJ, Isherwood B, Serra V, Davies BR, Barry ST, Lynch JT, Yusa K., AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors, Oncogene. 2022 Nov;41(46):5046-5060. doi: 10.1038/s41388-022-02482-9. Epub 2022 Oct 14.
Sun Y, Meyers BA, Czako B, Leonard P, Mseeh F, Harris AL, Wu Q, Johnson S, Parker CA, Cross JB, Di Francesco ME, Bivona BJ, Bristow CA, Burke JP, Carrillo CC, Carroll CL, Chang Q, Feng N, Gao G, Gera S, Giuliani V, Huang JK, Jiang Y, Kang Z, Kovacs JJ, Liu CY, Lopez AM, Ma X, Mandal PK, McAfoos T, Miller MA, Mullinax RA, Peoples M, Ramamoorthy V, Seth S, Spencer ND, Suzuki E, Williams CC, Yu SS, Zuniga AM, Draetta GF, Marszalek JR, Heffernan TP, Kohl NE, Jones P., Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib, Cancer Res. 2020 Nov 1;80(21):4840-4853. doi: 10.1158/0008-5472.CAN-20-1634. Epub 2020 Sep 14.
Zhang, R., Pan, D., Cai, X., Yang, X., Senpan, A., Allen, J. S., . . . Wang, L. V. (2015), alphaVbeta3-targeted copper nanoparticles incorporating an sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment., Theranostics, 5(2), 124-133. doi:10.7150/thno.10014 [doi]
Bush, T. L., Payton, M., Heller, S., Chung, G., Hanestad, K., Rottman, J. B., . . . Radinsky, R. (2013), AMG 900, a small-molecule inhibitor of aurora kinases, potentiates the activity of microtubule-targeting agents in human metastatic breast cancer models, Molecular Cancer Therapeutics, 12(11), 2356-2366. doi:10.1158/1535-7163.MCT-12-1178 [doi]
Asundi, J., Crocker, L., Tremayne, J., Chang, P., Sakanaka, C., Tanguay, J., . . . Firestein, R. (2015), An antibody-drug conjugate directed against lymphocyte antigen 6 complex, locus E (LY6E) provides robust tumor killing in a wide range of solid tumor malignancies., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(14), 3252-3262. doi:10.1158/1078-0432.CCR-15-0156 [doi]
Citron, F., Armenia, J., Franchin, G., Polesel, J., Talamini, R., D'Andrea, S., . . . Baldassarre, G. (2017), An integrated approach identifies mediators of local recurrence in head and neck squamous carcinoma, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(14), 3769-3780. doi:10.1158/1078-0432.CCR-16-2814 [doi]
Zhang, F., Li, Y., Zhang, H., Huang, E., Gao, L., Luo, W., . . . Ji, P. (2017)., Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)., Oncotarget, 8(8), 12968-12982. doi:10.18632/oncotarget.14673 [doi]
Miles, L. A., Burga, L. N., Gardner, E. E., Bostina, M., Poirier, J. T., & Rudin, C. M. (2017)., Anthrax toxin receptor 1 is the cellular receptor for seneca valley virus., The Journal of Clinical Investigation, 127(8), 2957-2967. doi:10.1172/JCI93472 [doi]
Moody, G., Belmontes, B., Masterman, S., Wang, W., King, C., Murawsky, C., . . . Beltran, P. J. (2016)., Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo, International Journal of Cancer, 139(6), 1340-1349. doi:10.1002/ijc.30180 [doi]
Tabernero, J., Chawla, S. P., Kindler, H., Reckamp, K., Chiorean, E. G., Azad, N. S., . . . Baselga, J. (2015)., Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab., argeted Oncology, 10(1), 65-76. doi:10.1007/s11523-014-0315-z [doi]
Zhang S, Zhao L, Guo M, Liu P, Li S, Xie W, Tian AL, Pol JG, Chen H, Pan H, Mao M, Li Y, Zitvogel L, Jin Y, Kepp O, Kroemer G., Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses., J Immunother Cancer. 2023 Jul;11(7). pii: e006785. doi: 10.1136/jitc-2023-006785.
Li, X., Wu, J. B., Chung, L. W., & Huang, W. C. (2015)., Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations., Oncotarget, 6(38), 41018-41032. doi:10.18632/oncotarget.5879 [doi]
Yan, H., Kapoor, V., Nguyen, K., Akers, W. J., Li, H., Scott, J., . . . Hallahan, D. (2016)., Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers., Oncotarget, 7(28), 43352-43362. doi:10.18632/oncotarget.9713 [doi]
Juzeniene, A., Bernoulli, J., Suominen, M., Halleen, J., & Larsen, R. H. (2018)., Antitumor activity of novel bone-seeking, alpha-emitting (224)ra-solution in a breast cancer skeletal metastases model, Anticancer Research, 38(4), 1947-1955. doi:38/4/1947 [pii]
Brignole C, Calarco E, Bensa V, Giusto E, Perri P, Ciampi E, Corrias MV, Astigiano S, Cilli M, Loo D, Bonvini E, Pastorino F, Ponzoni M., Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma., J Immunother Cancer. 2023 Sep;11(9). pii: e007174. doi: 10.1136/jitc-2023-007174.
Ben-Eltriki M, Deb S, Shankar G, Meckling G, Hassona M, Yamazaki T, Fazli L, Chin MY, Tomlinson Guns ES., Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer, Medicines (Basel). 2021 Jun 4;8(6):28. doi: 10.3390/medicines8060028.
Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, Laguer J, Medwid J, Vanderpool D, Lifset E, Trinh D, Hoffman N, Wang X, David Lawson J, Gunn RJ, Smith CR, Thomas NC, Martinson M, Bergstrom A, Sullivan F, Bouhana K, Winski S, He L, Fernandez-Banet J, Pavlicek A, Haling JR, Rahbaek L, Marx MA, Olson P, Christensen JG., Anti-tumor efficacy of a potent and selective non-covalent KRAS(G12D) inhibitor, Nat Med. 2022 Oct;28(10):2171-2182. doi: 10.1038/s41591-022-02007-7. Epub 2022 Oct 10.
Su W, Mukherjee R, Yaeger R, Son J, Xu J, Na N, Merna Timaul N, Hechtman J, Paroder V, Lin M, Mattar M, Qiu J, Chang Q, Zhao H, Zhang J, Little M, Adachi Y, Han SW, Taylor BS, Ebi H, Abdel-Wahab O, de Stanchina E, Rudin CM, Jänne PA, McCormick F, Yao Z, Rosen N., ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1, Mol Cell. 2022 Jul 7;82(13):2443-2457.e7. doi: 10.1016/j.molcel.2022.04.034. Epub 2022 May 24.
Smith RA, Zammit DJ, Damle NK, Usansky H, Reddy SP, Lin JH, Mistry M, Rao NS, Denis LJ, Gupta S., ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models, Mol Cancer Ther. 2021 Aug;20(8):1327-1337. doi: 10.1158/1535-7163.MCT-20-0565. Epub 2021 May 27.
Zumwalt, T. J., Wodarz, D., Komarova, N. L., Toden, S., Turner, J., Cardenas, J., . . . Goel, A. (2017)., Aspirin-induced chemoprevention and response kinetics are enhanced by PIK3CA mutations in colorectal cancer cells., Cancer Prevention Research (Philadelphia, Pa.), 10(3), 208-218. doi:10.1158/1940-6207.CAPR-16-0175 [doi]
Green, D. J., Shadman, M., Jones, J. C., Frayo, S. L., Kenoyer, A. L., Hylarides, M. D., . . . Press, O. W. (2015)., Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model, Blood, 125(13), 2111-2119. doi:10.1182/blood-2014-11-612770 [doi]
Davis SL, Hartman SJ, Bagby SM, Schlaepfer M, Yacob BW, Tse T, Simmons DM, Diamond JR, Lieu CH, Leal AD, Cadogan EB, Hughes GD, Durant ST, Messersmith WA, Pitts TM., ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer, BMC Cancer. 2022 Oct 29;22(1):1107. doi: 10.1186/s12885-022-10084-7.
Di Francesco M, Pastorino F, Ferreira M, Fragassi A, Di Francesco V, Palange AL, Celia C, Di Marzio L, Cilli M, Bensa V, Ponzoni M, Decuzzi P., Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma, Pharmacol Res. 2022 Dec 28;188:106639. doi: 10.1016/j.phrs.2022.106639. Online ahead of print.
Di Francesco M, Pastorino F, Ferreira M, Fragassi A, Di Francesco V, Palange AL, Celia C, Di Marzio L, Cilli M, Bensa V, Ponzoni M, Decuzzi P., Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma., Pharmacol Res. 2023 Feb;188:106639. doi: 10.1016/j.phrs.2022.106639. Epub 2022 Dec 28.
Johnson SS, Liu D, Ewald JT, Robles-Planells C, Bayanbold K, Wels BR, Solst SR, O'Dorisio MS, Allen BG, Menda Y, Spitz DR, Fath MA., Auranofin Inhibition of Thioredoxin Reductase in a Preclinical Model of Small Cell Lung Cancer., bioRxiv. 2023 May 9. pii: 2023.05.07.539772. doi: 10.1101/2023.05.07.539772.
Yeo, S. K., Wen, J., Chen, S., & Guan, J. L. (2016)., Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR/Stat3 and Tgfbeta/Smad signaling, Cancer Research, 76(11), 3397-3410. doi:10.1158/0008-5472.CAN-15-2946 [doi]
Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G., Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy, J Immunother Cancer. 2020 Mar;8(1):e000462. doi: 10.1136/jitc-2019-000462.
Loddick, S. A., Ross, S. J., Thomason, A. G., Robinson, D. M., Walker, G. E., Dunkley, T. P., . . . Brooks, A. N. (2013)., AZD3514: A small molecule that modulates androgen receptor signaling and function in vitro and in vivo., Molecular Cancer Therapeutics, 12(9), 1715-1727. doi:10.1158/1535-7163.MCT-12-1174 [doi]
Fok, Jacqueline H L; Ramos-Montoya, Antonio; Vazquez-Chantada, Mercedes; Wijnhoven, Paul W G; Follia, Valeria; James, Neil; Farrington, Paul M; Karmokar, Ankur; Willis, Sophie E; Cairns, Jonathan; Nikkilä, Jenni; Beattie, David; Lamont, Gillian M; Finlay, M Raymond V; Wilson, Joanne; Smith, Aaron; OConnor, Lenka Oplustil; Ling, Stephanie; Fawell, Stephen E; OConnor, Mark J; Hollingsworth, Simon J; Dean, Emma; Goldberg, Frederick W; Davies, Barry R; Cadogan, Elaine B;, AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity., Nature communications Vol.10, 2019
Rello-Varona, Santi; Fuentes-Guirado, Miriam; LĂłpez-Alemany, Roser; Contreras-PĂŠrez, Aida; Mulet-Margalef, NĂşria; GarcĂa-MonclĂşs, Silvia; Tirado, Oscar M; GarcĂa Del Muro, Xavier, Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas, Scientific reports Vol.9, 2019
San Millan, C., Soldevilla, B., Martin, P., Gil-Calderon, B., Compte, M., Perez-Sacristan, B., . . . Dominguez, G. (2015), Beta-cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through DeltaNP73 negative regulation in colon cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(19), 4398-4409. doi:10.1158/1078-0432.CCR-14-2027 [doi]
Jansen, M. H., Lagerweij, T., Sewing, A. C., Vugts, D. J., van Vuurden, D. G., Molthoff, C. F., . . . Hulleman, E. (2016)., Bevacizumab targeting diffuse intrinsic pontine glioma: Results of 89Zr-bevacizumab PET imaging in brain tumor models., Molecular Cancer Therapeutics, 15(9), 2166-2174. doi:10.1158/1535-7163.MCT-15-0558 [doi]
Singh AK, Dadey DY, Rau MJ, Fitzpatrick J, Shah HK, Saikia M, Townsend R, Thotala D, Hallahan DE, Kapoor V., Blocking the functional domain of TIP1 by antibodies sensitizes cancer to radiation therapy., Biomed Pharmacother. 2023 Oct;166:115341. doi: 10.1016/j.biopha.2023.115341. Epub 2023 Aug 23.
Zhang, Y., Chen, X., Qiao, M., Zhang, B. Q., Wang, N., Zhang, Z., . . . Zhang, H. (2014)., Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells., Oncology Reports, 32(3), 1013-1020. doi:10.3892/or.2014.3308 [doi]
Chiou AE, Liu C, Moreno-Jiménez I, Tang T, Wagermaier W, Dean MN, Fischbach C, Fratzl P., Breast cancer-secreted factors perturb murine bone growth in regions prone to metastasis, Sci Adv. 2021 Mar 17;7(12):eabf2283. doi: 10.1126/sciadv.abf2283. Print 2021 Mar.
Bai L, Li X, Yang Y, Zhao R, White EZ, Danaher A, Bowen NJ, Hinton CV, Cook N, Li D, Wu AY, Qui M, Du Y, Fu H, Kucuk O, Wu D., Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models., Transl Oncol. 2023 Aug;34:101707. doi: 10.1016/j.tranon.2023.101707. Epub 2023 Jun 2.
Patel N, Kommineni N, Surapaneni SK, Kalvala A, Yaun X, Gebeyehu A, Arthur P, Duke LC, York SB, Bagde A, Meckes DG Jr, Singh M., Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models, Int J Pharm. 2021 Sep 25;607:120943. doi: 10.1016/j.ijpharm.2021.120943. Epub 2021 Jul 27.
Bort, A., Spinola, E., Rodriguez-Henche, N., & Diaz-Laviada, I. (2017)., Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation, Oncotarget, 8(50), 87684-87698. doi:10.18632/oncotarget.21196 [doi]
Kim, H. S., Masko, E. M., Poulton, S. L., Kennedy, K. M., Pizzo, S. V., Dewhirst, M. W., & Freedland, S. J. (2012)., Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer., BJU International, 110(7), 1062-1069. doi:10.1111/j.1464-410X.2012.10971.x [doi]
Moon, Henry H; Clines, Katrina L; Cooks, Mark A; Cialek, Charlotte A; Esvelt, Marian A; Clines, Gregory A;, Castration Determines the Efficacy of ETAR Blockade in a Mouse Model of Prostate Cancer Bone, Endocrinology Vol.160, 2019
Li, H., Xie, N., Gleave, M. E., & Dong, X. (2015, Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression., Oncotarget, 6(24), 20474-20484. doi:4105 [pii]
Assimon, Victoria A; Tang, Yangzhong; Vargas, Jesse D; Lee, Grace J; Wu, Zhi Yong; Lou, Kenny; Yao, Bing; Menon, Mary-Kamala; Pios, Ariel; Perez, Kristy C; Madriaga, Antonett; Buchowiecki, Peter K; Rolfe, Mark; Shawver, Laura; Jiao, Xianyun; Le Moigne, Ronan; Zhou, Han-Jie; Anderson, Daniel J;, CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity. ACS chemical biology, ACS chemical biology Vol.14, 2019
Casagrande, Naike; Borghese, Cinzia; Visser, Lydia; Mongiat, Maurizio; Colombatti, Alfonso; Aldinucci, Donatella, CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth., Haematologica Vol.104, 2019
Domínguez JM, Pérez-Chacón G, Guillén MJ, Muñoz-Alonso MJ, Somovilla-Crespo B, Cibrián D, Acosta-Iborra B, Adrados M, Muñoz-Calleja C, Cuevas C, Sánchez-Madrid F, Avilés P, Zapata JM., CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110, J Hematol Oncol. 2020 Apr 7;13(1):32. doi: 10.1186/s13045-020-00865-7.
Puigdelloses M, Garcia-Moure M, Labiano S, Laspidea V, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, De la Nava D, Ausejo I, Hervás-Stubbs S, Herrador G, Chen Z, Hambardzumyan D, Patino Garcia A, Jiang H, Gomez-Manzano C, Fueyo J, Gállego Pérez-Larraya J, Alonso M., CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models, J Immunother Cancer. 2021 Jul;9(7):e002644. doi: 10.1136/jitc-2021-002644.
Hernandez, R., Sun, H., England, C. G., Valdovinos, H. F., Ehlerding, E. B., Barnhart, T. E., . . . Cai, W. (2016), CD146-targeted immunoPET and NIRF imaging of hepatocellular carcinoma with a dual-labeled monoclonal antibody., Theranostics, 6(11), 1918-1933. doi:10.7150/thno.15568 [doi]
McKnight BN, Kim S, Boerner JL, Viola NT., Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer, Breast Cancer Res. 2020 Apr 15;22(1):37. doi: 10.1186/s13058-020-01270-1.
Smith, M. C., Mader, M. M., Cook, J. A., Iversen, P., Ajamie, R., Perkins, E., . . . Wacheck, V. (2016)., Characterization of LY3023414, a novel PI3K/mTOR dual inhibitor eliciting transient target modulation to impede tumor growth., Molecular Cancer Therapeutics, 15(10), 2344-2356. doi:1535-7163.MCT-15-0996 [pii]
Fritsch C, Huang A, Chatenay-Rivauday C, Schnell C, Reddy A, Liu M, Kauffmann A, Guthy D, Erdmann D, De Pover A, Furet P, Gao H, Ferretti S, Wang Y, Trappe J, Brachmann SM, Maira SM, Wilson C, Boehm M, Garcia-Echeverria C, Chene P, Wiesmann M, Cozens R, Lehar J, Schlegel R, Caravatti G, Hofmann F, Sellers WR., Characterization of the novel and specific PI3K? inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials, Mol Cancer Ther. 2014 May;13(5):1117-29. doi: 10.1158/1535-7163.MCT-13-0865. Epub 2014 Mar 7.
Bolaender A, Zatorska D, He H, Joshi S, Sharma S, Digwal CS, Patel HJ, Sun W, Imber BS, Ochiana SO, Patel MR, Shrestha L, Shah SK, Wang S, Karimov R, Tao H, Patel PD, Martin AR, Yan P, Panchal P, Almodovar J, Corben A, Rimner A, Ginsberg SD, Lyashchenko S, Burnazi E, Ku A, Kalidindi T, Lee SG, Grkovski M, Beattie BJ, Zanzonico P, Lewis JS, Larson S, Rodina A, Pillarsetty N, Tabar V, Dunphy MP, Taldone T, Shimizu F, Chiosis G., Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system, Nat Commun. 2021 Aug 3;12(1):4669. doi: 10.1038/s41467-021-24821-2.
Weitzenfeld, P., Kossover, O., Korner, C., Meshel, T., Wiemann, S., Seliktar, D., . . . Ben-Baruch, A. (2016)., Chemokine axes in breast cancer: Factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors., Journal of Leukocyte Biology, 99(6), 1009-1025. doi:10.1189/jlb.3MA0815-373R [doi]
Hain, Brian A; Xu, Haifang; Wilcox, Jenna R; Mutua, Daniel; Waning, David L;, Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia., JCSM rapid communications Vol.2,
Russo M, Panini N, Fabbrizio P, Formenti L, Becchetti R, Matteo C, Meroni M, Nastasi C, Cappelleri A, Frapolli R, Nardo G, Scanziani E, Ponzetta A, Bani MR, Ghilardi C, Giavazzi R., Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells., Oncoimmunology. 2023 Aug 1;12(1):2239035. doi: 10.1080/2162402X.2023.2239035. eCollection 2023.
Sen, T., Tong, P., Stewart, C. A., Cristea, S., Valliani, A., Shames, D. S., . . . Byers, L. A. (2017)., CHK1 inhibition in small-cell lung cancer produces single-agent activity in biomarker-defined disease subsets and combination activity with cisplatin or olaparib., Cancer Research, 77(14), 3870-3884. doi:10.1158/0008-5472.CAN-16-3409 [doi]
Li, J., Qu, X., Tian, J., Zhang, J. T., & Cheng, J. X. (2018)., Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation., PloS One, 13(2), e0193318. doi:10.1371/journal.pone.0193318 [doi]
Sobot, D., Mura, S., Rouquette, M., Vukosavljevic, B., Cayre, F., Buchy, E., . . . Couvreur, P. (2017)., Circulating lipoproteins: A trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells., Molecular Therapy : The Journal of the American Society of Gene Therapy, 25(7), 1596-1605. doi:S1525-0016(17)30234-4 [pii]
Yu, W., Chen, Y., Dubrulle, J., Stossi, F., Putluri, V., Sreekumar, A., . . . Sandulache, V. C. (2018)., Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism, Scientific Reports, 8(1), 4306-018-22640-y. doi:10.1038/s41598-018-22640-y [doi]
Tornan J, Mateu-Sanz M, Rey V, Murillo D, Huergo C, Gallego B, RodrÃguez A, RodrÃguez R, Canal C., Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma., Redox Biol. 2023 Jun;62:102685. doi: 10.1016/j.redox.2023.102685. Epub 2023 Mar 20.
Parsels LA, Engelke CG, Parsels J, Flanagan SA, Zhang Q, Tanska D, Wahl DR, Canman CE, Lawrence TS, Morgan MA., Combinatorial efficacy of olaparib with radiation and ATR inhibitor requires PARP1 protein in homologous recombination proficient pancreatic cancer, Mol Cancer Ther. 2020 Dec 2:molcanther.0365.2020. doi: 10.1158/1535-7163.MCT-20-0365. Online ahead of print.
Parsels LA, Engelke CG, Parsels J, Flanagan SA, Zhang Q, Tanska D, Wahl DR, Canman CE, Lawrence TS, Morgan MA., Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic Cancer, Mol Cancer Ther. 2021 Feb;20(2):263-273. doi: 10.1158/1535-7163.MCT-20-0365. Epub 2020 Dec 2.
Belli, Valentina; Matrone, Nunzia; Napolitano, Stefania; Migliardi, Giorgia; Cottino, Francesca; Bertotti, Andrea; Trusolino, Livio; Martinelli, Erika; Morgillo, Floriana; Ciardiello, Davide; De Falco, Vincenzo; Giunta, Emilio Francesco; Bracale, Umberto; Ciardiello, Fortunato; Troiani, Teresa;, Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models., Journal of experimental & clinical cancer research : CR Vol.38, 2019
Frost, S. H., Frayo, S. L., Miller, B. W., Orozco, J. J., Booth, G. C., Hylarides, M. D., . . . Press, O. W. (2015), Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models., PloS One, 10(3), e0120561. doi:10.1371/journal.pone.0120561 [doi]
Vugts, D. J., Klaver, C., Sewing, C., Poot, A. J., Adamzek, K., Huegli, S., . . . van Dongen, G. A. (2017)., Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)zr-immuno-PET., European Journal of Nuclear Medicine and Molecular Imaging, 44(2), 286-295. doi:10.1007/s00259-016-3499-x [doi]
Pattarawat P, Hong T, Wallace S, Hu Y, Donnell R, Wang TH, Tsai CL, Wang J, Wang HR., Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma, Br J Cancer. 2020 Jul;123(2):226-239. doi: 10.1038/s41416-020-0877-8. Epub 2020 May 11.
Kennedy AL, Rai R, Isingizwe ZR, Zhao YD, Lightfoot SA, Benbrook DM., Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib, Cancers (Basel). 2020 May 17;12(5):1269. doi: 10.3390/cancers12051269.
Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, Singh A, Hoque MO., Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy, Mol Cancer Ther. 2020 Oct;19(10):2175-2185. doi: 10.1158/1535-7163.MCT-20-0024. Epub 2020 Aug 26.
Restifo D, McDermott JR, Cvetkovic D, Dos Santos T, Ogier C, Surumbayeva A, Handorf EA, Schimke C, Ma C, Cai KQ, Olszanski AJ, Kathad U, Bhatia K, Sharma P, Kulkarni A, Astsaturov I., Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies., Mol Cancer Ther. 2023 Oct 2;22(10):1182-1190. doi: 10.1158/1535-7163.MCT-22-0818.
Patel SS, Hoogenboezem EN, Yu F, DeJulius CR, Fletcher RB, Sorets AG, Cherry FK, Lo JH, Bezold MG, Francini N, d'Arcy R, Brasuell JE, Cook RS, Duvall CL., Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing., Biomaterials. 2023 Jun;297:122098. doi: 10.1016/j.biomaterials.2023.122098. Epub 2023 Mar 28.
Liu, Peng; Zhao, Liwei; Pol, Jonathan; Levesque, Sarah; Petrazzuolo, Adriana; Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen; Yamazaki, Takahiro; Iribarren, Kristina; Senovilla, Laura; Bezu, Lucillia; Vacchelli, Erika; Sica, Valentina; Melis, AndrÊa; Martin, Tiffany; Xia, Lin; Yang, Heng; Li, Qingqing; Chen, Jinfeng; Durand, Sylvère; Aprahamian, Fanny; Lefevre, Deborah; Broutin, Sophie; Paci, Angelo; Bongers, Amaury; Minard-Colin, Veronique; Tartour, Eric; Zitvogel, Laurence; Apetoh, Lionel; Ma, Yuting; Pittet, Mikael J; Kepp, Oliver; Kroemer, Guido;, Crizotinib-induced immunogenic cell death in non-small cell lung cancer, Nature communications Vol.10, 2019
Grand-Guillaume J, Mansi R, Gaonkar RH, Zanger S, Fani M, Eugster PJ, Beck Popovic M, Grouzmann E, Abid K., CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake ((123/131)I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors., J Transl Med. 2023 Sep 7;21(1):604. doi: 10.1186/s12967-023-04466-z.
Yamaguchi, M., Zhu, S., Zhang, S., Wu, D., Moore, T. M., Snyder, J. P., & Shoji, M. (2014)., Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: Involvement in osteoblastogenesis and osteoclastogenesis, Cell and Tissue Research, 357(1), 245-252. doi:10.1007/s00441-014-1846-4 [doi]
Domanska, U. M., Boer, J. C., Timmer-Bosscha, H., van Vugt, M. A., Hoving, H. D., Kliphuis, N. M., . . . Walenkamp, A. M. (2014)., CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model, Clinical & Experimental Metastasis, 31(7), 829-839. doi:10.1007/s10585-014-9673-2 [doi]
Sharvit L, Bar-Shalom R, Azzam N, Yechiel Y, Wasser S, Fares F., Cyathus striatus Extract Induces Apoptosis in Human Pancreatic Cancer Cells and Inhibits Xenograft Tumor Growth In Vivo, Cancers (Basel). 2021 Apr 22;13(9):2017. doi: 10.3390/cancers13092017.
Garcia, M., Velez, R., Romagosa, C., Majem, B., Pedrola, N., Olivan, M., . . . Doll, A. (2014)., Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice, BJU International, 113(5b), E164-77. doi:10.1111/bju.12503 [doi]
Kapoor S, Gustafson T, Zhang M, Chen YS, Li J, Nguyen N, Perez JET, Dashwood WM, Rajendran P, Dashwood RH., Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells, Cancers (Basel). 2021 Mar 22;13(6):1438. doi: 10.3390/cancers13061438.
McCarthy GA, Di Niro R, Finan JM, Jain A, Guo Y, Wyatt CR, Guimaraes AR, Waugh TA, Keith D, Morgan TK, Sears RC, Brody JR., Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity., NAR Cancer. 2023 Apr 19;5(2):zcad016. doi: 10.1093/narcan/zcad016. eCollection 2023 Jun.
Bayanbold K, Singhania M, Fath MA, Searby CC, Stolwijk JM, Henrich JB, Pulliam CF, Schoenfeld JD, Mapuskar KA, Sho S, Caster JM, Allen BG, Buettner GR, Spies M, Goswami PC, Petronek MS, Spitz DR., Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer., Antioxidants (Basel). 2023 Nov 15;12(11). pii: 2005. doi: 10.3390/antiox12112005.
Kinneer K, Wortmann P, Cooper ZA, Dickinson NJ, Masterson L, Cailleau T, Hutchinson I, Vijayakrishnan B, McFarlane M, Ball K, Davies M, Lewis A, Huang Y, Rosenbaum AI, Yuan J, Chesebrough J, Anderton J, Monks N, Novick S, Wang J, Dimasi N, Christie RJ, et al., Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305., Clin Cancer Res. 2023 Mar 14;29(6):1086-1101. doi: 10.1158/1078-0432.CCR-22-2630.
Perez, O. D., Logg, C. R., Hiraoka, K., Diago, O., Burnett, R., Inagaki, A., . . . Jolly, D. J. (2012)., Design and selection of toca 511 for clinical use: Modified retroviral replicating vector with improved stability and gene expression, Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(9), 1689-1698. doi:10.1038/mt.2012.83 [doi]
Nordmaj MA, Roberts ME, Sachse ES, Dagil R, Andersen AP, Skeltved N, Grunddal KV, Erdoğan SM, Choudhary S, Gustsavsson T, Ørum-Madsen MS, Moskalev I, Tian W, Yang Z, Clausen TM, Theander TG, Daugaard M, Nielsen MA, Salanti A., Development of a bispecific immune engager using a recombinant malaria protein, Cell Death Dis. 2021 Apr 6;12(4):353. doi: 10.1038/s41419-021-03611-0.
Metwally K, Bastiancich C, Correard F, Novell A, Fernandez S, Guillet B, Larrat B, Mensah S, Estčve MA, Da Silva A., Development of a multi-functional preclinical device for the treatment of glioblastoma, Biomed Opt Express. 2021 Mar 23;12(4):2264-2279. doi: 10.1364/BOE.419412. eCollection 2021 Apr 1.
D'Hollander, A., Mathieu, E., Jans, H., Vande Velde, G., Stakenborg, T., Van Dorpe, P., . . . Lagae, L. (2016), Development of nanostars as a biocompatible tumor contrast agent: Toward in vivo SERS imaging., International Journal of Nanomedicine, 11, 3703-3714. doi:10.2147/IJN.S91340 [doi]
Navarro-Villaran, E., Tinoco, J., Jimenez, G., Pereira, S., Wang, J., Aliseda, S., . . . Muntane, J. (2016)., Differential antitumoral properties and renal-associated tissue damage induced by tacrolimus and mammalian target of rapamycin inhibitors in hepatocarcinoma: In vitro and in vivo studies, PloS One, 11(8), e0160979. doi:10.1371/journal.pone.0160979 [doi]
Zaher A, Mapuskar KA, Sarkaria JN, Spitz DR, Petronek MS, Allen BG., Differential H(2)O(2) Metabolism among Glioblastoma Subtypes Confers Variable Responses to Pharmacological Ascorbate Therapy Combined with Chemoradiation., Int J Mol Sci. 2023 Dec 5;24(24). pii: 17158. doi: 10.3390/ijms242417158.
Oksala, R., Moilanen, A., Riikonen, R., Rummakko, P., Karjalainen, A., Passiniemi, M., . . . Mustonen, M. V. (2018), Discovery and development of ODM-204: A novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1, The Journal of Steroid Biochemistry and Molecular Biology, doi:S0960-0760(18)30078-5 [pii]
Toader D, Fessler SP, Collins SD, Conlon PR, Bollu R, Catcott KC, Chin CN, Dirksen A, Du B, Duvall JR, Higgins S, Kozytska MV, Bellovoda K, Faircloth C, Lee D, Li F, Qin L, Routhier C, Shaw P, Stevenson CA, Wang J, Wongthida P, et al., Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer., Mol Cancer Ther. 2023 Sep 5;22(9):999-1012. doi: 10.1158/1535-7163.MCT-22-0786.
Hiriyan, J., Shivarudraiah, P., Gavara, G., Annamalai, P., Natesan, S., Sambasivam, G., & Sukumaran, S. K. (2015)., Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models. Anticancer, Anticancer Research, 35(1), 229-237. doi:35/1/229 [pii]
Donabedian, P. L., Kossatz, S., Engelbach, J. A., Jannetti, S. A., Carney, B., Young, R. J., . . . Reiner, T. (2018)., Discriminating radiation injury from recurrent tumor with [(18)F]PARPi and amino acid PET in mouse models., EJNMMI Research, 8(1), 59-018-0399-z. doi:10.1186/s13550-018-0399-z [doi]
Ridwan SM, El-Tayyeb F, Hainfeld JF, Smilowitz HM., Distributions of intravenous injected iodine nanoparticles in orthotopic u87 human glioma xenografts over time and tumor therapy, Nanomedicine (Lond). 2020 Oct;15(24):2369-2383. doi: 10.2217/nnm-2020-0178. Epub 2020 Sep 25.
Tuomela, J., Sandholm, J., Kaakinen, M., Patel, A., Kauppila, J. H., Ilvesaro, J., . . . Selander, K. S. (2013)., DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells., Breast Cancer Research and Treatment, 142(3), 477-487. doi:10.1007/s10549-013-2762-0 [doi]
Laakso H, Ylä-Herttuala E, Sierra A, Jambor I, Poutanen M, Liljenbäck H, Virtanen H, Merisaari H, Aronen H, Minn H, Roivainen A, Liimatainen T., Docetaxel chemotherapy response in PC3 prostate cancer mouse model detected by rotating frame relaxations and water diffusion, NMR Biomed. 2021 Apr;34(4):e4483. doi: 10.1002/nbm.4483. Epub 2021 Feb 4.
Youngblood MW, Tran AN, Wang W, An S, Scholtens D, Zhang L, O'Shea K, Pokorny JL, Magill ST, Sachdev S, Lukas RV, Ahmed A, Unruh D, Walshon J, McCortney K, Wang Y, Baran A, Sahm F, Aldape K, Chandler JP, David James C, Heimberger AB, et al., Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas., Neuro Oncol. 2023 Mar 14;25(3):508-519. doi: 10.1093/neuonc/noac206.
Zhang Y, Wang Y, Valdivia A, Huang H, Matei D., DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling., Mol Cancer Res. 2023 Feb 1;21(2):140-154. doi: 10.1158/1541-7786.MCR-22-0418.
Sciegienka, S. J., Solst, S. R., Falls, K. C., Schoenfeld, J. D., Klinger, A. R., Ross, N. L., . . . Fath, M. A. (2017)., D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress., Free Radical Biology & Medicine, 108, 354-361. doi:S0891-5849(17)30192-2 [pii]
Tsoneva, D., Stritzker, J., Bedenk, K., Zhang, Q., Frentzen, A., Cappello, J., . . . Szalay, A. A. (2015)., Drug-encoded biomarkers for monitoring biological therapies, PloS One, 10(9), e0137573. doi:10.1371/journal.pone.0137573 [doi]
Ohana, J., Sandler, U., Kass, G., Stemmer, S. M., & Devary, Y. (2017)., dTCApFs, a derivative of a novel human hormone peptide, induces apoptosis in cancer cells through a mechanism involving loss of golgi function., Molecular and Clinical Oncology, 7(6), 991-999. doi:10.3892/mco.2017.1453 [doi]
Kostecki KL, Iida M, Wiley AL, Kimani S, Mehall B, Tetreault K, Alexandridis R, Yu M, Hong S, Salgia R, Bruce JY, Birge RB, Harari PM, Wheeler DL., Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer., Head Neck. 2023 May;45(5):1255-1271. doi: 10.1002/hed.27340. Epub 2023 Mar 20.
Luo, H., England, C. G., Shi, S., Graves, S. A., Hernandez, R., Liu, B., . . . Cai, W. (2016)., Dual targeting of tissue factor and CD105 for preclinical PET imaging of pancreatic cancer., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(15), 3821-3830. doi:10.1158/1078-0432.CCR-15-2054 [doi]
Kleczko EK, Hinz TK, Nguyen TT, Gurule NJ, Navarro A, Le AT, Johnson AM, Kwak J, Polhac DI, Clambey ET, Weiser-Evans M, Merrick DT, Yang MC, Patil T, Schenk EL, Heasley LE, Nemenoff RA., Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity., NPJ Precis Oncol. 2023 Feb 4;7(1):15. doi: 10.1038/s41698-023-00355-2.
Tan, Q., Joshua, A. M., Saggar, J. K., Yu, M., Wang, M., Kanga, N., . . . Tannock, I. F. (2015), Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy., British Journal of Cancer, 112(5), 832-840. doi:10.1038/bjc.2015.17 [doi]
Ionkina, A. A., Tentler, J. J., Kim, J., Capasso, A., Pitts, T. M., Ryall, K. A., . . . Diamond, J. R. (2017)., Efficacy and molecular mechanisms of differentiated response to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical models of p53-mutated triple-negative breast cancer., Frontiers in Oncology, 7, 94. doi:10.3389/fonc.2017.00094 [doi]
Kong, Y., Barisone, G. A., Sidhu, R. S., O'Donnell, R. T., & Tuscano, J. M. (2015)., Efficacy of combined histone deacetylase and checkpoint kinase inhibition in a preclinical model of human burkitt lymphoma., Molecular Medicine (Cambridge, Mass.), 21(1), 824-832. doi:10.2119/molmed.2015.00032 [doi]
Akla, Barbara; Broussas, Matthieu; Loukili, Noureddine; Robert, Alain; Beau-Larvor, Charlotte; Malissard, Martine; Boute, Nicolas; Champion, Thierry; Haeuw, Jean-Francois; Beck, Alain; Perez, Michel; Dreyfus, Cyrille; Pavlyuk, Mariya; Chetaille, Eric; Corvaia, Nathalie;, Efficacy of the Antibody-Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors., Molecular cancer therapeutics Vol.19, 2020
Kang J, Chun J, Hwang JS, Pan C, Li J, Boese AC, Young I, Malin CM, Kang Y, Gibbons DL, Sica G, Fu H, Ramalingam SS, Jin L, Kang S., EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer, Cell Rep. 2022 Dec 13;41(11):111827. doi: 10.1016/j.celrep.2022.111827.
Zalles M, Smith N, Saunders D, Guzman M, Lerner M, Fung KM, Babu A, Battiste J, Chung J, Hwang K, Jin J, Towner RA., ELTD1 as a multi-focal target for malignant gliomas: preclinical studies, Neurooncol Adv. 2021 Sep 17;3(1):vdab132. doi: 10.1093/noajnl/vdab132. eCollection 2021 Jan-Dec.
Choi, A. H., O'Leary, M. P., Lu, J., Kim, S. I., Fong, Y., & Chen, N. G. (2018), Endogenous akt activity promotes virus entry and predicts efficacy of novel chimeric orthopoxvirus in triple-negative breast cancer., Molecular Therapy Oncolytics, 9, 22-29. doi:10.1016/j.omto.2018.04.001 [doi]
Nwagwu CD, Defensor E, Jiang MY, Rolle-McFarland DA, Carbonell AE, Carbonell WS., Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics, Lab Anim (NY). 2020 Aug;49(8):227-232. doi: 10.1038/s41684-020-0594-1. Epub 2020 Jul 20.
Sancho-Albero M, Facchetti G, Panini N, Meroni M, Bello E, Rimoldi I, Zucchetti M, Frapolli R, De Cola L., Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli-Responsive Nanocages., Adv Healthc Mater. 2023 Jul;12(17):e2202932. doi: 10.1002/adhm.202202932. Epub 2023 Mar 28.
Siddique HR, Liao DJ, Mishra SK, Schuster T, Wang L, Matter B, Campbell PM, Villalta P, Nanda S, Deng Y, Saleem M., Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model, Int J Cancer. 2012 Oct 1;131(7):1720-31. doi: 10.1002/ijc.27409. Epub 2012 Feb 18.
Toden, S., Tran, H. M., Tovar-Camargo, O. A., Okugawa, Y., & Goel, A. (2016), Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer., Oncotarget, 7(13), 16158-16171. doi:10.18632/oncotarget.7567 [doi]
Wang, X., Tan, Y., Cao, X., Kim, J. A., Chen, T., Hu, Y., . . . Wang, X. (2018)., Epigenetic activation of HORMAD1 in basal-like breast cancer: Role in rucaparib sensitivity., Oncotarget, 9(53), 30115-30127. doi:10.18632/oncotarget.25728 [doi]
Evans JS, Beaumont J, Braga M, Masrour N, Mauri F, Beckley A, Butt S, Karali CS, Cawthorne C, Archibald S, Aboagye EO, Sharma R., Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy, Eur J Cancer. 2022 Nov;176:110-120. doi: 10.1016/j.ejca.2022.09.009. Epub 2022 Oct 5.
Jauhiainen S, Ilmonen H, Vuola P, Rasinkangas H, Pulkkinen HH, Keränen S, Kiema M, Liikkanen JJ, Laham-Karam N, Laidinen S, Beter M, Aavik E, Lappalainen K, Lohi J, Aronniemi J, Örd T, Kaikkonen MU, Salminen P, Tukiainen E, Ylä-Herttuala S, Laakkonen JP., ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component., Elife. 2023 May 18;12. pii: e82543. doi: 10.7554/eLife.82543.
Li, D., & Marchenko, N. D. (2017), ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells, Oncotarget, 8(4), 5823-5833. doi:10.18632/oncotarget.12878 [doi]
Schmitt, D. C., Madeira da Silva, L., Zhang, W., Liu, Z., Arora, R., Lim, S., . . . Tan, M. (2015)., ErbB2-intronic microRNA-4728: A novel tumor suppressor and antagonist of oncogenic MAPK signaling., Cell Death & Disease, 6, e1742. doi:10.1038/cddis.2015.116 [doi]
Bhagwat SV, McMillen WT, Cai S, Zhao B, Whitesell M, Shen W, Kindler L, Flack RS, Wu W, Anderson B, Zhai Y, Yuan XJ, Pogue M, Van Horn RD, Rao X, McCann D, Dropsey AJ, Manro J, Walgren J, Yuen E, Rodriguez MJ, Plowman GD, Tiu RV, Joseph S, Peng SB., ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine, Mol Cancer Ther. 2020 Feb;19(2):325-336. doi: 10.1158/1535-7163.MCT-19-0183. Epub 2019 Nov 19.
Maaland, Astri Fjelde; Heyerdahl, Helen; OShea, Adam; Eiriksdottir, Bergthora; Pascal, VĂŠronique; Andersen, Jan Terje; Kolstad, Arne; Dahle, Jostein;, European journal of nuclear medicine and molecular imaging Vol.46, 2019, European journal of nuclear medicine and molecular imaging Vol.46, 2019
Tuominen S, Keller T, Petruk N, López-Picón F, Eichin D, Löyttyniemi E, Verhassel A, Rajander J, Sandholm J, Tuomela J, Grönroos TJ., Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy, Eur J Nucl Med Mol Imaging. 2021 May;48(5):1312-1326. doi: 10.1007/s00259-020-05115-z. Epub 2020 Dec 19.
da Costa Rosa M, Yamashita AS, Riggins GJ., Evaluation of a DNA demethylating agent in combination with all-trans retinoic acid for IDH1-mutant gliomas, Neuro Oncol. 2022 May 4;24(5):711-723. doi: 10.1093/neuonc/noab263.
Rossi SM, Ryan BK, Kelly HM., Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancer, Br J Cancer. 2020 Aug;123(3):369-377. doi: 10.1038/s41416-020-0904-9. Epub 2020 May 27.
Scott, A. J., Song, E. K., Bagby, S., Purkey, A., McCarter, M., Gajdos, C., . . . Messersmith, W. A. (2017)., Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model., PloS One, 12(11), e0187173. doi:10.1371/journal.pone.0187173 [doi]
Scutigliani EM, Liang Y, IJff M, Rodermond H, Mei X, Korver MP, Orie VS, Hoebe RA, Picavet DI, Oei A, Kanaar R, Krawczyk PM., Evaluation of the Heat Shock Protein 90 Inhibitor Ganetespib as a Sensitizer to Hyperthermia-Based Cancer Treatments, Cancers (Basel). 2022 Oct 26;14(21):5250. doi: 10.3390/cancers14215250.
Siddiqui, I. A., Bharali, D. J., Nihal, M., Adhami, V. M., Khan, N., Chamcheu, J. C., . . . Mukhtar, H. (2014)., Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo., Nanomedicine : Nanotechnology, Biology, and Medicine, 10(8), 1619-1626. doi:10.1016/j.nano.2014.05.007 [doi]
Gonzalez-Sanchez L, Cobos-Fernandez MA, Lopez-Nieva P, Villa-Morales M, Stamatakis K, Cuezva JM, Marin-Rubio JL, Vazquez-Dominguez I, Gonzalez-Vasconcellos I, Salido E, Llamas P, Lopez-Lorenzo JL, Santos J, Fernandez-Piqueras J., Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells, Carcinogenesis. 2020 Aug 12;41(8):1113-1122. doi: 10.1093/carcin/bgz185.
Sperger JM, Helzer KT, Stahlfeld CN, Jiang D, Singh A, Kaufmann KR, Niles DJ, Heninger E, Rydzewski NR, Wang L, Wang L, Yang R, Ren Y, Engle JW, Huang P, Kyriakopoulos CE, Slovin SF, Soule HR, Zhao SG, Kohli M, Tagawa ST, Cai W, et al., Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer., Clin Cancer Res. 2023 Jun 13;29(12):2324-2335. doi: 10.1158/1078-0432.CCR-22-1305.
Bownes LV, Williams AP, Marayati R, Stafman LL, Markert H, Quinn CH, Wadhwani N, Aye JM, Stewart JE, Yoon KJ, Mroczek-Musulman E, Beierle EA., EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth, PLoS One. 2021 Mar 9;16(3):e0246244. doi: 10.1371/journal.pone.0246244. eCollection 2021.
Shen JZ, Qiu Z, Wu Q, Finlay D, Garcia G, Sun D, Rantala J, Barshop W, Hope JL, Gimple RC, Sangfelt O, Bradley LM, Wohlschlegel J, Rich JN, Spruck C., FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells, Cell. 2021 Jan 21;184(2):352-369.e23. doi: 10.1016/j.cell.2020.11.042. Epub 2020 Dec 23.
Hicks HM, Pozdeyev N, Sams SB, Pugazhenthi U, Bales ES, Hofmann MC, McKenna LR, Schweppe RE., Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2., Mol Cancer Res. 2023 Sep 1;21(9):867-880. doi: 10.1158/1541-7786.MCR-22-1031.
Capasso, Anna; Bagby, Stacey M; Dailey, Kyrie L; Currimjee, Naomi; Yacob, Betelehem W; Ionkina, Anastasia; Frank, Julie G; Kim, Deog Joong; George, Christina; Lee, Young B; Benaim, Ely; Gittleman, Brian; Hartman, Sarah J; Tan, Aik Choon; Kim, Jihye; Pitts, Todd M; Eckhardt, S Gail; Tentler, John J; Diamond, Jennifer R;, First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits ??-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer, Molecular cancer therapeutics Vol.18, 2019
Xu, L., Yeudall, W. A., & Yang, H. (2017)., Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery., Acta Biomaterialia, 57, 251-261. doi:S1742-7061(17)30262-3 [pii]
Faugeroux V, Pailler E, Oulhen M, Deas O, Brulle-Soumare L, Hervieu C, Marty V, Alexandrova K, Andree KC, Stoecklein NH, Tramalloni D, Cairo S, NgoCamus M, Nicotra C, Terstappen LWMM, Manaresi N, Lapierre V, Fizazi K, Scoazec JY, Loriot Y, Judde JG, Farace F., Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model, Nat Commun. 2020 Apr 20;11(1):1884. doi: 10.1038/s41467-020-15426-2.
Sasaki, K., Kurahara, H., Young, E. D., Natsugoe, S., Ijichi, A., Iwakuma, T., & Welch, D. R. (2017)., Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer., Clinical & Experimental Metastasis, 34(3-4), 229-239. doi:10.1007/s10585-017-9840-3 [doi]
Lampa, M., Arlt, H., He, T., Ospina, B., Reeves, J., Zhang, B., . . . Srinivasan, L. (2017)., Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition, PloS One, 12(9), e0185092. doi:10.1371/journal.pone.0185092 [doi]
Sharp PS, Stylianou M, Arellano LM, Neves JC, Gravagnuolo AM, Dodd A, Barr K, Lozano N, Kisby T, Kostarelos K., Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models, Adv Healthc Mater. 2023 Jan;12(3):e2201968. doi: 10.1002/adhm.202201968. Epub 2022 Nov 11.
Sorin, V., Ohana, P., Gallula, J., Birman, T., Matouk, I., Hubert, A., . . . Czerniak, A. (2012)., H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer, ISRN Oncology, 2012, 351750. doi:10.5402/2012/351750 [doi]
Zhou, Y., Li, G., Zhu, L., Li, C., Cornelius, L. A., & Wang, L. V. (2015)., Handheld photoacoustic probe to detect both melanoma depth and volume at high speed in vivo., Journal of Biophotonics, 8(11-12), 961-967. doi:10.1002/jbio.201400143 [doi]
Cui J, Xu F, Bai W, Zhao T, Hong J, Zuo W., HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism., J Transl Med. 2023 Feb 15;21(1):125. doi: 10.1186/s12967-023-03973-3.
Chomet M, Schreurs M, Bolijn MJ, Verlaan M, Beaino W, Brown K, Poot AJ, Windhorst AD, Gill H, Marik J, Williams S, Cowell J, Gasser G, Mindt TL, van Dongen GAMS, Vugts DJ., Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical (89)Zr-immuno-PET, Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):694-707. doi: 10.1007/s00259-020-05002-7. Epub 2020 Sep 5.
Arzumanyan, A., Sambandam, V., Clayton, M. M., Choi, S. S., Xie, G., Diehl, A. M., . . . Feitelson, M. A. (2012)., Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein., Cancer Research, 72(22), 5912-5920. doi:10.1158/0008-5472.CAN-12-2329 [doi]
Elwaie TA, Abbas SE, Aly EI, George RF, Ali H, Kraiouchkine N, Abdelwahed KS, Fandy TE, El Sayed KA, Abd Elmageed ZY, Ali HI., HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability, J Med Chem. 2020 Dec 24;63(24):15906-15945. doi: 10.1021/acs.jmedchem.0c01647. Epub 2020 Dec 14.
Phillips DC, Buchanan FG, Cheng D, Solomon LR, Xiao Y, Xue J, Tahir SK, Smith ML, Zhang H, Widomski D, Abraham VC, Xu N, Liu Z, Zhou L, DiGiammarino E, Lu X, Rudra-Ganguly N, Trela B, Morgan-Lappe SE., Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors, Cancer Res. 2021 Jun 15;81(12):3402-3414. doi: 10.1158/0008-5472.CAN-20-2178. Epub 2021 Mar 9.
Sánchez-Guixé M, Hierro C, Jiménez J, Viaplana C, Villacampa G, Monelli E, Brasó-Maristany F, Ogbah Z, Parés M, Guzmán M, Grueso J, Rodríguez O, Oliveira M, Azaro A, Garralda E, Tabernero J, Casanovas O, Scaltriti M, Prat A, Dienstmann R, Nuciforo P, Saura C, Graupera M, Vivancos A, Rodon J, Serra V., High FGFR1-4 mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer, Clin Cancer Res. 2022 Jan 1;28(1):137-149. doi: 10.1158/1078-0432.CCR-21-1810. Epub 2021 Sep 30.
Huhtaniemi R, Sipilä P, Junnila A, Oksala R, Knuuttila M, Mehmood A, Aho E, Laajala TD, Aittokallio T, Laiho A, Elo L, Ohlsson C, Thulin MH, Kallio P, Mäkelä S, Mustonen MVJ, Poutanen M., High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice, iScience. 2022 Apr 25;25(5):104287. doi: 10.1016/j.isci.2022.104287. eCollection 2022 May 20.
Kumar N, Rachagani S, Natarajan G, Crook A, Gopal T, Rajamanickam V, Kaushal JB, Nagabhishek SN, Powers R, Batra SK, Saraswathi V., Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant-Antioxidant Balance., Cancers (Basel). 2023 May 3;15(9). pii: 2593. doi: 10.3390/cancers15092593.
Efimova, E. V., Ricco, N., Labay, E., Mauceri, H. J., Flor, A. C., Ramamurthy, A., . . . Kron, S. J. (2018)., HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation., Molecular Cancer Therapeutics, 17(2), 407-418. doi:10.1158/1535-7163.MCT-17-0288 [doi]
Lelj-Garolla, B., Kumano, M., Beraldi, E., Nappi, L., Rocchi, P., Ionescu, D. N., . . . Gleave, M. E. (2015)., Hsp27 inhibition with OGX-427 sensitizes non-small cell lung cancer cells to erlotinib and chemotherapy., Molecular Cancer Therapeutics, 14(5), 1107-1116. doi:10.1158/1535-7163.MCT-14-0866 [doi]
Lu J, Chen L, Song Z, Das M, Chen J., Hypothermia Effectively Treats Tumors with Temperature-Sensitive p53 Mutations, Cancer Res. 2021 Jul 15;81(14):3905-3915. doi: 10.1158/0008-5472.CAN-21-0033. Epub 2021 Mar 9.
Lu, Y., Liu, Y., Oeck, S., & Glazer, P. M. (2018)., Hypoxia promotes resistance to EGFR inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1., Molecular Cancer Research : MCR, 16(10), 1458-1469. doi:10.1158/1541-7786.MCR-17-0637 [doi]
Serra V, Wang AT, Castroviejo-Bermejo M, Polanska UM, Palafox M, Herencia-Ropero A, Jones GN, Lai Z, Armenia J, Michopoulos F, Llop-Guevara A, Brough R, Gulati A, Pettitt SJ, Bulusu KC, Nikkilä J, Wilson Z, Hughes A, Wijnhoven PWG, Ahmed A, Bruna A, Gris-Oliver A, Guzman M, Rodríguez O, Grueso J, Arribas J, Cortés J, Saura C, Lau A, Critchlow S, Dougherty B, Caldas C, Mills GB, Barrett JC, Forment JV, Cadogan E, Lord CJ, Cruz C, Balmaña J, O'Connor MJ., Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance, Clin Cancer Res. 2022 Oct 14;28(20):4536-4550. doi: 10.1158/1078-0432.CCR-22-0568.
Fell JB, Fischer JP, Baer BR, Blake JF, Bouhana K, Briere DM, Brown KD, Burgess LE, Burns AC, Burkard MR, Chiang H, Chicarelli MJ, Cook AW, Gaudino JJ, Hallin J, Hanson L, Hartley DP, Hicken EJ, Hingorani GP, Hinklin RJ, Mejia MJ, Olson P, Otten JN, Rhodes SP, Rodriguez ME, Savechenkov P, Smith DJ, Sudhakar N, Sullivan FX, Tang TP, Vigers GP, Wollenberg L, Christensen JG, Marx MA., Identification of the Clinical Development Candidate MRTX849, a Covalent KRAS(G12C) Inhibitor for the Treatment of Cancer, J Med Chem. 2020 Jul 9;63(13):6679-6693. doi: 10.1021/acs.jmedchem.9b02052. Epub 2020 Apr 6.
Abourbeh, G., Itamar, B., Salnikov, O., Beltsov, S., & Mishani, E. (2015)., Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET., EJNMMI Research, 5, 4-014-0080-0. eCollection 2015. doi:10.1186/s13550-014-0080-0 [doi]
Gargini R, Segura-Collar B, Garranzo-Asensio M, Hortigüela R, Iglesias-Hernández P, Lobato-Alonso D, Moreno-Raja M, Esteban-Martin S, Sepúlveda-Sánchez JM, Nevola L, Sánchez-Gómez P., IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas, Neurotherapeutics. 2022 Jan;19(1):408-420. doi: 10.1007/s13311-021-01176-6. Epub 2022 Jan 31.
Attaluri, A., Seshadri, M., Mirpour, S., Wabler, M., Marinho, T., Furqan, M., . . . Liapi, E. (2016), Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. International Journal of Hyperthermia, The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 32(5), 543-557. doi:10.3109/02656736.2016.1159737 [doi]
Brignole, C., Pastorino, F., Marimpietri, D., Pagnan, G., Pistorio, A., Allen, T. M., . . . Ponzoni, M. (2004)., Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs., Journal of the National Cancer Institute, 96(15), 1171-1180. doi:10.1093/jnci/djh221 [doi]
Alvero AB, Fox A, Madina BR, Krady MM, Gogoi R, Chehade H, Nakaar V, Almassian B, Yarovinsky TO, Rutherford T, Mor G., Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory., Cancer Immunol Res. 2023 Dec 11. doi: 10.1158/2326-6066.CIR-23-0127. [Epub ahead of print]
Sun, H., England, C. G., Hernandez, R., Graves, S. A., Majewski, R. L., Kamkaew, A., . . . Cai, W. (2016)., ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer, European Journal of Nuclear Medicine and Molecular Imaging, 43(12), 2169-2179. doi:10.1007/s00259-016-3442-1 [doi]
Hernandez, R., England, C. G., Yang, Y., Valdovinos, H. F., Liu, B., Wong, H. C., . . . Cai, W. (2017)., ImmunoPET imaging of tissue factor expression in pancreatic cancer with (89)zr-df-ALT-836, Journal of Controlled Release : Official Journal of the Controlled Release Society, 264, 160-168. doi:S0168-3659(17)30796-4 [pii]
Li M, Wei W, Barnhart TE, Jiang D, Cao T, Fan K, Engle JW, Liu J, Chen W, Cai W., ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma, Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2737-2748. doi: 10.1007/s00259-021-05216-3. Epub 2021 Feb 3.
Guffanti F, Alvisi MF, Caiola E, Ricci F, De Maglie M, Soldati S, Ganzinelli M, Decio A, Giavazzi R, Rulli E, Damia G., Impact of ERCC1, XPF and DNA Polymerase ? Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts, Cancers (Basel). 2020 Aug 24;12(9):2398. doi: 10.3390/cancers12092398.
Heinrich, A. K., Lucas, H., Schindler, L., Chytil, P., Etrych, T., Mader, K., & Mueller, T. (2016), Improved tumor-specific drug accumulation by polymer therapeutics with pH-sensitive drug release overcomes chemotherapy resistance, Molecular Cancer Therapeutics, 15(5), 998-1007. doi:10.1158/1535-7163.MCT-15-0824 [doi]
Hughes, P. E., Rex, K., Caenepeel, S., Yang, Y., Zhang, Y., Broome, M. A., . . . Coxon, A. (2016)., In vitro and in vivo activity of AMG 337, a potent and selective MET kinase inhibitor, in MET-dependent cancer models., Molecular Cancer Therapeutics, 15(7), 1568-1579. doi:10.1158/1535-7163.MCT-15-0871 [doi]
Baldini E, Presutti D, Favoriti P, Santini S, Papoff G, Tuccilli C, Carletti R, Di Gioia C, Lori E, Ferent IC, Gagliardi F, Catania A, Pironi D, Tripodi D, D'Andrea V, Sorrenti S, Ruberti G, Ulisse S., In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines, Int J Mol Sci. 2022 Mar 28;23(7):3724. doi: 10.3390/ijms23073724.
Xia, C. F., Chen, G., Gangadharmath, U., Gomez, L. F., Liang, Q., Mu, F., . . . Kolb, H. C. (2013), In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors., Molecular Imaging and Biology : MIB : The Official Publication of the Academy of Molecular Imaging, 15(6), 748-757. doi:10.1007/s11307-013-0646-7 [doi]
Takahashi-Ruiz L, Morris JD, Crews P, Johnson TA, Risinger AL., In Vivo Evaluation of (-)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site, Molecules. 2022 Jul 1;27(13):4244. doi: 10.3390/molecules27134244.
He, Y., Wang, L., Shi, J., Yao, J., Li, L., Zhang, R., . . . Wang, L. V. (2016), In vivo label-free photoacoustic flow cytography and on-the-spot laser killing of single circulating melanoma cells, Scientific Reports, 6, 39616. doi:10.1038/srep39616 [doi]
Irrera P, Consolino L, Roberto M, Capozza M, Dhakan C, Carella A, Corrado A, Villano D, Anemone A, Navarro-Tableros V, Bracesco M, Dastrù W, Aime S, Longo DL., In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models, Cancers (Basel). 2022 Oct 7;14(19):4916. doi: 10.3390/cancers14194916.
Rybczynska, A. A., de Bruyn, M., Ramakrishnan, N. K., de Jong, J. R., Elsinga, P. H., Helfrich, W., . . . van Waarde, A. (2013)., In vivo responses of human A375M melanoma to a sigma ligand: 18F-FDG PET imaging., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 54(9), 1613-1620. doi:10.2967/jnumed.113.122655 [doi]
Colmegna, B., Uboldi, S., Frapolli, R., Licandro, S. A., Panini, N., Galmarini, C. M., . . . D'Incalci, M. (2015), Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin., British Journal of Cancer, 113(12), 1687-1693. doi:10.1038/bjc.2015.407 [doi]
Gunsalus, K. T., Wagoner, M. P., Meyer, K., Potter, W. B., Schoenike, B., Kim, S., . . . Roopra, A. (2012)., Induction of the RNA regulator LIN28A is required for the growth and pathogenesis of RESTless breast tumors, Cancer Research, 72(13), 3207-3216. doi:10.1158/0008-5472.CAN-11-1639 [doi]
Wang, X., Solban, N., Khanna, P., Callea, M., Song, J., Alsop, D. C., . . . Bhatt, R. S. (2016)., Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma., Oncotarget, 7(27), 41857-41869. doi:10.18632/oncotarget.9621 [doi]
Zhou Q, Howard ME, Tu X, Zhu Q, Denbeigh JM, Remmes NB, Herman MG, Beltran CJ, Yuan J, Greipp PT, Boughey JC, Wang L, Johnson N, Goetz MP, Sarkaria JN, Lou Z, Mutter RW., Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining, Cancer Res. 2021 Jun 15;81(12):3333-3346. doi: 10.1158/0008-5472.CAN-20-2960. Epub 2021 Feb 17.
Cook Sangar, M. L., Genovesi, L. A., Nakamoto, M. W., Davis, M. J., Knobluagh, S. E., Ji, P., . . . Olson, J. M. (2017)., Inhibition of CDK4/6 by palbociclib significantly extends survival in medulloblastoma patient-derived xenograft mouse models., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(19), 5802-5813. doi:10.1158/1078-0432.CCR-16-2943 [doi]
Luna AJ, Young JM, Sterk RT, Bondu V, Schultz FA, Kusewitt DF, Kang H, Ozbun MA., Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression., bioRxiv. 2023 Apr 24. pii: 2023.03.14.532042. doi: 10.1101/2023.03.14.532042. Update in: Antiviral Res. 2023 Aug;216:105667.
Zhang, Y., Wang, Q., Chen, L., & Yang, H. S. (2015), Inhibition of p70S6K1 activation by Pdcd4 overcomes the resistance to an IGF-1R/IR inhibitor in colon carcinoma cells., Molecular Cancer Therapeutics, 14(3), 799-809. doi:10.1158/1535-7163.MCT-14-0648 [doi]
Shao, C., Ahmad, N., Hodges, K., Kuang, S., Ratliff, T., & Liu, X. (2015)., Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer., The Journal of Biological Chemistry, 290(4), 2024-2033. doi:10.1074/jbc.M114.596817 [doi]
Gómez-Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernández-Jiménez E, Maetens M, Salgado R, Zafeiroglou M, Pellegrini P, Venet D, Garaud S, Trinidad EM, Benítez S, Vuylsteke P, Polastro L, Wildiers H, Simon P, Lindeman G, Larsimont D, Van den Eynden G, Velghe C, Rothé F, Willard-Gallo K, Michiels S, Muñoz P, Walzer T, Planelles L, Penninger J, Azim HA Jr, Loi S, Piccart M, Sotiriou C, González-Suárez E., Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells, Nat Commun. 2020 Dec 10;11(1):6335. doi: 10.1038/s41467-020-20138-8.
Humeau J, Sauvat A, Cerrato G, Xie W, Loos F, Iannantuoni F, Bezu L, Lévesque S, Paillet J, Pol J, Leduc M, Zitvogel L, de Thé H, Kepp O, Kroemer G., Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress, EMBO Mol Med. 2020 May 8;12(5):e11622. doi: 10.15252/emmm.201911622. Epub 2020 Apr 23.
Cao W, Shen R, Richard S, Liu Y, Jalalirad M, Cleary MP, D'Assoro AB, Gradilone SA, Yang DQ., Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt, Oncol Rep. 2022 Feb;47(2):41. doi: 10.3892/or.2021.8252. Epub 2021 Dec 27.
Zhou K, Cheong JE, Krishnaji ST, Ghalali A, Fu H, Sui L, Alix-Panabières C, Cayrefourcq L, Bielenberg D, Sun L, Zetter B., Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation, Mol Cancer Ther. 2023 Jan 3;22(1):25-36. doi: 10.1158/1535-7163.MCT-21-0801.
Puente, P., Fettig, N., Luderer, M. J., Jin, A., Shah, S., Muz, B., . . . Azab, A. K. (2018)., Injectable hydrogels for localized chemotherapy and radiotherapy in brain tumors., Journal of Pharmaceutical Sciences, 107(3), 922-933. doi:S0022-3549(17)30829-8 [pii]
Wu, Jiao; Minikes, Alexander M; Gao, Minghui; Bian, Huijie; Li, Yong; Stockwell, Brent R; Chen, Zhi-Nan; Jiang, Xuejun;, Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling, Nature Vol.572, 2019
Hwang SY, Park S, Jo H, Hee Seo S, Jeon KH, Kim S, Jung AR, Song C, Ahn M, Yeon Kwak S, Lee HJ, Uesugi M, Na Y, Kwon Y., Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers, J Adv Res. 2022 Aug 10:S2090-1232(22)00171-0. doi: 10.1016/j.jare.2022.08.003. Online ahead of print.
Hwang SY, Park S, Jo H, Hee Seo S, Jeon KH, Kim S, Jung AR, Song C, Ahn M, Yeon Kwak S, Lee HJ, Uesugi M, Na Y, Kwon Y., Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers., J Adv Res. 2023 May;47:173-187. doi: 10.1016/j.jare.2022.08.003. Epub 2022 Aug 10.
Eyme KM, Carvalho L, Badr CE., Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models, STAR Protoc. 2021 Jan 21;2(1):100290. doi: 10.1016/j.xpro.2020.100290. eCollection 2021 Mar 19.
Wang, W., Cho, H. Y., Rosenstein-Sisson, R., Marin Ramos, N. I., Price, R., Hurth, K., . . . Chen, T. C. (2018), Intratumoral delivery of bortezomib: Impact on survival in an intracranial glioma tumor model, Journal of Neurosurgery, 128(3), 695-700. doi:10.3171/2016.11.JNS161212 [doi]
Relation, T., Yi, T., Guess, A. J., La Perle, K., Otsuru, S., Hasgur, S., . . . Horwitz, E. M. (2018)., Intratumoral delivery of interferongamma-secreting mesenchymal stromal cells repolarizes tumor-associated macrophages and suppresses neuroblastoma proliferation in vivo., Stem Cells (Dayton, Ohio), 36(6), 915-924. doi:10.1002/stem.2801 [doi]
Eluu SC, Obayemi JD, Salifu AA, Yiporo D, Oko AO, Aina T, Oparah JC, Ezeala CC, Etinosa PO, Ugwu CM, Esimone CO, Soboyejo WO., In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer., Sci Rep. 2024 Jan 2;14(1):31. doi: 10.1038/s41598-023-50656-6.
Turchan, W. T., Shapiro, R. H., Sevigny, G. V., Chin-Sinex, H., Pruden, B., & Mendonca, M. S. (2016)., Irradiated human endothelial progenitor cells induce bystander killing in human non-small cell lung and pancreatic cancer cells, International Journal of Radiation Biology, 92(8), 427-433. doi:10.1080/09553002.2016.1186299 [doi]
Wu Q, Tian AL, Durand S, Aprahamian F, Nirmalathasan N, Xie W, Liu P, Zhao L, Zhang S, Pan H, Carmona-Gutierrez D, Madeo F, Tu Y, Kepp O, Kroemer G., Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy, Cell Death Dis. 2020 Nov 26;11(11):1015. doi: 10.1038/s41419-020-03226-x.
Bouguenina H, Nicolaou S, Le Bihan YV, Bowling EA, Calderon C, Caldwell JJ, Harrington B, Hayes A, McAndrew PC, Mitsopoulos C, Sialana FJ, Scarpino A, Stubbs M, Thapaliya A, Tyagi S, Wang HZ, Wood F, Burke R, Raynaud F, Choudhary J, van Montfort RLM, Sadok A, et al., iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells., iScience. 2023 Jun 7;26(7):107059. doi: 10.1016/j.isci.2023.107059. eCollection 2023 Jul 21.
Imig JD, Hye Khan MA, Burkhan A, Chen G, Adebesin AM, Falck JR., Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity, Int J Mol Sci. 2021 Mar 10;22(6):2793. doi: 10.3390/ijms22062793.
Gelsomino L, Naimo GD, Malivindi R, Augimeri G, Panza S, Giordano C, Barone I, Bonofiglio D, Mauro L, Catalano S, Andò S., Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression, Cancers (Basel). 2020 Jul 27;12(8):2078. doi: 10.3390/cancers12082078.
Dwivedi SKD, Shameer K, Dey A, Mustafi SB, Xiong X, Bhattacharya U, Neizer-Ashun F, Rao G, Wang Y, Ivan C, Yang D, Dudley JT, Xu C, Wren JD, Mukherjee P, Bhattacharya R., KRCC1: A potential therapeutic target in ovarian cancer, FASEB J. 2020 Feb;34(2):2287-2300. doi: 10.1096/fj.201902259R. Epub 2019 Dec 23.
Eskra, Jillian N; Schlicht, Michael J; Bosland, Maarten C;, Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer., The Prostate Vol.79, 2019
Pascual-Pasto G, Resa-Pares C, Castillo-Ecija H, Aschero R, Baulenas-Farres M, Vila-Ubach M, Burgueño V, Balaguer-Lluna L, Cuadrado-Vilanova M, Olaciregui NG, Martinez-Velasco N, Perez-Jaume S, de Alava E, Tirado OM, Lavarino C, Mora J, Carcaboso AM., Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma, Biochem Pharmacol. 2023 Jan 2;208:115408. doi: 10.1016/j.bcp.2022.115408. Online ahead of print.
Pascual-Pasto G, Resa-Pares C, Castillo-Ecija H, Aschero R, Baulenas-Farres M, Vila-Ubach M, Burgueño V, Balaguer-Lluna L, Cuadrado-Vilanova M, Olaciregui NG, Martinez-Velasco N, Perez-Jaume S, de Alava E, Tirado OM, Lavarino C, Mora J, Carcaboso AM., Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma., Biochem Pharmacol. 2023 Feb;208:115408. doi: 10.1016/j.bcp.2022.115408. Epub 2023 Jan 2.
Haedicke, K., Graefe, S., Teichgraeber, U., & Hilger, I. (2016)., Lowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing mice, Biomedical Optics Express, 7(7), 2641-2649. doi:10.1364/BOE.7.002641 [doi]
Santamaria Nunez, G., Robles, C. M., Giraudon, C., Martinez-Leal, J. F., Compe, E., Coin, F., . . . Egly, J. M. (2016)., Lurbinectedin specifically triggers the degradation of phosphorylated RNA polymerase II and the formation of DNA breaks in cancer cells., Molecular Cancer Therapeutics, 15(10), 2399-2412. doi:1535-7163.MCT-16-0172 [pii]
Johnson, J. L., Dia, V. P., Wallig, M., & Gonzalez de Mejia, E. (2015), Luteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse model., Pancreas, 44(1), 144-151. doi:10.1097/MPA.0000000000000215 [doi]
Schregel K, Nowicki MO, Palotai M, Nazari N, Zane R, Sinkus R, Lawler SE, Patz S., Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model, Cancer Imaging. 2020 May 12;20(1):35. doi: 10.1186/s40644-020-00314-1.
Roger E, Gout J, Arnold F, Beutel AK, Müller M, Abaei A, Barth TFE, Rasche V, Seufferlein T, Perkhofer L, Kleger A., Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy, Cells. 2020 Sep 16;9(9):2110. doi: 10.3390/cells9092110.
Lodestijn SC, Miedema DM, Lenos KJ, Nijman LE, Belt SC, El Makrini K, Lecca MC, Waasdorp C, van den Bosch T, Bijlsma MF, Vermeulen L., Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer, Cell Rep. 2021 Oct 19;37(3):109852. doi: 10.1016/j.celrep.2021.109852.
Bernardo, M. M., Kaplun, A., Dzinic, S. H., Li, X., Irish, J., Mujagic, A., . . . Sheng, S. (2015), Maspin expression in prostate tumor cells averts stemness and stratifies drug sensitivity, Cancer Research, 75(18), 3970-3979. doi:10.1158/0008-5472.CAN-15-0234 [doi]
Kalev P, Hyer ML, Gross S, Konteatis Z, Chen CC, Fletcher M, Lein M, Aguado-Fraile E, Frank V, Barnett A, Mandley E, Goldford J, Chen Y, Sellers K, Hayes S, Lizotte K, Quang P, Tuncay Y, Clasquin M, Peters R, Weier J, Simone E, Murtie J, Liu W, Nagaraja R, Dang L, Sui Z, Biller SA, Travins J, Marks KM, Marjon K., MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage, Cancer Cell. 2021 Feb 8;39(2):209-224.e11. doi: 10.1016/j.ccell.2020.12.010. Epub 2021 Jan 14.
Crotty EE, Smith SMC, Brasel K, Pakiam F, Girard EJ, Connor YD, Zindy F, Mhyre AJ, Roussel MF, Olson JM., Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival, J Neurooncol. 2021 Jun;153(2):225-237. doi: 10.1007/s11060-021-03767-x. Epub 2021 May 8.
Franklin DA, Sharick JT, Ericsson-Gonzalez PI, Sanchez V, Dean PT, Opalenik SR, Cairo S, Judde JG, Lewis MT, Chang JC, Sanders ME, Cook RS, Skala MC, Bordeaux J, Orozco Bender J, Vaupel C, Geiss G, Hinerfeld D, Balko JM., MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC, JCI Insight. 2020 Aug 6;5(15):e134290. doi: 10.1172/jci.insight.134290.
García-García , Celina; Rivas, Martín A; Ibrahim, Yasir H; Calvo, María Teresa; Gris-Oliver, Albert; Rodríguez , Olga; Grueso, Judit; Antón, Pilar; Guzmán, Marta; Aura, Claudia; Nuciforo, Paolo; Jessen, Katti; Argilés, Guillem; Dienstmann, Rodrigo; Bertotti, Andrea; Trusolino, Livio; Matito, Judit; Vivancos, Ana; Chicote, Irene; Palmer, Héctor G; Tabernero, Josep; Scaltriti, Maurizio; Baselga, José; Serra, Violeta, MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer., Clinical cancer research : an official journal of the American Association for Cancer Research Vol.21, 2015
Ramesh S, Cifci A, Javeri S, Minne R, Longhurst CA, Nickel KP, Kimple RJ, Baschnagel AM., MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer., bioRxiv. 2023 Oct 27. pii: 2023.10.26.564232. doi: 10.1101/2023.10.26.564232. Update in: Int J Radiat Oncol Biol Phys. 2023 Nov 16;:.
Sharick JT, Walsh CM, Sprackling CM, Pasch CA, Pham DL, Esbona K, Choudhary A, Garcia-Valera R, Burkard ME, McGregor SM, Matkowskyj KA, Parikh AA, Meszoely IM, Kelley MC, Tsai S, Deming DA, Skala MC., Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment, Front Oncol. 2020 May 15;10:553. doi: 10.3389/fonc.2020.00553. eCollection 2020.
Mascaraque-Checa M, Gallego-Rentero M, Nicolás-Morala J, Portillo-Esnaola M, Cuezva JM, González S, Gilaberte Y, Juarranz Á., Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy, Mol Metab. 2022 Jun;60:101496. doi: 10.1016/j.molmet.2022.101496. Epub 2022 Apr 9.
Yan, S. B., Um, S. L., Peek, V. L., Stephens, J. R., Zeng, W., Konicek, B. W., . . . Walgren, R. A. (2018)., MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping., Investigational New Drugs, 36(4), 536-544. doi:10.1007/s10637-017-0545-x [doi]
Al-Jamal WT, Kostarelos K., Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes, Nanotheranostics. 2022 Jan 1;6(3):230-242. doi: 10.7150/ntno.61280. eCollection 2022.
Punturi NB, Seker S, Devarakonda V, Mazumder A, Kalra R, Chen CH, Li S, Primeau T, Ellis MJ, Kavuri SM, Haricharan S., Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer, Nat Commun. 2021 May 19;12(1):2940. doi: 10.1038/s41467-021-23271-0.
Gonzalvez F, Vincent S, Baker TE, Gould AE, Li S, Wardwell SD, Nadworny S, Ning Y, Zhang S, Huang WS, Hu Y, Li F, Greenfield MT, Zech SG, Das B, Narasimhan NI, Clackson T, Dalgarno D, Shakespeare WC, Fitzgerald M, Chouitar J, Griffin RJ, Liu S, Wong KK, Zhu X, Rivera VM., Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer, Cancer Discov. 2021 Jul;11(7):1672-1687. doi: 10.1158/2159-8290.CD-20-1683. Epub 2021 Feb 25.
Lv X, Lu X, Cao J, Luo Q, Ding Y, Peng F, Pataer A, Lu D, Han D, Malmberg E, Chan DW, Wang X, Savage SR, Mao S, Yu J, Peng F, Yan L, Meng H, Maneix L, Han Y, Chen Y, Yao W, et al., Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors., Science. 2023 Sep 8;381(6662):eabn4180. doi: 10.1126/science.abn4180. Epub 2023 Sep 8.
Yan P, Patel HJ, Sharma S, Corben A, Wang T, Panchal P, Yang C, Sun W, Araujo TL, Rodina A, Joshi S, Robzyk K, Gandu S, White JR, de Stanchina E, Modi S, Janjigian YY, Hill EG, Liu B, Erdjument-Bromage H, Neubert TA, Que NLS, Li Z, Gewirth DT, Taldone T, Chiosis G., Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone, Cell Rep. 2020 Jun 30;31(13):107840. doi: 10.1016/j.celrep.2020.107840.
Morcillo, M. A., Garcia de Lucas, A., Oteo, M., Romero, E., Magro, N., Ibanez, M., . . . Martinez-Torrecuadrada, J. (2018)., MT1-MMP as a PET imaging biomarker for pancreas cancer management., Contrast Media & Molecular Imaging, 2018, 8382148. doi:10.1155/2018/8382148 [doi]
Kumar, A., Dhar, S., Campanelli, G., Butt, N. A., Schallheim, J. M., Gomez, C. R., & Levenson, A. S. (2018), MTA1 drives malignant progression and bone metastasis in prostate cancer., Molecular Oncology, 12(9), 1596-1607. doi:10.1002/1878-0261.12360 [doi]
Haedicke, K., Kozlova, D., Grafe, S., Teichgraber, U., Epple, M., & Hilger, I. (2015)., Multifunctional calcium phosphate nanoparticles for combining near-infrared fluorescence imaging and photodynamic therapy, Acta Biomaterialia, 14, 197-207. doi:10.1016/j.actbio.2014.12.009 [doi]
Huang H, Zhao G, Cardenas H, Valdivia AF, Wang Y, Matei D., N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase., Mol Cancer Ther. 2023 Mar 2;22(3):393-405. doi: 10.1158/1535-7163.MCT-22-0278.
Peddi S, Roberts SK, MacKay JA., Nanotoxicology of an Elastin-like Polypeptide Rapamycin Formulation for Breast Cancer, Biomacromolecules. 2020 Mar 9;21(3):1091-1102. doi: 10.1021/acs.biomac.9b01431. Epub 2020 Feb 6.
Zhu Y, Yue P, Dickinson CF, Yang JK, Datanagan K, Zhai N, Zhang Y, Miklossy G, Lopez-Tapia F, Tius MA, Turkson J., Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo, Cell Death Dis. 2022 Dec 6;13(12):1022. doi: 10.1038/s41419-022-05477-2.
Veeraraghavan J, Gutierrez C, Sethunath V, Mehravaran S, Giuliano M, Shea MJ, Mitchell T, Wang T, Nanda S, Pereira R, Davis R, Goutsouliak K, Qin L, De Angelis C, Diala I, Lalani AS, Nagi C, Hilsenbeck SG, Rimawi MF, Osborne CK, Schiff R., Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models, NPJ Breast Cancer. 2021 May 27;7(1):63. doi: 10.1038/s41523-021-00274-0.
Wang, P. Y., Swain, H. M., Kunkler, A. L., Chen, C. Y., Hutzen, B. J., Arnold, M. A., . . . Cripe, T. P. (2016)., Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility., Gene Therapy, 23(2), 135-143. doi:10.1038/gt.2015.105 [doi]
Zheng ZY, Anurag M, Lei JT, Cao J, Singh P, Peng J, Kennedy H, Nguyen NC, Chen Y, Lavere P, Li J, Du XH, Cakar B, Song W, Kim BJ, Shi J, Seker S, Chan DW, Zhao GQ, Chen X, Banks KC, Lanman RB, Shafaee MN, Zhang XH, Vasaikar S, Zhang B, Hilsenbeck SG, Li W, Foulds CE, Ellis MJ, Chang EC., Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer, Cancer Cell. 2020 Mar 16;37(3):387-402.e7. doi: 10.1016/j.ccell.2020.02.003. Epub 2020 Mar 5.
Li X, Chen Y, Bai L, Zhao R, Wu Y, Xie ZR, Wu JM, Bowen NJ, Danaher A, Cook N, Li D, Qui M, Du Y, Fu H, Osunkoya AO, Kucuk O, Wu D., Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models., Br J Cancer. 2023 Sep;129(5):884-894. doi: 10.1038/s41416-023-02359-y. Epub 2023 Jul 20.
Yu, X., Liu, F., Zeng, L., He, F., Zhang, R., Yan, S., . . . Chen, L. (2018)., Niclosamide exhibits potent anticancer activity and synergizes with sorafenib in human renal cell cancer cells., Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 47(3), 957-971. doi:10.1159/000490140 [doi]
Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol JL, Calvayrac O, Moll HP, Glasson Y, Pirot N, Turtoi A, CaĂąamero M, Wong KK, Yarden Y, Casanova E, Soria JC, Colinge J, Siebel CW, Mazieres J, Favre G, Paz-Ares L, Maraver A., Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma, J Clin Invest. 2020 Feb 3;130(2):612-624. doi: 10.1172/JCI126896.
Chen, H., Jacobson, O., Niu, G., Weiss, I. D., Kiesewetter, D. O., Liu, Y., . . . Chen, X. (2017)., Novel "add-on" molecule based on evans blue confers superior pharmacokinetics and transforms drugs to theranostic agents. Journal of Nuclear Medicin, Official Publication, Society of Nuclear Medicine, 58(4), 590-597. doi:10.2967/jnumed.116.182097 [doi]
Choi, A. H., O'Leary, M. P., Chaurasiya, S., Lu, J., Kim, S. I., Fong, Y., & Chen, N. G. (2018)., Novel chimeric parapoxvirus CF189 as an oncolytic immunotherapy in triple-negative breast cancer, Surgery, 163(2), 336-342. doi:S0039-6060(17)30670-0 [pii]
Kleczko EK, Le AT, Hinz TK, Nguyen TT, Navarro A, Hu CJ, Selman AM, Clambey ET, Merrick DT, Lu S, Weiser-Evans M, Nemenoff RA, Heasley LE., Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response, Cancer Lett. 2023 Jan 16:216062. doi: 10.1016/j.canlet.2023.216062. Online ahead of print.
Kleczko EK, Le AT, Hinz TK, Nguyen TT, Navarro A, Hu CJ, Selman AM, Clambey ET, Merrick DT, Lu S, Weiser-Evans M, Nemenoff RA, Heasley LE., Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response., Cancer Lett. 2023 Mar 1;556:216062. doi: 10.1016/j.canlet.2023.216062. Epub 2023 Jan 16.
Kanthala, S., Banappagari, S., Gokhale, A., Liu, Y. Y., Xin, G., Zhao, Y., & Jois, S. (2015)., Novel peptidomimetics for inhibition of HER2:HER3 heterodimerization in HER2-positive breast cancer., Chemical Biology & Drug Design, 85(6), 702-714. doi:10.1111/cbdd.12453 [doi]
Marayati R, Williams AP, Bownes LV, Quinn CH, Stewart JE, Mroczek-Musulman E, Atigadda VR, Beierle EA., Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma, J Pediatr Surg. 2020 Jun;55(6):1072-1080. doi: 10.1016/j.jpedsurg.2020.02.027. Epub 2020 Feb 28.
Chen Y, Li X, Mamouni K, Yang Y, Danaher A, White J, Liu H, Kucuk O, Gera L, Wu D., Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer, Prostate. 2020 Sep;80(12):993-1005. doi: 10.1002/pros.24032. Epub 2020 Jun 19.
Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha JK, Jeyarajah R, Guzik P, Ranjan AP., Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer, Pharmaceutics. 2022 Jan 5;14(1):128. doi: 10.3390/pharmaceutics14010128.
Hegde, Ganapati V; de la Cruz, Cecile; Giltnane, Jennifer M; Crocker, Lisa; Venkatanarayan, Avinashnarayan; Schaefer, Gabriele; Dunlap, Debra; Hoeck, Joerg D; Piskol, Robert; Gnad, Florian; Modrusan, Zora; de Sauvage, Frederic J; Siebel, Christian W; Jackson, Erica L;, NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma, eLife Vol.8, 2019
Somwar R, Hofmann NE, Smith B, Odintsov I, Vojnic M, Linkov I, Tam A, Khodos I, Mattar MS, de Stanchina E, Flynn D, Ladanyi M, Drilon A, Shinde U, Davare MA., NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors, Commun Biol. 2020 Dec 16;3(1):776. doi: 10.1038/s42003-020-01508-w.
Servetto A, Kollipara R, Formisano L, Lin CC, Lee KM, Sudhan DR, Gonzalez-Ericsson PI, Chatterjee S, Guerrero-Zotano A, Mendiratta S, Akamatsu H, James N, Bianco R, Hanker AB, Kittler R, Arteaga CL., Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer, Clin Cancer Res. 2021 Aug 1;27(15):4379-4396. doi: 10.1158/1078-0432.CCR-20-3905. Epub 2021 May 19.
Yi J, Zhu J, Wu J, Thompson CB, Jiang X., Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis, Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31189-31197. doi: 10.1073/pnas.2017152117. Epub 2020 Nov 23.
Vasciaveo A, Arriaga JM, de Almeida FN, Zou M, Douglass EF, Picech F, Shibata M, Rodriguez-Calero A, de Brot S, Mitrofanova A, Chua CW, Karan C, Realubit R, Pampou S, Kim JY, Afari SN, Mukhammadov T, Zanella L, Corey E, Alvarez MJ, Rubin MA, Shen MM, et al., OncoLoop: A Network-Based Precision Cancer Medicine Framework., Cancer Discov. 2023 Feb 6;13(2):386-409. doi: 10.1158/2159-8290.CD-22-0342.
Kottke T, Tonne J, Evgin L, Driscoll CB, van Vloten J, Jennings VA, Huff AL, Zell B, Thompson JM, Wongthida P, Pulido J, Schuelke MR, Samson A, Selby P, Ilett E, McNiven M, Roberts LR, Borad MJ, Pandha H, Harrington K, Melcher A, Vile RG., Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy, Nat Commun. 2021 Mar 26;12(1):1930. doi: 10.1038/s41467-021-22115-1.
Lagerweij, T., Dusoswa, S. A., Negrean, A., Hendrikx, E. M. L., de Vries, H. E., Kole, J., . . . Wurdinger, T. (2017)., Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment., Angiogenesis, 20(4), 533-546. doi:10.1007/s10456-017-9565-6 [doi]
Walsh, Alex J; Castellanos, Jason A; Nagathihalli, Nagaraj S; Merchant, Nipun B; Skala, Melissa C;, Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response., Pancreas Vol.45, 2016
Pearson, H. E., Iida, M., Orbuch, R. A., McDaniel, N. K., Nickel, K. P., Kimple, R. J., . . . Wheeler, D. L. (2018)., Overcoming resistance to cetuximab with honokiol, A small-molecule polyphenol., Molecular Cancer Therapeutics, 17(1), 204-214. doi:10.1158/1535-7163.MCT-17-0384 [doi]
Al-Azayzih, A., Gao, F., & Somanath, P. R. (2015)., P21 activated kinase-1 mediates transforming growth factor beta1-induced prostate cancer cell epithelial to mesenchymal transition., Biochimica Et Biophysica Acta, 1853(5), 1229-1239. doi:10.1016/j.bbamcr.2015.02.023 [doi]
Lubik, A. A., Nouri, M., Truong, S., Ghaffari, M., Adomat, H. H., Corey, E., . . . Buttyan, R. (2017), Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment., International Journal of Cancer, 140(2), 358-369. doi:10.1002/ijc.30450 [doi]
Staniszewska AD, Armenia J, King M, Michaloglou C, Reddy A, Singh M, San Martin M, Prickett L, Wilson Z, Proia T, Russell D, Thomas M, Delpuech O, O'Connor MJ, Leo E, Angell H, Valge-Archer V., PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors, Oncoimmunology. 2022 Jun 18;11(1):2083755. doi: 10.1080/2162402X.2022.2083755. eCollection 2022.
Gozgit JM, Vasbinder MM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Molina JR, Minissale E, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, Varsamis ZA, Nayak SP, Bamberg E, Mo JR, Church WD, Mady ASA, Song J, Utley L, Rao PE, Mitchison TJ, Kuntz KW, Richon VM, Keilhack H., PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity, Cancer Cell. 2021 Sep 13;39(9):1214-1226.e10. doi: 10.1016/j.ccell.2021.06.018. Epub 2021 Jul 22.
Yang A, Zhang Z, Chaurasiya S, Park AK, Lu J, Kim SI, Valencia H, Fong Y, Woo Y., Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases., Mol Ther Oncolytics. 2023 Oct 19;31:100734. doi: 10.1016/j.omto.2023.100734. eCollection 2023 Dec 19.
Stokes ME, Calvo V, Fujisawa S, Dudgeon C, Huang S, Ballal N, Shen L, Gasparek J, Betzenhauser M, Taylor SJ, Staschke KA, Rigby AC, Mulvihill MJ, Bose N, Lightcap ES, Surguladze D., PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors., Clin Cancer Res. 2023 Dec 1;29(23):4870-4882. doi: 10.1158/1078-0432.CCR-23-1182.
Kamiyama, H., Rauenzahn, S., Shim, J. S., Karikari, C. A., Feldmann, G., Hua, L., . . . Eshleman, J. R. (2013)., Personalized chemotherapy profiling using cancer cell lines from selectable mice., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(5), 1139-1146. doi:10.1158/1078-0432.CCR-12-2127 [doi]
Zhang Z, Yang A, Chaurasiya S, Park AK, Kim SI, Lu J, Olafsen T, Warner SG, Fong Y, Woo Y., PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1, Mol Ther Oncolytics. 2021 Dec 31;24:331-339. doi: 10.1016/j.omto.2021.12.022. eCollection 2022 Mar 17.
Berk C, Civenni G, Wang Y, Steuer C, Catapano CV, Hall J., Pharmacodynamic and Pharmacokinetic Properties of Full Phosphorothioate Small Interfering RNAs for Gene Silencing In Vivo, Nucleic Acid Ther. 2021 Jun;31(3):237-244. doi: 10.1089/nat.2020.0852. Epub 2020 Apr 20.
Steers GJ, O'Leary BR, Du J, Wagner BA, Carroll RS, Domann FE, Goswami PC, Buettner GR, Cullen JJ., Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer., Antioxidants (Basel). 2023 Aug 29;12(9). pii: 1683. doi: 10.3390/antiox12091683.
Carroll RS, Du J, O'Leary BR, Steers G, Goswami PC, Buettner GR, Cullen JJ., Pharmacological ascorbate induces sustained mitochondrial dysfunction., Free Radic Biol Med. 2023 Aug 1;204:108-117. doi: 10.1016/j.freeradbiomed.2023.04.023. Epub 2023 May 1.
Alexander, M. S., Wilkes, J. G., Schroeder, S. R., Buettner, G. R., Wagner, B. A., Du, J., . . . Cullen, J. J. (2018)., Pharmacological ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer., Cancer Research, doi:canres.1680.2018 [pii]
Li X, Gera L, Zhang S, Chen Y, Lou L, Wilson LM, Xie ZR, Sautto G, Liu D, Danaher A, Mamouni K, Yang Y, Du Y, Fu H, Kucuk O, Osunkoya AO, Zhou J, Wu D., Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer, Theranostics. 2021 May 8;11(14):6873-6890. doi: 10.7150/thno.49235. eCollection 2021.
Zhang, Y. J., Zhan, X., Wang, L., Ho, R. J., & Sasaki, T. (2015), pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model., Journal of Pharmaceutical Sciences, 104(5), 1815-1824. doi:10.1002/jps.24407 [doi]
Pandya, K., Wyatt, D., Gallagher, B., Shah, D., Baker, A., Bloodworth, J., . . . Osipo, C. (2016)., PKCalpha attenuates jagged-1-mediated notch signaling in ErbB-2-positive breast cancer to reverse trastuzumab resistance., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(1), 175-186. doi:10.1158/1078-0432.CCR-15-0179 [doi]
Galmarini, C. M., Martin, M., Bouchet, B. P., Guillen-Navarro, M. J., Martinez-Diez, M., Martinez-Leal, J. F., . . . Aviles, P. (2018)., Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells., BMC Cancer, 18(1), 164-018-4086-2. doi:10.1186/s12885-018-4086-2 [doi]
Chen F, Byrd AL, Liu J, Flight RM, DuCote TJ, Naughton KJ, Song X, Edgin AR, Lukyanchuk A, Dixon DT, Gosser CM, Esoe DP, Jayswal RD, Orkin SH, Moseley HNB, Wang C, Brainson CF., Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors., Nat Commun. 2023 Jan 20;14(1):336. doi: 10.1038/s41467-023-35784-x.
Carlier, C., Strese, S., Viktorsson, K., Velander, E., Nygren, P., Uustalu, M., . . . Gullbo, J. (2016)., Preclinical activity of melflufen (J1) in ovarian cancer., Oncotarget, 7(37), 59322-59335. doi:10.18632/oncotarget.11163 [doi]
Janku F, Han SW, Doi T, Amatu A, Ajani JA, Kuboki Y, Cortez A, Cellitti SE, Mahling PC, Subramanian K, Schoenfeld HA, Choi SM, Iaconis LA, Lee LH, Pelletier MR, Dranoff G, Askoxylakis V, Siena S., Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies, Cancer Immunol Res. 2022 Dec 2;10(12):1441-1461. doi: 10.1158/2326-6066.CIR-21-0722.
Bähr-Mahmud, H., Ellinghaus, U., Stadler, C. R., Fischer, L., Lindemann, C., Chaturvedi, A., Diekmann, J., Wöll, S., Biermann, I., Hebich, B., Scharf, C., Siefke, M., Roth, A. S., Rao, M., Brettschneider, K., Ewen, E. M., Şahin, U., & Türeci, Ö., Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody., Oncoimmunology. 2023 Oct 16;12(1):2255041. doi: 10.1080/2162402X.2023.2255041. eCollection 2023.
Staniszewska AD, Pilger D, Gill SJ, Jamal K, Bohin N, Guzzetti S, Gordon J, Hamm G, Mundin G, Illuzzi G, Pike A, McWilliams L, Maglennon G, Rose J, Hawthorne G, Cortes Gonzalez M, Halldin C, Johnström P, Schou M, Critchlow SE, Fawell S, Johannes JW, et al., Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1., Clin Cancer Res. 2023 Nov 15. doi: 10.1158/1078-0432.CCR-23-2094. [Epub ahead of print]
Scribner JA, Brown JG, Son T, Chiechi M, Li P, Sharma S, Li H, De Costa A, Li Y, Chen Y, Easton A, Yee-Toy NC, Chen FZ, Gorlatov S, Barat B, Huang L, Wolff CR, Hooley J, Hotaling TE, Gaynutdinov T, Ciccarone V, Tamura J, Koenig S, Moore PA, Bonvini E, Loo D., Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer, Mol Cancer Ther. 2020 Sep 23:molcanther.0116.2020. doi: 10.1158/1535-7163.MCT-20-0116. Online ahead of print.
Diamond JR, Pitts TM, Ungermannova D, Nasveschuk CG, Zhang G, Phillips AJ, Bagby SM, Pafford J, Yacob BW, Newton TP, Tentler JJ, Gittleman B, Hartman SJ, DeMattei JA, Winkler JD, Wendt MK, Schiemann WP, Eckhardt SG, Liu X, Piscopio AD., Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors, Mol Cancer Ther. 2022 Mar 1;21(3):397-406. doi: 10.1158/1535-7163.MCT-21-0455.
Hammer S, Hagemann UB, Zitzmann-Kolbe S, Larsen A, Ellingsen C, Geraudie S, Grant D, Indrevoll B, Smeets R, von Ahsen O, Kristian A, Lejeune P, Hennekes H, Karlsson J, Bjerke RM, Ryan OB, Cuthbertson AS, Mumberg D., Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer, Clin Cancer Res. 2020 Apr 15;26(8):1985-1996. doi: 10.1158/1078-0432.CCR-19-2268. Epub 2019 Dec 12.
Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., . . . Idbaih, A. (2016)., Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2-amplified and TP53 wild-type glioblastomas, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(5), 1185-1196. doi:10.1158/1078-0432.CCR-15-1015 [doi]
Scribner JA, Hicks SW, Sinkevicius KW, Yoder NC, Diedrich G, Brown JG, Lucas J, Fuller ME, Son T, Dastur A, Hooley J, Espelin C, Themeles M, Chen FZ, Li Y, Chiechi M, Lee J, Barat B, Widjaja L, Gorlatov S, Tamura J, Ciccarone V, Ab O, McEachem KA, Koenig S, Westin EH, Moore PA, Chittenden T, Gregory RJ, Bonvini E, Loo D., Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors, Mol Cancer Ther. 2022 Jul 5;21(7):1047-1059. doi: 10.1158/1535-7163.MCT-21-0915.
Harper, J., Lloyd, C., Dimasi, N., Toader, D., Marwood, R., Lewis, L., . . . Kamal, A. (2017)., Preclinical evaluation of MEDI0641, a pyrrolobenzodiazepine-conjugated antibody-drug conjugate targeting 5T4., Molecular Cancer Therapeutics, 16(8), 1576-1587. doi:10.1158/1535-7163.MCT-16-0825 [doi]
Waters, A. M., Stewart, J. E., Atigadda, V. R., Mroczek-Musulman, E., Muccio, D. D., Grubbs, C. J., & Beierle, E. A. (2016)., Preclinical evaluation of UAB30 in pediatric renal and hepatic malignancies., Molecular Cancer Therapeutics, 15(5), 911-921. doi:10.1158/1535-7163.MCT-15-0521 [doi]
Dela Cruz Chuh J, Go M, Chen Y, Guo J, Rafidi H, Mandikian D, Sun Y, Lin Z, Schneider K, Zhang P, Vij R, Sharpnack D, Chan P, de la Cruz C, Sadowsky J, Seshasayee D, Koerber JT, Pillow TH, Phillips GD, Rowntree RK, Boswell CA, Kozak KR, Polson AG, Polakis P, Yu SF, Dragovich PS, Agard NJ., Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response, MAbs. 2021 Jan-Dec;13(1):1862452. doi: 10.1080/19420862.2020.1862452.
Segatto, I., Massarut, S., Boyle, R., Baldassarre, G., Walker, D., & Belletti, B. (2016)., Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer., Aging, 8(5), 958-976. doi:10.18632/aging.100954 [doi]
Advani, S. J., Buckel, L., Chen, N. G., Scanderbeg, D. J., Geissinger, U., Zhang, Q., . . . Szalay, A. A. (2012)., Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(9), 2579-2590. doi:10.1158/1078-0432.CCR-11-2394 [doi]
Kim SI, Chaurasiya S, Sivanandam V, Kang S, Park AK, Lu J, Yang A, Zhang Z, Bagdasarian IA, Woo Y, Morgan JT, Yin Z, Fong Y, Warner SG., Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer, Mol Ther Oncolytics. 2022 Feb 22;24:864-872. doi: 10.1016/j.omto.2022.02.022. eCollection 2022 Mar 17.
Avasarala, S., Van Scoyk, M., Karuppusamy Rathinam, M. K., Zerayesus, S., Zhao, X., Zhang, W., . . . Bikkavilli, R. K. (2015)., PRMT1 is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer, The Journal of Biological Chemistry, 290(21), 13479-13489. doi:10.1074/jbc.M114.636050 [doi]
Carter J, Hulse M, Sivakumar M, Burtell J, Thodima V, Wang M, Agarwal A, Vykuntam K, Spruance J, Bhagwat N, Rager J, Ruggeri B, Scherle P, Ito K., PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies., Cancer Res Commun. 2023 Nov 6;3(11):2233-2243. doi: 10.1158/2767-9764.CRC-23-0070.
Zhang, Y., Thayele Purayil, H., Black, J. B., Fetto, F., Lynch, L. D., Masannat, J. N., & Daaka, Y. (2017)., Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis., Cancer Letters, 391, 50-58. doi:S0304-3835(17)30029-0 [pii]
Dou, Liping; Yan, Fei; Pang, Jiuxia; Zheng, Dehua; Li, Dandan; Gao, Li; Wang, Lijun; Xu, Yihan; Shi, Jinlong; Wang, Qian; Zhou, Lei; Shen, Na; Singh, Puja; Wang, Lili; Li, Yonghui; Gao, Yvchi; Liu, Tao; Chen, Chongjian; Al-Kali, Aref; Litzow, Mark R; Chi, Young-In; Bode, Ann M; Liu, Chunhui; Huang, Haojie; Liu, Daihong; Marcucci, Guido; Liu, Shujun; Yu, Li;, Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia., Nature communications Vol.10, 2019
Tozzi M, Sørensen CE, Magni L, Christensen NM, Bouazzi R, Buch CM, Stefanini M, Duranti C, Arcangeli A, Novak I., Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H(+), K(+)-ATPases in Pancreatic Cancer and Stellate Cells, Cancers (Basel). 2020 Mar 10;12(3):640. doi: 10.3390/cancers12030640.
Mohammadabadi A, Huynh RN, Wadajkar AS, Lapidus RG, Kim AJ, Raub CB, Frenkel V., Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors, Phys Med Biol. 2020 Jun 22;65(12):125017. doi: 10.1088/1361-6560/ab9705.
Kenny HA, Lal-Nag M, Shen M, Kara B, Nahotko DA, Wroblewski K, Fazal S, Chen S, Chiang CY, Chen YJ, Brimacombe KR, Marugan J, Ferrer M, Lengyel E., Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis, Mol Cancer Ther. 2020 Jan;19(1):52-62. doi: 10.1158/1535-7163.MCT-19-0052. Epub 2019 Sep 27.
Gupta K, Vuckovic I, Zhang S, Xiong Y, Carlson BL, Jacobs J, Olson I, Petterson XM, Macura SI, Sarkaria J, Burns TC., Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma, Front Oncol. 2020 May 5;10:535. doi: 10.3389/fonc.2020.00535. eCollection 2020.
Deshayes, E., Ladjohounlou, R., Le Fur, P., Pichard, A., Lozza, C., Boudousq, V., . . . Pouget, J. P. (2018)., Radiolabeled antibodies against mullerian-inhibiting substance receptor, type II: New tools for a theranostic approach in ovarian cancer., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(8), 1234-1242. doi:10.2967/jnumed.118.208611 [doi]
Jiang, D., Im, H. J., Sun, H., Valdovinos, H. F., England, C. G., Ehlerding, E. B., . . . Cai, W. (2017)., Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer., European Journal of Nuclear Medicine and Molecular Imaging, 44(8), 1296-1305. doi:10.1007/s00259-017-3663-y [doi]
Albertoni, C., Leoni, B., Rosi, A., D'Alessio, V., Carollo, V., Spagnoli, L. G., . . . De Santis, R. (2015)., Radionuclide therapy of unresectable tumors with AvidinOX and (90)Y-biotinDOTA: Tongue cancer paradigm., Cancer Biotherapy & Radiopharmaceuticals, 30(7), 291-298. doi:10.1089/cbr.2015.1837 [doi]
't Hart E, Bianco J, Bruin MAC, Derieppe M, Besse HC, Berkhout K, Chin Joe Kie LA, Su Y, Hoving EW, Huitema ADR, Ries MG, van Vuurden DG., Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model., J Control Release. 2023 May;357:287-298. doi: 10.1016/j.jconrel.2023.03.058. Epub 2023 Apr 5.
Houweling M, Abdul UK, Brahm C, Lagerweij T, Heukelom S, Koken PW, Honeywell R, Wedekind LE, Peters GJ, Verheul H, Sminia P, Noske D, Wurdinger T, Westerman BA., Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo., J Cancer Res Clin Oncol. 2023 Jan;149(1):297-305. doi: 10.1007/s00432-022-04483-3. Epub 2022 Dec 1.
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Bradley, M. D., Wagner, B. A., Buettner, G. R., . . . Allen, B. G. (2018)., Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models., Redox Biology, 14, 417-422. doi:S2213-2317(17)30582-7 [pii]
Mantis, C., Kandela, I., Aird, F., & Reproducibility Project: Cancer Biology. (2017)., Replication study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs., Elife, 6, 10.7554/eLife.17584. doi:10.7554/eLife.17584 [doi]
Ramachandran S, Srivastava SK., Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy, Mol Ther Oncolytics. 2020 Sep 2;19:19-32. doi: 10.1016/j.omto.2020.08.019. eCollection 2020 Dec 16.
Kizilbash, S. H., Gupta, S. K., Chang, K., Kawashima, R., Parrish, K. E., Carlson, B. L., . . . Sarkaria, J. N. (2017)., Restricted delivery of talazoparib across the blood-brain barrier limits the sensitizing effects of PARP inhibition on temozolomide therapy in glioblastoma., Molecular Cancer Therapeutics, 16(12), 2735-2746. doi:10.1158/1535-7163.MCT-17-0365 [doi]
Brown A, Pan Q, Fan L, Indersie E, Tian C, Timchenko N, Li L, Hansen BS, Tan H, Lu M, Peng J, Pruett-Miller SM, Yu J, Cairo S, Zhu L., Ribonucleotide Reductase Subunit Switching in Hepatoblastoma Drug Response and Relapse., bioRxiv. 2023 Jan 24. pii: 2023.01.24.525404. doi: 10.1101/2023.01.24.525404. Update in: Commun Biol. 2023 Mar 8;6(1):249.
Smith, Bryan D; Kaufman, Michael D; Lu, Wei-Ping; Gupta, Anu; Leary, Cynthia B; Wise, Scott C; Rutkoski, Thomas J; Ahn, Yu Mi; Al-Ani, Gada; Bulfer, Stacie L; Caldwell, Timothy M; Chun, Lawrence; Ensinger, Carol L; Hood, Molly M; McKinley, Arin; Patt, William C; Ruiz-Soto, Rodrigo; Su, Ying; Telikepalli, Hanumaiah; Town, Ajia; Turner, Benjamin A; Vogeti, Lakshminarayana; Vogeti, Subha; Yates, Karen; Janku, Filip; Abdul Razak, Albiruni Ryan; Rosen, Oliver; Heinrich, Michael C; Flynn, Daniel L;, Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants., Cancer cell Vol.35, 2019
Mi, S., Lin, M., Brouwer-Visser, J., Heim, J., Smotkin, D., Hebert, T., . . . Huang, G. S. (2016), RNA-seq identification of RACGAP1 as a metastatic driver in uterine carcinosarcoma., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(18), 4676-4686. doi:10.1158/1078-0432.CCR-15-2116 [doi]
Kumar A, Kumar P, Sharma M, Kim S, Singh S, Kridel SJ, Deep G., Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells, Cancer Drug Resist. 2022 Jun 21;5(3):612-624. doi: 10.20517/cdr.2022.26. eCollection 2022.
Cai, Demin; Wang, Junjian; Gao, Bei; Li, Jin; Wu, Feng; Zou, June X; Xu, Jianzhen; Jiang, Yuqian; Zou, Hongye; Huang, Zenghong; Borowsky, Alexander D; Bold, Richard J; Lara, Primo N; Li, Jian Jian; Chen, Xinbin; Lam, Kit S; To, Ka-Fai; Kung, Hsing-Jien; Fiehn, Oliver; Zhao, Ruqian; Evans, Ronald M; Chen, Hong-Wu;, ROR? is a targetable master regulator of cholesterol biosynthesis in a cancer subtype., Nature communications Vol.10, 2019
Winter, U., Mena, H. A., Negrotto, S., Arana, E., Pascual-Pasto, G., Laurent, V., . . . Schaiquevich, P. (2016)., Schedule-dependent antiangiogenic and cytotoxic effects of chemotherapy on vascular endothelial and retinoblastoma cells., PloS One, 11(7), e0160094. doi:10.1371/journal.pone.0160094 [doi]
Robles, A. J., Cai, S., Cichewicz, R. H., & Mooberry, S. L. (2016)., Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer., Breast Cancer Research and Treatment, 157(3), 475-488. doi:10.1007/s10549-016-3841-9 [doi]
Yu, Z., He, S., Wang, D., Patel, H. K., Miller, C. P., Brown, J. L., . . . Saeh, J. C. (2017), Selective androgen receptor modulator RAD140 inhibits the growth of Androgen/Estrogen receptor-positive breast cancer models with a distinct mechanism of action., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(24), 7608-7620. doi:10.1158/1078-0432.CCR-17-0670 [doi]
Kausar, T., Schreiber, J. S., Karnak, D., Parsels, L. A., Parsels, J. D., Davis, M. A., . . . Morgan, M. A. (2015)., Sensitization of pancreatic cancers to gemcitabine chemoradiation by WEE1 kinase inhibition depends on homologous recombination repair, Neoplasia (New York, N.Y.), 17(10), 757-766. doi:10.1016/j.neo.2015.09.006 [doi]
Gray E, Ulrich M, Epp A, Younan P, Sahetya D, Hensley K, Allred S, Huang LY, Hahn J, Gahnberg K, Treuting PM, Trueblood ES, Gosink JJ, Thurman R, Wo S, Spahr K, Haass EJ, Snead K, Miller D, Padilla M, Smith AJ, Frantz C, et al., SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models., J Immunother Cancer. 2023 Oct;11(10). pii: e007572. doi: 10.1136/jitc-2023-007572.
Kietzman, William B; Graham, Garrett T; Ory, Virginie; Sharif, Ghada M; Kushner, Max H; Gallanis, Gregory T; Kallakury, Bhaskar; Wellstein, Anton; Riegel, Anna T;, Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer., Molecular cancer therapeutics Vol.18, 2019
Leelatian, N., Doxie, D. B., Greenplate, A. R., Mobley, B. C., Lehman, J. M., Sinnaeve, J., . . . Irish, J. M. (2017)., Single cell analysis of human tissues and solid tumors with mass cytometry., Cytometry.Part B, Clinical Cytometry, 92(1), 68-78. doi:10.1002/cyto.b.21481 [doi]
Tchoghandjian, A., Jennewein, C., Eckhardt, I., Momma, S., Figarella-Branger, D., & Fulda, S. (2014)., Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-kappaB., Cell Death and Differentiation, 21(5), 735-747. doi:10.1038/cdd.2013.200 [doi]
Pandey SK, Paul A, Shteinfer-Kuzmine A, Zalk R, Bunz U, Shoshan-Barmatz V., SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis, Mol Oncol. 2021 Nov;15(11):3037-3061. doi: 10.1002/1878-0261.12959. Epub 2021 May 4.
Yoshida, K., Toden, S., Weng, W., Shigeyasu, K., Miyoshi, J., Turner, J., . . . Goel, A. (2017)., SNORA21 - an oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer., Ebiomedicine, 22, 68-77. doi:S2352-3964(17)30282-7 [pii]
Al-Akhrass H, Pietilä M, Lilja J, Vesilahti EM, Anttila JM, Haikala HM, Munne PM, Klefström J, Peuhu E, Ivaska J., Sortilin-related receptor is a druggable therapeutic target in breast cancer, Mol Oncol. 2022 Jan;16(1):116-129. doi: 10.1002/1878-0261.13106. Epub 2021 Oct 10.
Bach, P., Abel, T., Hoffmann, C., Gal, Z., Braun, G., Voelker, I., . . . Buchholz, C. J. (2013)., Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus., Cancer Research, 73(2), 865-874. doi:10.1158/0008-5472.CAN-12-2221 [doi]
Stossel C, Raitses-Gurevich M, Atias D, Beller T, Glick Gorman Y, Halperin S, Peer E, Denroche RE, Zhang A, Notta F, Wilson JM, O'Kane GM, Haimov Talmoud E, Amison N, Schvimer M, Salpeter SJ, Bar V, Zundelevich A, Tirosh I, Tal R, Dinstag G, Kinar Y, et al., Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting., Cancer Discov. 2023 Aug 4;13(8):1826-1843. doi: 10.1158/2159-8290.CD-22-0412.
Hasgur S, Desbourdes L, Relation T, Overholt KM, Stanek JR, Guess AJ, Yu M, Patel P, Roback L, Dominici M, Otsuru S, Horwitz EM., Splenic macrophage phagocytosis of intravenously infused mesenchymal stromal cells attenuates tumor localization, Cytotherapy. 2021 May;23(5):411-422. doi: 10.1016/j.jcyt.2020.04.102. Epub 2021 Mar 26.
Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W., & Huang, W. C. (2016), SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-myc in prostate cancer., Oncotarget, 7(11), 12869-12884. doi:10.18632/oncotarget.7331 [doi]
Zhang L, Nesvick CL, Day CA, Choi J, Lu VM, Peterson T, Power EA, Anderson JB, Hamdan FH, Decker PA, Simons R, Welby JP, Siada R, Ge J, Kaptzan T, Johnsen SA, Hinchcliffe EH, Daniels DJ., STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma, Neuro Oncol. 2022 Oct 3;24(10):1700-1711. doi: 10.1093/neuonc/noac093.
Gergen AK, Kohtz PD, Halpern AL, White AM, Meng X, Fullerton DA, Weyant MJ., Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells, J Surg Res. 2021 Apr;260:436-447. doi: 10.1016/j.jss.2020.11.016. Epub 2020 Nov 30.
Trotta F, Avena P, Chimento A, Rago V, De Luca A, Sculco S, Nocito MC, Malivindi R, Fallo F, Pezzani R, Pilon C, Lasorsa FM, Barile SN, Palmieri L, Lerario AM, Pezzi V, Casaburi I, Sirianni R., Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth, Mol Cancer Ther. 2020 Sep;19(9):1909-1921. doi: 10.1158/1535-7163.MCT-19-1063. Epub 2020 Jun 16.
Gao, F., Alwhaibi, A., Sabbineni, H., Verma, A., Eldahshan, W., & Somanath, P. R. (2017)., Suppression of Akt1-beta-catenin pathway in advanced prostate cancer promotes TGFbeta1-mediated epithelial to mesenchymal transition and metastasis., Cancer Letters, 402, 177-189. doi:S0304-3835(17)30374-9 [pii]
England RM, Moss JI, Gunnarsson A, Parker JS, Ashford MB., Synthesis and Characterization of Dendrimer-Based Polysarcosine Star Polymers: Well-Defined, Versatile Platforms Designed for Drug-Delivery Applications, Biomacromolecules. 2020 Aug 10;21(8):3332-3341. doi: 10.1021/acs.biomac.0c00768. Epub 2020 Jul 28.
Vanderburgh, Joseph P; Kwakwa, Kristin A; Werfel, Thomas A; Merkel, Alyssa R; Gupta, Mukesh K; Johnson, Rachelle W; Guelcher, Scott A; Duvall, Craig L; Rhoades, Julie A;, Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease, Journal of controlled release : official journal of the Controlled Release Society Vol.311-312, 2019
Babae, N., Bourajjaj, M., Liu, Y., Van Beijnum, J. R., Cerisoli, F., Scaria, P. V., . . . Schiffelers, R. M. (2014)., Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma., Oncotarget, 5(16), 6687-6700. doi:2235 [pii]
Li M, Liu D, Lee D, Cheng Y, Baumhover NJ, Marks BM, Sagastume EA, Ballas ZK, Johnson FL, Morris ZS, Schultz MK., Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma, Cancers (Basel). 2021 Jul 22;13(15):3676. doi: 10.3390/cancers13153676.
Dragojevic S, Ryu JS, Hall ME, Raucher D., Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity, Molecules. 2022 May 24;27(11):3371. doi: 10.3390/molecules27113371.
Rudnick-Glick, S., Corem-Salkmon, E., Grinberg, I., & Margel, S. (2016)., Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model., Journal of Nanobiotechnology, 14(1), 80-016-0233-6. doi:10.1186/s12951-016-0233-6 [doi]
Chan, C. M., Jing, X., Pike, L. A., Zhou, Q., Lim, D. J., Sams, S. B., . . . Schweppe, R. E. (2012)., Targeted inhibition of src kinase with dasatinib blocks thyroid cancer growth and metastasis., . Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(13), 3580-3591. doi:10.1158/1078-0432.CCR-11-3359 [doi]
Kandimalla R, Aqil F, Alhakeem SS, Jeyabalan J, Tyagi N, Agrawal A, Yan J, Spencer W, Bondada S, Gupta RC., Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes, Cancers (Basel). 2021 Jul 23;13(15):3700. doi: 10.3390/cancers13153700.
Zhang S, Kapoor S, Tripathi C, Perez JT, Mohan N, Dashwood WM, Zhang K, Rajendran P, Dashwood R., Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis., NPJ Precis Oncol. 2023 Feb 18;7(1):20. doi: 10.1038/s41698-023-00361-4.
Sen, T., Tong, P., Diao, L., Li, L., Fan, Y., Hoff, J., . . . Byers, L. A. (2017)., Targeting AXL and mTOR pathway overcomes primary and acquired resistance to WEE1 inhibition in small-cell lung cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(20), 6239-6253. doi:10.1158/1078-0432.CCR-17-1284 [doi]
Ramkumar K, Tanimoto A, Della Corte CM, Stewart CA, Wang Q, Shen L, Cardnell RJ, Wang J, Polanska UM, Andersen C, Saeh J, Pease JE, Travers J, Fabbri G, Gay CM, Urosevic J, Byers LA., Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer., Clin Cancer Res. 2023 Aug 15;29(16):3237-3249. doi: 10.1158/1078-0432.CCR-23-0375.
Lallous, N., Leblanc, E., Munuganti, R. S., Hassona, M. D., Nakouzi, N. A., Awrey, S., . . . Cherkasov, A. (2016)., Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation., Molecular Cancer Therapeutics, 15(12), 2936-2945. doi:1535-7163.MCT-16-0354 [pii]
Dogra S, Elayapillai SP, Qu D, Pitts K, Filatenkov A, Houchen CW, Berry WL, Moxley K, Hannafon BN., Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer., Cancer Lett. 2023 Dec 1;578:216437. doi: 10.1016/j.canlet.2023.216437. Epub 2023 Oct 12.
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM., Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer., J Clin Invest. 2023 Dec 15;133(24). pii: e172503. doi: 10.1172/JCI172503.
Pittala, S., Krelin, Y., & Shoshan-Barmatz, V. (2018), Targeting liver cancer and associated pathologies in mice with a mitochondrial VDAC1-based peptide., Neoplasia (New York, N.Y.), 20(6), 594-609. doi:S1476-5586(17)30508-0 [pii]
de Lucas, A. G., Schuhmacher, A. J., Oteo, M., Romero, E., Camara, J. A., de Martino, A., . . . Mulero, F. (2016), Targeting MT1-MMP as an ImmunoPET-based strategy for imaging gliomas., PloS One, 11(7), e0158634. doi:10.1371/journal.pone.0158634 [doi]
Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., . . . Beierle, E. A. (2018)., Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma., Oncotarget, 9(32), 22665-22679. doi:10.18632/oncotarget.25205 [doi]
Stafman, Laura L; Williams, Adele P; Garner, Evan F; Aye, Jamie M; Stewart, Jerry E; Yoon, Karina J; Whelan, Kimberly; Beierle, Elizabeth A;, Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma., Translational oncology Vol.12, 2019
de Boer, D. V., Martens-de Kemp, S. R., Buijze, M., Stigter-van Walsum, M., Bloemena, E., Dietrich, R., . . . Brakenhoff, R. H. (2017)., Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck., Oncotarget, 8(58), 97928-97940. doi:10.18632/oncotarget.17880 [doi]
Alimova, I., Pierce, A. M., Harris, P., Donson, A., Birks, D. K., Prince, E., . . . Vibhakar, R. (2017)., Targeting polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor, Oncotarget, 8(57), 97290-97303. doi:10.18632/oncotarget.21932 [doi]
Zhang X, Yao J, Li X, Niu N, Liu Y, Hajek RA, Peng G, Westin S, Sood AK, Liu J., Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer., Sci Adv. 2023 Jul 21;9(29):eadf7195. doi: 10.1126/sciadv.adf7195. Epub 2023 Jul 21.
Sorokin AV, Kanikarla Marie P, Bitner L, Syed M, Woods M, Manyam G, Kwong LN, Johnson B, Morris VK, Jones P, Menter DG, Lee MS, Kopetz S., Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6, Cancer Res. 2022 Sep 16;82(18):3335-3344. doi: 10.1158/0008-5472.CAN-22-0198.
Rowell MC, Deschênes-Simard X, Lopes-Paciencia S, Le Calvé B, Kalegari P, Mignacca L, Fernandez-Ruiz A, Guillon J, Lessard F, Bourdeau V, Igelmann S, Duman AM, Stanom Y, Kottakis F, Deshpande V, Krizhanovsky V, Bardeesy N, Ferbeyre G., Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer., Cell Cycle. 2023 Oct;22(19):2172-2193. doi: 10.1080/15384101.2023.2278945. Epub 2023 Dec 5.
Sen, M., Joyce, S., Panahandeh, M., Li, C., Thomas, S. M., Maxwell, J., . . . Grandis, J. R. (2012), Targeting Stat3 abrogates EGFR inhibitor resistance in cancer., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(18), 4986-4996. doi:10.1158/1078-0432.CCR-12-0792 [doi]
Jimbo, M., Blanco, F. F., Huang, Y. H., Telonis, A. G., Screnci, B. A., Cosma, G. L., . . . Brody, J. R. (2015), Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells, Oncotarget, 6(29), 27312-27331. doi:10.18632/oncotarget.4743 [doi]
Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R., Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy, Oncogene. 2020 Feb;39(6):1231-1245. doi: 10.1038/s41388-019-1059-0. Epub 2019 Oct 15.
Tocci P, Roman C, Sestito R, Di Castro V, Sacconi A, Molineris I, Paolini F, Carosi M, Tonon G, Blandino G, Bagnato A., Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition, Cell Death Dis. 2023 Jan 5;14(1):5. doi: 10.1038/s41419-022-05538-6.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G., Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma, Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989.
Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, Dolan JT, Blatchford PJ, Freed BM, Torres RM, Davila E, Slansky JE, Pelanda R, Eckhardt SG, Messersmith WA, Diamond JR, Lieu CH, Verneris MR, Wang JH, Kiseljak-Vassiliades K, Pitts TM, Lang J., Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes, Front Immunol. 2021 Mar 29;12:607282. doi: 10.3389/fimmu.2021.607282. eCollection 2021.
Timilsina S, Rajamanickam S, Rao A, Subbarayalu P, Nirzhor S, Abdelfattah N, Viswanadhapalli S, Chen Y, Jatoi I, Brenner A, Rao MK, Vadlamudi R, Kaklamani V., The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events, Cancer Lett. 2022 Aug 1;540:215717. doi: 10.1016/j.canlet.2022.215717. Epub 2022 May 12.
Luna AJ, Young JM, Sterk RT, Bondu V, Schultz FA, Kusewitt DF, Kang H, Ozbun MA., The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis., Antiviral Res. 2023 Aug;216:105667. doi: 10.1016/j.antiviral.2023.105667. Epub 2023 Jul 8.
Jin, U. H., Lee, S. O., Pfent, C., & Safe, S. (2014)., The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis., BMC Cancer, 14, 498-2407-14-498. doi:10.1186/1471-2407-14-498 [doi]
Bado IL, Zhang W, Hu J, Xu Z, Wang H, Sarkar P, Li L, Wan YW, Liu J, Wu W, Lo HC, Kim IS, Singh S, Janghorban M, Muscarella AM, Goldstein A, Singh P, Jeong HH, Liu C, Schiff R, Huang S, Ellis MJ, Gaber MW, Gugala Z, Liu Z, Zhang XH., The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells, Dev Cell. 2021 Apr 19;56(8):1100-1117.e9. doi: 10.1016/j.devcel.2021.03.008.
Zhang W, Bado IL, Hu J, Wan YW, Wu L, Wang H, Gao Y, Jeong HH, Xu Z, Hao X, Lege BM, Al-Ouran R, Li L, Li J, Yu L, Singh S, Lo HC, Niu M, Liu J, Jiang W, Li Y, Wong STC, Cheng C, Liu Z, Zhang XH., The bone microenvironment invigorates metastatic seeds for further dissemination, Cell. 2021 Apr 29;184(9):2471-2486.e20. doi: 10.1016/j.cell.2021.03.011. Epub 2021 Apr 19.
Morell, C., Bort, A., Vara, D., Ramos-Torres, A., Rodriguez-Henche, N., & Diaz-Laviada, I. (2016)., The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells., Prostate Cancer and Prostatic Diseases, 19(3), 248-257. doi:10.1038/pcan.2016.19 [doi]
Soukupová J, Bordoni C, Turnham DJ, Yang WW, Seaton G, Gruca A, French R, Lee KY, Varnava A, Piggott L, Clarkson RWE, Westwell AD, Brancale A., The Discovery of a Novel Antimetastatic Bcl3 Inhibitor, Mol Cancer Ther. 2021 May;20(5):775-786. doi: 10.1158/1535-7163.MCT-20-0283. Epub 2021 Mar 1.
Anastasia A, Dellavedova G, Ramos-Montoya A, James N, Chiorino G, Russo M, Baakza H, Wilson J, Ghilardi C, Cadogan EB, Giavazzi R, Bani MR., The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases, Mol Cancer Ther. 2022 Apr 1;21(4):555-567. doi: 10.1158/1535-7163.MCT-21-0420.
Nguyen MR, Ma E, Wyatt D, Knight KL, Osipo C., The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells., Front Oncol. 2023 Nov 23;13:1292635. doi: 10.3389/fonc.2023.1292635. eCollection 2023.
Diéguez-Martínez N, Espinosa-Gil S, Yoldi G, Megías-Roda E, Bolinaga-Ayala I, Viñas-Casas M, Gorgisen G, Domingo-Ortí I, Pérez-Montoyo H, Bayascas JR, Colas E, Dolcet X, Lizcano JM., The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival, Cell Mol Life Sci. 2022 Sep 19;79(10):524. doi: 10.1007/s00018-022-04541-6.
van Senten, Jeffrey R; Bebelman, Maarten P; Fan, Tian Shu; Heukers, Raimond; Bergkamp, Nick D; van Gasselt, Puck; Langemeijer, Ellen V; Slinger, Erik; Lagerweij, Tonny; Rahbar, Afsar; Stigter-van Walsum, Marijke; Maussang, David; Leurs, Rob; Musters, RenĂŠ J P; van Dongen, Guus A M S; SĂśderberg-NauclĂŠr, Cecilia; WĂźrdinger, Thomas; Siderius, Marco; Smit, Martine J;, The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties, . The Journal of biological chemistry Vol.294, 2019
Laprevotte, E., Cochaud, S., du Manoir, S., Lapierre, M., Dejou, C., Philippe, M., . . . Bonnefoy, N. (2017)., The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway, Oncotarget, 8(69), 113360-113372. doi:10.18632/oncotarget.23008 [doi]
Canon, J., Osgood, T., Olson, S. H., Saiki, A. Y., Robertson, R., Yu, D., . . . Radinsky, R. (2015)., The MDM2 inhibitor AMG 232 demonstrates robust antitumor efficacy and potentiates the activity of p53-inducing cytotoxic agents, Molecular Cancer Therapeutics, 14(3), 649-658. doi:10.1158/1535-7163.MCT-14-0710 [doi]
Schuller, A. G., Barry, E. R., Jones, R. D., Henry, R. E., Frigault, M. M., Beran, G., . . . D'Cruz, C. M. (2015), The MET inhibitor AZD6094 (savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(12), 2811-2819. doi:10.1158/1078-0432.CCR-14-2685 [doi]
Parisotto M, Vuong-Robillard N, Kalegari P, Meharwade T, Joumier L, Igelmann S, Bourdeau V, Rowell MC, Pollak M, Malleshaiah M, Schmitzer A, Ferbeyre G., The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells, Cancers (Basel). 2022 Nov 14;14(22):5597. doi: 10.3390/cancers14225597.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology Vol.48, 2019, The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis., De La Chapa, Jorge J; Singha, Prajjal K; Self, Kristen K; Sallaway, McKay L; McHardy, Stanton F; Hart, Matthew J; McGuff, Howard Stan; Valdez, Matthew C; Ruiz, Francisco; Polusani, Srikanth R; Gonzales, Cara B;
Kalvala AK, Nimma R, Bagde A, Surapaneni SK, Patel N, Arthur P, Sun L, Singh R, Kommineni N, Nathani A, Li Y, Singh M., The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice, Biochimie. 2022 Dec 17;208:19-30. doi: 10.1016/j.biochi.2022.12.008. Online ahead of print.
Kalvala AK, Nimma R, Bagde A, Surapaneni SK, Patel N, Arthur P, Sun L, Singh R, Kommineni N, Nathani A, Li Y, Singh M., The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice., Biochimie. 2023 May;208:19-30. doi: 10.1016/j.biochi.2022.12.008. Epub 2022 Dec 17.
Leal AS, Moerland JA, Zhang D, Carapellucci S, Lockwood B, Krieger-Burke T, Aleiwi B, Ellsworth E, Liby KT., The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer, Cancers (Basel). 2021 Oct 6;13(19):5004. doi: 10.3390/cancers13195004.
Dabaghi M, Quaas R, Hilger I., The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone, Cancers (Basel). 2020 Sep 9;12(9):2562. doi: 10.3390/cancers12092562.
Martin-Fernandez, M., Valencia, K., Zandueta, C., Ormazabal, C., Martinez-Canarias, S., Lecanda, F., & de la Piedra, C. (2017), The usefulness of bone biomarkers for monitoring treatment disease: A comparative study in osteolytic and osteosclerotic bone metastasis models., Translational Oncology, 10(2), 255-261. doi:S1936-5233(16)30223-6 [pii]
Noll A, Myers C, Biery MC, Meechan M, Tahiri S, Rajendran A, Berens ME, Paine D, Byron S, Zhang J, Winter C, Pakiam F, Leary SES, Cole BL, Jackson ER, Dun MD, Foster JB, Evans MK, Pattwell SS, Olson JM, Vitanza NA., Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma., Neoplasia. 2023 Sep;43:100921. doi: 10.1016/j.neo.2023.100921. Epub 2023 Aug 19.
Kampel L, Goldsmith M, Ramishetti S, Veiga N, Rosenblum D, Gutkin A, Chatterjee S, Penn M, Lerman G, Peer D, Muhanna N., Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles, J Control Release. 2021 Sep 10;337:378-389. doi: 10.1016/j.jconrel.2021.07.034. Epub 2021 Jul 23.
Barbhuiya, M. A., Mirando, A. C., Simons, B. W., Lemtiri-Chlieh, G., Green, J. J., Popel, A. S., . . . Tran, P. T. (2017)., Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma, Oncotarget, 8(60), 101520-101534. doi:10.18632/oncotarget.21148 [doi]
Gadkari K, Kolhatkar U, Hemani R, Campanelli G, Cai Q, Kumar A, Levenson AS., Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study, Nutrients. 2020 Nov 26;12(12):3631. doi: 10.3390/nu12123631.
Wang X, Veeraraghavan J, Liu CC, Cao X, Qin L, Kim JA, Tan Y, Loo SK, Hu Y, Lin L, Lee S, Shea MJ, Mitchell T, Li S, Ellis MJ, Hilsenbeck SG, Schiff R, Wang XS., Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer, Clin Cancer Res. 2021 May 1;27(9):2648-2662. doi: 10.1158/1078-0432.CCR-20-2961. Epub 2021 Feb 4.
Jo U, Murai Y, Agama KK, Sun Y, Saha LK, Yang X, Arakawa Y, Gayle S, Jones K, Paralkar V, Sundaram RK, Van Doorn J, Vasquez JC, Bindra RS, Choi WS, Pommier Y., TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor, Mol Cancer Ther. 2022 Jul 5;21(7):1090-1102. doi: 10.1158/1535-7163.MCT-21-1000.
Redko, B., Tuchinsky, H., Segal, T., Tobi, D., Luboshits, G., Ashur-Fabian, O., . . . Gellerman, G. (2017)., Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma, Oncotarget, 8(1), 757-768. doi:10.18632/oncotarget.12748 [doi]
Kiesel, B. F., Parise, R. A., Guo, J., Huryn, D. M., Johnston, P. A., Colombo, R., . . . Eiseman, J. L. (2016)., Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation., Cancer Chemotherapy and Pharmacology, 78(6), 1225-1235. doi:10.1007/s00280-016-3181-9 [doi]
Zhang, Z., Li, Z., Wu, X., Zhang, C. F., Calway, T., He, T. C., . . . Yuan, C. S. (2015)., TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol., Journal of Pharmacological Sciences, 127(1), 83-91. doi:10.1016/j.jphs.2014.11.003 [doi]
Zhu, Jiajun; Berisa, Mirela; SchwĂśrer, Simon; Qin, Weige; Cross, Justin R; Thompson, Craig B;, Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation, Cell metabolism Vol.30, 2019
Theunissen, J. W., Cai, A. G., Bhatti, M. M., Cooper, A. B., Avery, A. D., Dorfman, R., . . . Migone, T. S. (2018)., Treating tissue factor-positive cancers with antibody-drug conjugates that do not affect blood clotting., Molecular Cancer Therapeutics, doi:molcanther.0471.2018 [pii]
Ferraro MG, Bocchetti M, Riccardi C, Trifuoggi M, Paduano L, Montesarchio D, Misso G, Santamaria R, Piccolo M, Irace C., Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem., Int J Mol Sci. 2023 Mar 30;24(7). pii: 6473. doi: 10.3390/ijms24076473.
Ostler, K. R., Yang, Q., Looney, T. J., Zhang, L., Vasanthakumar, A., Tian, Y., . . . Godley, L. A. (2012)., Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma., Cancer Research, 72(18), 4714-4723. doi:10.1158/0008-5472.CAN-12-0886 [doi]
Dziegielewska, B., Casarez, E. V., Yang, W. Z., Gray, L. S., Dziegielewski, J., & Slack-Davis, J. K. (2016), T-type Ca2+ channel inhibition sensitizes ovarian cancer to carboplatin., Molecular Cancer Therapeutics, 15(3), 460-470. doi:10.1158/1535-7163.MCT-15-0456 [doi]
Lingasamy P, Laarmann AH, Teesalu T., Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting, Curr Cancer Drug Targets. 2021;21(1):70-79. doi: 10.2174/1568009620666201001112749.
Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumäe M, Rätsep T, Asser T, Bjerkvig R, Teesalu T., Tumor-penetrating peptide for systemic targeting of Tenascin-C, Sci Rep. 2020 Apr 2;10(1):5809. doi: 10.1038/s41598-020-62760-y.
Emmenegger, U., Francia, G., Chow, A., Shaked, Y., Kouri, A., Man, S., & Kerbel, R. S. (2011)., Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide, Neoplasia (New York, N.Y.), 13(1), 40-48.
Brunetti, J., Pillozzi, S., Falciani, C., Depau, L., Tenori, E., Scali, S., . . . Bracci, L. (2015)., Tumor-selective peptide-carrier delivery of paclitaxel increases in vivo activity of the drug, Scientific Reports, 5, 17736. doi:10.1038/srep17736 [doi]
Gayle S, Aiello R, Leelatian N, Beckta JM, Bechtold J, Bourassa P, Csengery J, Maguire RJ, Marshall D, Sundaram RK, Van Doorn J, Jones K, Moore H, Lopresti-Morrow L, Paradis T, Tylaska L, Zhang Q, Visca H, Reshetnyak YK, Andreev OA, Engelman DM, Glazer PM, Bindra RS, Paralkar VM., Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity, NAR Cancer. 2021 Jun 4;3(2):zcab021. doi: 10.1093/narcan/zcab021. eCollection 2021 Jun.
Petreus T, Cadogan E, Hughes G, Smith A, Pilla Reddy V, Lau A, O'Connor MJ, Critchlow S, Ashford M, Oplustil O'Connor L., Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response, Commun Biol. 2021 Aug 24;4(1):1001. doi: 10.1038/s42003-021-02526-y.
González-Rubio S, Salgado C, Manzaneda-González V, Muñoz-Úbeda M, Ahijado-Guzmán R, Natale P, Almendro-Vedia VG, Junquera E, Barcina JO, Ferrer I, Guerrero-Martínez A, Paz-Ares L, López-Montero I., Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy, Nanoscale. 2022 Jun 9;14(22):8028-8040. doi: 10.1039/d2nr02353a.
Yuan, B., Cheng, L., Gupta, K., Chiang, H. C., Gupta, H. B., Sareddy, G. R., . . . Li, R. (2016)., Tyrosine phosphorylation regulates ERbeta ubiquitination, protein turnover, and inhibition of breast cancer., Oncotarget, 7(27), 42585-42597. doi:10.18632/oncotarget.10018 [doi]
Williams, Adele P; Garner, Evan F; Stafman, Laura L; Aye, Jamie M; Quinn, Colin H; Marayati, Raoud; Stewart, Jerry E; Atigadda, Venkatram R; Mroczek-Musulman, Elizabeth; Moore, Blake P; Beierle, Elizabeth A; Friedman, Gregory K;, UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts., Translational oncology Vol.12, 2019
Nguyen, Tu; Kirsch, Brian James; Asaka, Ryoichi; Nabi, Karim; Quinones, Addison; Tan, Jessica; Antonio, Marjorie Justine; Camelo, Felipe; Li, Ting; Nguyen, Stephanie; Hoang, Giang; Nguyen, Kiet; Udupa, Sunag; Sazeides, Christos; Shen, Yao-An; Elgogary, Amira; Reyes, Juvenal; Zhao, Liang; Kleensang, Andre; Chaichana, Kaisorn Lee; Hartung, Thomas; Betenbaugh, Michael J; Marie, Suely K; Jung, Jin G; Wang, Tian-Li; Gabrielson, Edward; Le, Anne;, Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cance, Cell reports Vol.27, 2019
Lu H, Gomaa A, Wang-Bishop L, Ballout F, Hu T, McDonald O, Washington MK, Livingstone AS, Wang TC, Peng D, El-Rifai W, Chen Z., Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma, Cancers (Basel). 2022 Mar 9;14(6):1401. doi: 10.3390/cancers14061401.
Richter, K., Paakkola, T., Mennerich, D., Kubaichuk, K., Konzack, A., Kippari, H. A., . . . Kietzmann, T. (2018), USP28 deficiency promotes breast and liver carcinogenesis as well as tumor angiogenesis in a HIF-independent manner., Molecular Cancer Research : MCR, 16(6), 1000-1012. doi:10.1158/1541-7786.MCR-17-0452 [doi]
Gholami, S., Chen, C. H., Lou, E., Belin, L. J., Fujisawa, S., Longo, V. A., . . . Fong, Y. (2014), Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer., FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 28(2), 676-682. doi:10.1096/fj.13-237222 [doi]
Jamadar A, Dwivedi N, Mathew S, Calvet JP, Thomas SM, Rao R., Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation, Int J Mol Sci. 2022 Jul 9;23(14):7601. doi: 10.3390/ijms23147601.
Gruslova, A., Cavazos, D. A., Miller, J. R., Breitbart, E., Cohen, Y. C., Bangio, L., . . . Brenner, A. J. (2015)., VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme, Journal of Neuro-Oncology, 124(3), 365-372. doi:10.1007/s11060-015-1853-7 [doi]
O'Steen, S., Green, D. J., Gopal, A. K., Orozco, J. J., Kenoyer, A. L., Lin, Y., . . . Press, O. W. (2017)., Venetoclax synergizes with radiotherapy for treatment of B-cell lymphomas., Cancer Research, 77(14), 3885-3893. doi:10.1158/0008-5472.CAN-17-0082 [doi]
Smith BD, Kaufman MD, Wise SC, Ahn YM, Caldwell TM, Leary CB, Lu WP, Tan G, Vogeti L, Vogeti S, Wilky BA, Davis LE, Sharma M, Ruiz-Soto R, Flynn DL., Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages, Mol Cancer Ther. 2021 Nov;20(11):2098-2109. doi: 10.1158/1535-7163.MCT-21-0361. Epub 2021 Aug 25.
Patil, S. S., Gentschev, I., Adelfinger, M., Donat, U., Hess, M., Weibel, S., . . . Szalay, A. A. (2012)., Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody, PloS One, 7(10), e47472. doi:10.1371/journal.pone.0047472 [doi]
Kim SI, Chaurasiya S, Park AK, Kang S, Lu J, Woo Y, Yin HH, Yin Z, Fong Y, Warner SG., Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models, Int J Mol Sci. 2020 Oct 3;21(19):7326. doi: 10.3390/ijms21197326.
Thomson CS, Pundavela J, Perrino MR, Coover RA, Choi K, Chaney KE, Rizvi TA, Largaespada DA, Ratner N., WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth, Oncogene. 2021 Jun;40(24):4229-4241. doi: 10.1038/s41388-021-01773-x. Epub 2021 Jun 2.
Stein, A. P., Swick, A. D., Smith, M. A., Blitzer, G. C., Yang, R. Z., Saha, S., . . . Kimple, R. J. (2015)., Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies, Cancer Medicine, 4(5), 699-712. doi:10.1002/cam4.387 [doi]
Zhang, Q., Sun, X., Yang, J., Ding, H., LeBrun, D., Ding, K., . . . Li, M. (2015)., ZIP4 silencing improves bone loss in pancreatic cancer., Oncotarget, 6(28), 26041-26051. doi:10.18632/oncotarget.4667 [doi]
Del Vecchio V, Mele L, Panda SK, Sanchez-Pajares IR, Mosca L, Tirino V, Barbieri M, Bruzzese F, Luciano A, Marino FZ, Accardo M, Nicoletti GF, Papaccio G, Barbieri A, Desiderio V., β2-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery, Cell Death Dis. 2023 Sep 19;14(9):613. doi: 10.1038/s41419-023-06129-9.
Cam M, Charan M, Welker AM, Dravid P, Studebaker AW, Leonard JR, Pierson CR, Nakano I, Beattie CE, Hwang EI, Kambhampati M, Nazarian J, Finlay JL, Cam H., ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma, Neuro Oncol. 2020 Mar 5;22(3):345-356. doi: 10.1093/neuonc/noz190.
Kantak S, Faggioni R, Cai AG, Bhatti MM, Li J, Vainshtein I, Cheng J, Mendelsohn BA, Gaudreault J, Migone TS, Theunissen JW., Preclinical Characterization of XB002, an Anti-Tissue Factor Antibody-Drug Conjugate for the Treatment of Solid Tumors, Mol Cancer Ther - 10.1158/1535-7163.MCT-24-0002
Mossenta M, Argenziano M, Capolla S, Busato D, Durigutto P, Mangogna A, Polano M, Sblattero D, Cavalli R, Macor P, Toffoli G, Dal Bo M., Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma, Nanomedicine (Lond) - 10.1080/17435889.2025.2452154
Hawsawi O, Xue W, Du T, Guo M, Yu X, Zhang M, Hoffman PS, Bollag R, Li J, Zhou J, Wang H, Zhang J, Fu Z, Chen X, Yan C., Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth, Cell Rep Med - 10.1016/j.xcrm.2024.101890
Chicón-Bosch M, Sánchez-Serra S, Rosàs-Lapeña M, Costa-Fraga N, Besalú-Velázquez J, Illa-Bernadí J, Mateo-Lozano S, Cidre-Aranaz F, Grünewald TGP, Díaz-Lagares Á, Lopez-Alemany R, Tirado ÒM., Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis, Mol Oncol - 10.1002/1878-0261.13788
Di Cintio F, Argenziano M, Scomparin A, Capolla S, Busato D, Steffè A, Mangogna A, Sblattero D, Cavalli R, Macor P, Dal Bo M, Toffoli G., The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells, Nanomedicine (Lond) - 10.1080/17435889.2024.2434451
Taya M, Merenbakh-Lamin K, Zubkov A, Honig Z, Kurolap A, Mayer O, Shomron N, Wolf I, Rubinek T., Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer, Breast Cancer Res Treat - 10.1007/s10549-024-07507-3
Johnson SS, Liu D, Ewald JT, Robles-Planells C, Pulliam C, Christensen KA, Bayanbold K, Wels BR, Solst SR, O'Dorisio MS, Menda Y, Spitz DR, Fath MA., Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth, Cancer Biol Ther - 10.1080/15384047.2024.2382524
Ortega-Bertran S, Fernández-Rodríguez J, Magallón-Lorenz M, Zhang X, Creus-Bachiller E, Diazgranados AP, Uriarte-Arrazola I, Mazuelas H, Blanco I, Valverde C, Carrió M, Villanueva A, De Raedt T, Romagosa C, Gel B, Salvador H, Ferrer M, Lázaro C, Serra E., Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models, Clin Cancer Res - 10.1158/1078-0432.CCR-24-2807
Loos B, Salas-Bastos A, Nordin A, Debbache J, Stierli S, Cheng PF, Rufli S, Wyss C, Levesque MP, Dummer R, Wong WW, Pascolo S, Cantù C, Sommer L., TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis, Cell Death Dis - 10.1038/s41419-024-07305-1
Pranzini E, Muccillo L, Nesi I, Santi A, Mancini C, Lori G, Genovese M, Lottini T, Comito G, Caselli A, Arcangeli A, Sabatino L, Colantuoni V, Taddei ML, Cirri P, Paoli P., Limiting serine availability during tumor progression promotes muscle wasting in cancer cachexia, Cell Death Discov - 10.1038/s41420-024-02271-1
Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP., Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma, Mol Ther Oncol - 10.1016/j.omton.2024.200886
Sala R, Esquer H, Kellett T, Clune S, Awolade P, Pike LA, Zhou Q, Messersmith WA, LaBarbera DV., CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models, Int J Mol Sci - 10.3390/ijms252313160
Hwang SY, Jeon KH, Lee HJ, Moon I, Jung S, Kim SA, Jo H, Park S, Ahn M, Kwak SY, Na Y, Kwon Y., Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction, Elife - 10.7554/eLife.97051
Das A, Barry MM, Ernst CA, Dahiya R, Kim M, Rosario SR, Lo HC, Yu C, Dai T, Gugala Z, Zhang J, Dasgupta S, Wang H., Differential bone morphology and hypoxia activity in skeletal metastases of ER(+) and ER(-) breast cancer, Commun Biol - 10.1038/s42003-024-07247-6
Xie J, Barbolina MV., Dual Targeting of CX(3)CR1 and PARP in Models of High-Grade Serous Ovarian Carcinoma, Cancers (Basel) - 10.3390/cancers16223728
Saidi A, Stallons TA, Wong AG, Torgue JJ., Preclinical Investigation of [(212)Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model, J Nucl Med - 10.2967/jnumed.124.268101
Kang F, Niu M, Zhou Z, Zhang M, Xiong H, Zeng F, Wang J, Chen X., Spatiotemporal Concurrent PARP Inhibitor Sensitization Based on Radiation-Responsive Nanovesicles for Lung Cancer Chemoradiotherapy, Adv Healthc Mater - 10.1002/adhm.202400908
Zhou Q, Harding JC, Fan P, Spasojevic I, Kovacs A, Akk A, Mitchell A, Springer LE, Gaut JP, Rauch DA, Wickline SA, Pham CTN, Fuh K, Pan H., Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice, Nanomaterials (Basel) - 10.3390/nano14211752
Pangua C, Espuelas S, Simón JA, Álvarez S, Martínez-Ohárriz C, Collantes M, Peñuelas I, Calvo A, Irache JM., Enhancing bevacizumab efficacy in a colorectal tumor mice model using dextran-coated albumin nanoparticles, Drug Deliv Transl Res - 10.1007/s13346-024-01734-3
Cadzow L, Brenneman J, Tobin E, Sullivan P, Nayak S, Ali JA, Shenker S, Griffith J, McGuire M, Grasberger P, Mishina Y, Murray M, Dodson AE, Gannon H, Krall E, Hixon J, Chipumuro E, Sinkevicius K, Gokhale PC, Ganapathy S, Matulonis UA, Liu JF, Olaharski A, Sangurdekar D, Liu H, Wilt J, Schlabach M, Stegmeier F, Wylie AA., The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors, Cancer Res - 10.1158/0008-5472.CAN-24-0293
Gangula A, Suresh D, Babu AS, Li Z, Upendran A, Kannan R., Gelatin and lipidoid integrate to create gelasomes to enhance siRNA delivery with low toxicity, Bioact Mater - 10.1016/j.bioactmat.2024.06.008
Nathani A, Khan I, Tanimoto MH, Mejía JAA, DE Miranda AM, Rishi A, Dev S, Bastos JK, Singh M., Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis, Anticancer Res - 10.21873/anticanres.17248
Eisenberg V, Hoogi S, Katzman E, Ben Haim N, Zur-Toledano R, Radman M, Reboh Y, Zadok O, Kamer I, Bar J, Sagi I, Hendel A, Cohen CJ., Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells, Cancer Immunol Res - 10.1158/2326-6066.CIR-23-0823
Metselaar DS, Meel MH, Goulding JR, du Chatinier A, Rigamonti L, Waranecki P, Geisemeyer N, de Gooijer MC, Breur M, Koster J, Veldhuijzen van Zanten SEM, Bugiani M, Franke NE, Reddy A, Wesseling P, Kaspers GJL, Hulleman E., Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors, Cell Rep Med - 10.1016/j.xcrm.2024.101700
Bhattacharya D, Barrile R, Toukam DK, Gawali VS, Kallay L, Ahmed T, Brown H, Rezvanian S, Karve A, Desai PB, Medvedovic M, Wang K, Ionascu D, Harun N, Vallabhapurapu S, Wang C, Qi X, Baschnagel AM, Kritzer JA, Cook JM, Pomeranz Krummel DA, Sengupta S., GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors, Cancers (Basel) - 10.3390/cancers16183167
Kato Y, Rice N, Pokrass M, Jeong J, Rodriguez R, Field JJ, Nowyhed H., Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment, Commun Biol - 10.1038/s42003-024-06839-6
Lilja J, Kaivola J, Conway JRW, Vuorio J, Parkkola H, Roivas P, Dibus M, Chastney MR, Varila T, Jacquemet G, Peuhu E, Wang E, Pentikäinen U, Martinez D Posada I, Hamidi H, Najumudeen AK, Sansom OJ, Barsukov IL, Abankwa D, Vattulainen I, Salmi M, Ivaska J., SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers, Nat Commun - 10.1038/s41467-024-52326-1
Zhang X, Duan S, Apostolou PE, Wu X, Watanabe J, Gallitto M, Barron T, Taylor KR, Woo PJ, Hua X, Zhou H, Wei HJ, McQuillan N, Kang KD, Friedman GK, Canoll PD, Chang K, Wu CC, Hashizume R, Vakoc CR, Monje M, McKhann GM 2nd, Gogos JA, Zhang Z., CHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma, Cancer Discov - 10.1158/2159-8290.CD-23-0012
Yang H, Zingaro VA, Lincoff J, Tom H, Oikawa S, Oses-Prieto JA, Edmondson Q, Seiple I, Shah H, Kajimura S, Burlingame AL, Grabe M, Ruggero D., Remodelling of the translatome controls diet and its impact on tumorigenesis, Nature - 10.1038/s41586-024-07781-7
Sánchez-Ortega M, Garrido A, Cirauqui C, Sanz-Gonzalez L, Hernández MC, González-García A, Obregon K, Ferrer I, Paz-Ares L, Carrera AC., A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma, Redox Biol - 10.1016/j.redox.2024.103305
Jiménez-Reinoso A, Molero-Abraham M, Cirauqui C, Blanco B, Garrido-Martin EM, Nehme-Álvarez D, Domínguez-Alonso C, Ramírez-Fernández Á, Díez-Alonso L, Nuñez-Buiza Á, González-Murillo Á, Tobes R, Pareja E, Ramírez-Orellana M, Rodriguez-Peralto JL, Ferrer I, Zugazagoitia J, Paz-Ares L, Álvarez-Vallina L., CD4(+) tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts, Oncoimmunology - 10.1080/2162402X.2024.2392897
Chauhan S, Lian E, Habib I, Liu Q, Anders NM, Bugg MM, Federman NC, Reid JM, Stewart CF, Cates T, Michalek JE, Keller C., Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, Sci Rep - 10.1038/s41598-024-66545-5
Atkins HM, Uslu AA, Li JJ, Shearer DA, Brendle SA, Han C, Kozak M, Lopez P, Nayar D, Balogh KK, Abendroth C, Copper J, Cheng KC, Christensen ND, Zhu Y, Avril S, Burgener AD, Murooka TT, Hu J., Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening, mBio - 10.1128/mbio.01420-24
Zeppa L, Aguzzi C, Morelli MB, Marinelli O, Amantini C, Giangrossi M, Santoni G, Fanelli A, Luongo M, Nabissi M., In Vitro and In Vivo Effects of Melatonin-Containing Combinations in Human Pancreatic Ductal Adenocarcinoma, J Pineal Res - 10.1111/jpi.12997
Leung YK, Lee SG, Wang J, Guruvaiah P, Rusch NJ, Ho SM, Park C, Kim K., The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma, Adv Sci (Weinh) - 10.1002/advs.202308539
Riquelme MA, Wang X, Acosta FM, Zhang J, Chavez J, Gu S, Zhao P, Xiong W, Zhang N, Li G, Srinivasan S, Ma C, Rao MK, Sun LZ, Zhang N, An Z, Jiang JX., Antibody-activation of connexin hemichannels in bone osteocytes with ATP release suppresses breast cancer and osteosarcoma malignancy, Cell Rep - 10.1016/j.celrep.2024.114377
Elayapillai SP, Gandhi A, Dogra S, Saunders D, Smith N, Hladik C, Towner RA, Moxley KM, Hannafon BN., OKN-007 is an Effective Anticancer Therapeutic Agent Targeting Inflammatory and Immune Metabolism Pathways in Endometrial Cancer, J Pharmacol Exp Ther - 10.1124/jpet.124.002223
Ivancevic A, Simpson DM, Joyner OM, Bagby SM, Nguyen LL, Bitler BG, Pitts TM, Chuong EB., Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer, Sci Adv - 10.1126/sciadv.ado1218
Ryan MB, Quade B, Schenk N, Fang Z, Zingg M, Cohen SE, Swalm BM, Li C, Özen A, Ye C, Ritorto MS, Huang X, Dar AC, Han Y, Hoeflich KP, Hale M, Hagel M., The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers, Cancer Discov - 10.1158/2159-8290.CD-24-0139
Dias MH, Friskes A, Wang S, Fernandes Neto JM, van Gemert F, Mourragui S, Papagianni C, Kuiken HJ, Mainardi S, Alvarez-Villanueva D, Lieftink C, Morris B, Dekker A, van Dijk E, Wilms LHS, da Silva MS, Jansen RA, Mulero-Sánchez A, Malzer E, Vidal A, Santos C, Salazar R, Wailemann RAM, Torres TEP, De Conti G, Raaijmakers JA, Snaebjornsson P, Yuan S, Qin W, Kovach JS, Armelin HA, Te Riele H, van Oudenaarden A, Jin H, Beijersbergen RL, Villanueva A, Medema RH, Bernards R., Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy, Cancer Discov - 10.1158/2159-8290.CD-23-0216
Laverty DJ, Gupta SK, Bradshaw GA, Hunter AS, Carlson BL, Calmo NM, Chen J, Tian S, Sarkaria JN, Nagel ZD., ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma, Nat Commun - 10.1038/s41467-024-49316-8
Kim SS, Moghe M, Rait A, Donaldson K, Harford JB, Chang EH., SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors, Int J Nanomedicine - 10.2147/IJN.S458323
Geethadevi A, Ku Z, Tsaih SW, Parashar D, Kadamberi IP, Xiong W, Deng H, George J, Kumar S, Mittal S, Zhang N, Pradeep S, An Z, Chaluvally-Raghavan P., Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer, NPJ Precis Oncol - 10.1038/s41698-024-00593-y
Iida M, Crossman BE, Kostecki KL, Glitchev CE, Kranjac CA, Crow MT, Adams JM, Liu P, Ong I, Yang DT, Kang I, Salgia R, Wheeler DL., MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer, Int J Mol Sci - 10.3390/ijms25105109
Petersen ME, Brant MG, Lasalle M, Das S, Duan R, Wong J, Ding T, Wu KJ, Siddappa D, Fang C, Zhang W, Wu AML, Hirkala-Schaefer T, Garnett GAE, Fung V, Yang L, Hernandez Rojas A, Lawn SO, Barnscher SD, Rich JR, Colombo R., Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates, Mol Cancer Ther - 10.1158/1535-7163.MCT-23-0822
Calbert ML, Chandramouly G, Adams CM, Saez-Ayala M, Kent T, Tyagi M, Ayyadevara VSSA, Wang Y, Krais JJ, Gordon J, Atkins J, Toma MM, Betzi S, Boghossian AS, Rees MG, Ronan MM, Roth JA, Goldman AR, Gorman N, Mitra R, Childers WE, Graña X, Skorski T, Johnson N, Hurtz C, Morelli X, Eischen CM, Pomerantz RT., 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress, Mol Cancer Ther - 10.1158/1535-7163.MCT-23-0487
Elechalawar CK, Gulla SK, Roy RV, Means N, Zhang Y, Asifa S, Robertson DJ, Xu C, Bhattacharya R, Mukherjee P., Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer, Cancer Lett - 10.1016/j.canlet.2024.216810
Rupert PB, Buerger M, Girard EJ, Frutoso M, Parrilla D, Ng K, Gooley T, Groh V, Strong RK., Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys, Heliyon - 10.1016/j.heliyon.2024.e28583
Lazo JS, Isbell KN, Vasa SA, Llaneza DC, Mingledorff GA, Sharlow ER., Deletion of PTP4A3 phosphatase in high grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release, J Pharmacol Exp Ther - 10.1124/jpet.124.002110
Alhozeel B, Pandey SK, Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V., Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer, Cells - 10.3390/cells13070627
Arriaga JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, Afari S, Chhouri H, Vunjak-Novakovic G, Abate-Shen C., In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis, Oncogene - 10.1038/s41388-024-02995-5
Creus-Bachiller E, Fernández-Rodríguez J, Magallón-Lorenz M, Ortega-Bertran S, Navas-Rutete S, Romagosa C, Silva TM, Pané M, Estival A, Perez Sidelnikova D, Morell M, Mazuelas H, Carrió M, Lausová T, Reuss D, Gel B, Villanueva A, Serra E, Lázaro C., Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities, Mol Oncol - 10.1002/1878-0261.13534
Sahovaler A, Valic MS, Townson JL, Chan HHL, Zheng M, Tzelnick S, Mondello T, Pener-Tessler A, Eu D, El-Sayes A, Ding L, Chen J, Douglas CM, Weersink R, Muhanna N, Zheng G, Irish JC., Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models, Cancer Res Commun - 10.1158/2767-9764.CRC-23-0269
Wang Y, Situ X, Cardenas H, Siu E, Alhunayan SA, Keathley R, Tanner E, Wei JJ, Tan Y, Prabhu Dessai CV, Cheng JX, Matei D., Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer, Clin Cancer Res - 10.1158/1078-0432.CCR-23-2368
Marquez-Palencia M, Reza Herrera L, Parida PK, Ghosh S, Kim K, Das NM, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Diegeler S, Aguilera TA, Peng Y, Lewis CM, Arteaga CL, Hanker AB, Whitehurst AW, Lorens JB, Brekken RA, Davis AJ, Malladi S., AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer, Cancer Res - 10.1158/0008-5472.CAN-23-1459
Chaib S, López-Domínguez JA, Lalinde-Gutiérrez M, Prats N, Marin I, Boix O, García-Garijo A, Meyer K, Muñoz MI, Aguilera M, Mateo L, Stephan-Otto Attolini C, Llanos S, Pérez-Ramos S, Escorihuela M, Al-Shahrour F, Cash TP, Tchkonia T, Kirkland JL, Abad M, Gros A, Arribas J, Serrano M., The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2, Nat Cancer - 10.1038/s43018-023-00712-x
Mei X, Kok HP, Rodermond HM, van Bochove GGW, Snoek BC, van Leeuwen CM, Franken NAP, Ten Hagen TLM, Crezee J, Vermeulen L, Stalpers LJA, Oei AL., Radiosensitization by Hyperthermia Critically Depends on the Time Interval, Int J Radiat Oncol Biol Phys - 10.1016/j.ijrobp.2023.09.048
Kwon S, Meng F, Tamam H, Gadalla HH, Wang J, Dong B, Hopf Jannasch AS, Ratliff TL, Yeo Y., Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Antitumor Immunity and Eliminates Tumors, ACS Nano - 10.1021/acsnano.3c11445
Nathani A, Sun L, Khan I, Aare M, Bagde A, Li Y, Singh M., Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations, Pharmaceutics - 10.3390/pharmaceutics16010083
Eluu SC, Obayemi JD, Salifu AA, Yiporo D, Oko AO, Aina T, Oparah JC, Ezeala CC, Etinosa PO, Ugwu CM, Esimone CO, Soboyejo WO., In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer, Sci Rep - 10.1038/s41598-023-50656-6
Gendrau-Sanclemente N, Figueras A, Gracova K, Lahiguera Á, Alsina-Sanchís E, Marín-Jiménez JA, Vidal A, Matias-Guiu X, Fernandez-Gonzalez S, Barahona M, Martí L, Ponce J, Viñals F., Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread, Mol Oncol - 10.1002/1878-0261.13556
Surgical
Servetto A, Kollipara R, Formisano L, Lin CC, Lee KM, Sudhan DR, Gonzalez-Ericsson PI, Chatterjee S, Guerrero-Zotano A, Mendiratta S, Akamatsu H, James N, Bianco R, Hanker AB, Kittler R, Arteaga CL., Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer., Clin Cancer Res. 2021 Aug 1;27(15):4379-4396. doi: 10.1158/1078-0432.CCR-20-3905. Epub 2021 May 19.
Transplantation
Bansal A, Pandey MK, Yamada S, Goyal R, Schmit NR, Jeon R, Nesbitt JJ, Witt TA, Singh RD, Gunderson TM, Boroumand S, Li M, Crespo-Diaz RJ, Hillestad ML, Terzic A, Behfar A, DeGrado TR., [(89)Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure, Nucl Med Biol. 2020 Nov-Dec;90-91:23-30. doi: 10.1016/j.nucmedbio.2020.09.001. Epub 2020 Sep 9.
Xu, J., Li, K., Smith, R. A., Waterton, J. C., Zhao, P., Ding, Z., . . . Gore, J. C. (2017)., A comparative assessment of preclinical chemotherapeutic response of tumors using quantitative non-gaussian diffusion MRI, Magnetic Resonance Imaging, 37, 195-202. doi:S0730-725X(16)30239-9 [pii]
Caffrey, P. B., Frenkel, G. D., McAndrew, K. L., & Marks, K. (2016)., A model of the development of cisplatin resistance in human small cell lung cancer xenografts, In Vivo (Athens, Greece), 30(6), 745-749. doi:30/6/745 [pii]
Shimoda, M., Chen, S., Noguchi, H., Takita, M., Sugimoto, K., Itoh, T., . . . Grayburn, P. A. (2014)., A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1., Human Gene Therapy Methods, 25(3), 206-219. doi:10.1089/hgtb.2013.122 [doi]
Curtin, C., Nolan, J. C., Conlon, R., Deneweth, L., Gallagher, C., Tan, Y. J., . . . Piskareva, O. (2018)., A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models. Acta, Acta Biomaterialia, 70, 84-97. doi:S1742-7061(18)30074-6 [pii]
Hou, F., Dai, Y., Suen, J. Y., Fan, C., Saad, A. G., & Richter, G. T. (2013)., A xenograft animal model of human arteriovenous malformations, Orphanet Journal of Rare Diseases, 8, 199-1172-8-199. doi:10.1186/1750-1172-8-199 [doi]
Borgogna, C., Olivero, C., Lanfredini, S., Calati, F., De Andrea, M., Zavattaro, E., . . . Gariglio, M. (2018)., Beta-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort., Frontiers in Microbiology, 9, 117. doi:10.3389/fmicb.2018.00117 [doi]
Yan, S., Zhang, R., Wu, K., Cui, J., Huang, S., Ji, X., . . . Weng, Y. (2018)., Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference., Genes & Diseases, 5(2), 172-184. doi:10.1016/j.gendis.2018.04.006 [doi]
Yu Q, DiFeo Jacquet R, Landis WJ., Characterization of Tissue-Engineered Human Periosteum and Allograft Bone Constructs: The Potential of Periosteum in Bone Regenerative Medicine, Cells Tissues Organs. 2020;209(2-3):128-143. doi: 10.1159/000509036. Epub 2020 Sep 16.
Howard, C. B., McDowell, R., Feleke, K., Deer, E., Stamps, S., Thames, E., . . . Pervin, S. (2016)., Chemotherapeutic vulnerability of triple-negative breast cancer cell-derived tumors to pretreatment with vernonia amygdalina aqueous extracts., Anticancer Research, 36(8), 3933-3943. doi:36/8/3933 [pii]
Kilinc, M. O., Ehrig, K., Pessian, M., Minev, B. R., & Szalay, A. A. (2016)., Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells., Journal of Translational Medicine, 14(1), 340-016-1096-1. doi:10.1186/s12967-016-1096-1 [doi]
Pastor, D., Viso-Leon, M. C., Jones, J., Jaramillo-Merchan, J., Toledo-Aral, J. J., Moraleda, J. M., & Martinez, S. (2012)., Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model., Stem Cell Reviews, 8(2), 445-458. doi:10.1007/s12015-011-9295-x [doi]
Citro, L., Naidu, S., Hassan, F., Kuppusamy, M. L., Kuppusamy, P., Angelos, M. G., & Khan, M. (2014)., Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction, PloS One, 9(12), e116281. doi:10.1371/journal.pone.0116281 [doi]
Corona, B. T., Henderson, B. E., Ward, C. L., & Greising, S. M. (2017)., Contribution of minced muscle graft progenitor cells to muscle fiber formation after volumetric muscle loss injury in wild-type and immune deficient mice., Physiological Reports, 5(7), 10.14814/phy2.13249. doi:e13249 [pii]
Rodriguez Calleja, L., Jacques, C., Lamoureux, F., Baud'huin, M., Tellez Gabriel, M., Quillard, T., . . . Ory, B. (2016)., DeltaNp63alpha silences a miRNA program to aberrantly initiate a wound-healing program that promotes TGFbeta-induced metastasis, Cancer Research, 76(11), 3236-3251. doi:10.1158/0008-5472.CAN-15-2317 [doi]
Lee, C. W., Guo, L., Matei, D., & Stantz, K. (2015)., Development of follicle-stimulating hormone receptor binding probes to image ovarian xenografts, Journal of Biotechnology & Biomaterials, 5(3), 10.4172/2155-952X.1000198. Epub 2015 Sep 10. doi:198 [pii]
Kiseljak-Vassiliades, K., Zhang, Y., Bagby, S. M., Kar, A., Pozdeyev, N., Xu, M., . . . Wierman, M. E. (2018)., Development of new preclinical models to advance adrenocortical carcinoma research., Endocrine-Related Cancer, 25(4), 437-451. doi:10.1530/ERC-17-0447 [doi]
Song D, Huang S, Zhang L, Liu W, Huang B, Feng Y, Liu B, He TC, Huang D, Reid RR., Differential Responsiveness to BMP9 between Patent and Fused Suture Progenitor Cells from Craniosynostosis Patients, Plast Reconstr Surg. 2020 Mar;145(3):552e-562e. doi: 10.1097/PRS.0000000000006597.
Yang, Y. C., Liem, A., Lambert, P. F., & Sugden, B. (2017)., Dissecting the regulation of EBV's BART miRNAs in carcinomas, Virology, 505, 148-154. doi:S0042-6822(17)30054-5 [pii]
Novella-Maestre, E., Herraiz, S., Vila-Vives, J. M., Carda, C., Ruiz-Sauri, A., & Pellicer, A. (2012)., Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers., Fertility and Sterility, 98(5), 1209-1217. doi:10.1016/j.fertnstert.2012.07.1103 [doi]
Yu, X., Chen, L., Wu, K., Yan, S., Zhang, R., Zhao, C., . . . Gan, H. (2018)., Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs)., Genes & Diseases, 5(2), 137-149. doi:10.1016/j.gendis.2018.04.003 [doi]
Rodriguez, M., Silva, J., Herrera, A., Herrera, M., Pena, C., Martin, P., . . . Garcia-Barberan, V. (2015)., Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer., Oncotarget, 6(38), 40575-40587. doi:10.18632/oncotarget.5818 [doi]
Hoppela, E., Gronroos, T. J., Saarikko, A. M., Tervala, T. V., Kauhanen, S., Nuutila, P., . . . Hartiala, P. (2018)., Fat grafting can induce browning of white adipose tissue., Plastic and Reconstructive Surgery.Global Open, 6(6), e1804. doi:10.1097/GOX.0000000000001804 [doi]
Hubmann, R., Sieghart, W., Schnabl, S., Araghi, M., Hilgarth, M., Reiter, M., . . . Shehata, M. (2017)., Gliotoxin targets nuclear NOTCH2 in human solid tumor derived cell lines in vitro and inhibits melanoma growth in xenograft mouse model., Frontiers in Pharmacology, 8, 319. doi:10.3389/fphar.2017.00319 [doi]
Bueno, C., Ramirez, C., Rodriguez-Lozano, F. J., Tabares-Seisdedos, R., Rodenas, M., Moraleda, J. M., . . . Martinez, S. (2013)., Human adult periodontal ligament-derived cells integrate and differentiate after implantation into the adult mammalian brain, Cell Transplantation, 22(11), 2017-2028. doi:10.3727/096368912X657305 [doi]
Sareen, D., Gowing, G., Sahabian, A., Staggenborg, K., Paradis, R., Avalos, P., . . . Svendsen, C. N. (2014)., Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord., The Journal of Comparative Neurology, 522(12), 2707-2728. doi:10.1002/cne.23578 [doi]
Hernandez-Gonzalez F, Prats N, Ramponi V, López-DomÃnguez JA, Meyer K, Aguilera M, Muñoz MartÃn MI, MartÃnez D, Agusti A, Faner R, Sellarés J, Pietrocola F, Serrano M., Human senescent fibroblasts trigger progressive lung fibrosis in mice., Aging (Albany NY). 2023 Jul 1;15(14):6641-6657. doi: 10.18632/aging.204825. Epub 2023 Jul 1.
Melsens, E., De Vlieghere, E., Descamps, B., Vanhove, C., Kersemans, K., De Vos, F., . . . Pattyn, P. (2018)., Hypoxia imaging with (18)F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts., Radiation Oncology (London, England), 13(1), 39-018-0984-3. doi:10.1186/s13014-018-0984-3 [doi]
Benavides, O. M., Brooks, A. R., Cho, S. K., Petsche Connell, J., Ruano, R., & Jacot, J. G. (2015)., In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells., Journal of Biomedical Materials Research.Part A, 103(8), 2645-2653. doi:10.1002/jbm.a.35402 [doi]
Smink AM, Skrzypek K, Liefers-Visser JAL, Kuwabara R, de Haan BJ, de Vos P, Stamatialis D., In vivovascularization and islet function in a microwell device for pancreatic islet transplantation, Biomed Mater. 2021 Apr 21;16(3). doi: 10.1088/1748-605X/abf5ec.
Zhang B, Yang L, Zeng Z, Feng Y, Wang X, Wu X, Luo H, Zhang J, Zhang M, Pakvasa M, Wagstaff W, He F, Mao Y, Qin K, Ding H, Zhang Y, Niu C, Wu M, Zhao X, Wang H, Huang L, Shi D, Liu Q, Ni N, Fu K, Athiviraham A, Moriatis Wolf J, Lee MJ, Hynes K, Strelzow J, El Dafrawy M, Xia Y, He TC., Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling, Stem Cells Dev. 2020 Apr 15;29(8):498-510. doi: 10.1089/scd.2019.0292. Epub 2020 Mar 9.
Brand, C., Sadique, A., Houghton, J. L., Gangangari, K., Ponte, J. F., Lewis, J. S., . . . Reiner, T. (2018), Leveraging PET to image folate receptor alpha therapy of an antibody-drug conjugate., EJNMMI Research, 8(1), 87-018-0437-x. doi:10.1186/s13550-018-0437-x [doi]
Page, J. M., Merkel, A. R., Ruppender, N. S., Guo, R., Dadwal, U. C., Cannonier, S., . . . Sterling, J. A. (2015)., Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin beta3 and TGF-beta receptor type II., Biomaterials, 64, 33-44. doi:10.1016/j.biomaterials.2015.06.026 [doi]
Walker MM, Baumann ME, Alexander JH, Blackstone BN, Morgan CB, Scharschmidt TJ, Powell HM., Mechanical strain induces ex vivo expansion of periosteum, PLoS One. 2022 Dec 30;17(12):e0279519. doi: 10.1371/journal.pone.0279519. eCollection 2022.
Rooj, A. K., Ricklefs, F., Mineo, M., Nakano, I., Chiocca, E. A., Bronisz, A., & Godlewski, J. (2017)., MicroRNA-mediated dynamic bidirectional shift between the subclasses of glioblastoma stem-like cells., Cell Reports, 19(10), 2026-2032. doi:S2211-1247(17)30682-4 [pii]
Biyashev, D., Veliceasa, D., Topczewski, J., Topczewska, J. M., Mizgirev, I., Vinokour, E., . . . Volpert, O. V. (2012), miR-27b controls venous specification and tip cell fate, Blood, 119(11), 2679-2687. doi:10.1182/blood-2011-07-370635 [doi]
Tjalma, J. J., Garcia-Allende, P. B., Hartmans, E., Terwisscha van Scheltinga, A. G., Boersma-van Ek, W., Glatz, J., . . . Nagengast, W. B. (2016)., Molecular fluorescence endoscopy targeting vascular endothelial growth factor A for improved colorectal polyp detection., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 57(3), 480-485. doi:10.2967/jnumed.115.166975 [doi]
Vaes B, Van Houtven E, Caluwé E, Luttun A., Multipotent adult progenitor cells grown under xenobiotic-free conditions support vascularization during wound healing, Stem Cell Res Ther. 2020 Sep 7;11(1):389. doi: 10.1186/s13287-020-01912-3.
Cidonio G, Glinka M, Kim YH, Kanczler JM, Lanham SA, Ahlfeld T, Lode A, Dawson JI, Gelinsky M, Oreffo ROC., Nanoclay-based 3D printed scaffolds promote vascular ingrowth ex vivo and generate bone mineral tissue in vitro and in vivo, Biofabrication. 2020 May 12;12(3):035010. doi: 10.1088/1758-5090/ab8753.
Liao, J., Wei, Q., Zou, Y., Fan, J., Song, D., Cui, J., . . . Huang, W. (2017)., Notch signaling augments BMP9-induced bone formation by promoting the osteogenesis-angiogenesis coupling process in mesenchymal stem cells (MSCs)., Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 41(5), 1905-1923. doi:10.1159/000471945 [doi]
O'Leary, M. P., Choi, A. H., Kim, S. I., Chaurasiya, S., Lu, J., Park, A. K., . . . Chen, N. G. (2018)., Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose, Journal of Translational Medicine, 16(1), 110-018-1483-x. doi:10.1186/s12967-018-1483-x [doi]
Studebaker, A. W., Hutzen, B. J., Pierson, C. R., Haworth, K. B., Cripe, T. P., Jackson, E. M., & Leonard, J. R. (2017), Oncolytic herpes virus rRp450 shows efficacy in orthotopic xenograft group 3/4 medulloblastomas and atypical Teratoid/Rhabdoid tumors., Molecular Therapy Oncolytics, 6, 22-30. doi:10.1016/j.omto.2017.05.005 [doi]
Dost AFM, Moye AL, Vedaie M, Tran LM, Fung E, Heinze D, Villacorta-Martin C, Huang J, Hekman R, Kwan JH, Blum BC, Louie SM, Rowbotham SP, Sainz de Aja J, Piper ME, Bhetariya PJ, Bronson RT, Emili A, Mostoslavsky G, Fishbein GA, Wallace WD, Krysan K, Dubinett SM, Yanagawa J, Kotton DN, Kim CF., Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells, Cell Stem Cell. 2020 Oct 1;27(4):663-678.e8. doi: 10.1016/j.stem.2020.07.022. Epub 2020 Sep 4.
Golan, T., Stossel, C., Schvimer, M., Atias, D., Halperin, S., Buzhor, E., . . . Berger, R. (2017)., Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease, Oncotarget, 8(25), 40778-40790. doi:10.18632/oncotarget.17253 [doi]
Gong, H., An, S., Sassmann, A., Liu, M., Mastej, V., Mittal, M., . . . Malik, A. B. (2016)., PAR1 scaffolds TGFbetaRII to downregulate TGF-beta signaling and activate ESC differentiation to endothelial cells, Stem Cell Reports, 7(6), 1050-1058. doi:S2213-6711(16)30244-2 [pii]
Chao, C., Widen, S. G., Wood, T. G., Zatarain, J. R., Johnson, P., Gajjar, A., . . . Hellmich, M. R. (2017)., Patient-derived xenografts from colorectal carcinoma: A temporal and hierarchical study of murine stromal cell replacement., Anticancer Research, 37(7), 3405-3412. doi:37/7/3405 [pii]
Tamayo A, Gonçalves LM, Rodriguez-Diaz R, Pereira E, Canales M, Caicedo A, Almaça J., Pericyte Control of Blood Flow in Intraocular Islet Grafts Impacts Glucose Homeostasis in Mice, Diabetes. 2022 Aug 1;71(8):1679-1693. doi: 10.2337/db21-1104.
Leone MA, Gelati M, Profico DC, Gobbi C, Pravatà E, Copetti M, Conti C, Abate L, Amoruso L, Apollo F, Balzano RF, Bicchi I, Carella M, Ciampini A, Colosimo C, Crociani P, D'Aloisio G, Di Viesti P, Ferrari D, Fogli D, Fontana A, Frondizi D, et al., Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis., Cell Stem Cell. 2023 Dec 7;30(12):1597-1609.e8. doi: 10.1016/j.stem.2023.11.001. Epub 2023 Nov 27.
Bashyal N, Kim MG, Jung JH, Acharya R, Lee YJ, Hwang WS, Choi JM, Chang DY, Kim SS, Suh-Kim H., Preclinical Study on Biodistribution of Mesenchymal Stem Cells after Local Transplantation into the Brain., Int J Stem Cells. 2023 Nov 30;16(4):415-424. doi: 10.15283/ijsc23062. Epub 2023 Aug 30.
Nichols-Burns, S. M., Lotz, L., Schneider, H., Adamek, E., Daniel, C., Stief, A., . . . Dittrich, R. (2014)., Preliminary observations on whole-ovary xenotransplantation as an experimental model for fertility preservation., Reproductive Biomedicine Online, 29(5), 621-626. doi:10.1016/j.rbmo.2014.07.017 [doi]
Philips, B. J., Grahovac, T. L., Valentin, J. E., Chung, C. W., Bliley, J. M., Pfeifer, M. E., . . . Rubin, J. P. (2013)., Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model., Plastic and Reconstructive Surgery, 132(4), 845-858. doi:10.1097/PRS.0b013e31829fe5b1 [doi]
Manuel, C. A., Bagby, S. M., Reisinger, J. A., Pugazhenthi, U., Pitts, T. M., Keysar, S. B., . . . Leszczynski, J. K. (2017)., Procedure for horizontal transfer of patient-derived xenograft tumors to eliminate corynebacterium bovis., Journal of the American Association for Laboratory Animal Science : JAALAS, 56(2), 166-172.
Louie SM, Moye AL, Wong IG, Lu E, Shehaj A, Garcia-de-Alba C, Ararat E, Raby BA, Lu B, Paschini M, Bronson RT, Kim CF., Progenitor potential of lung epithelial organoid cells in a transplantation model, Cell Rep. 2022 Apr 12;39(2):110662. doi: 10.1016/j.celrep.2022.110662.
Banerjee, J., Papu John, A. M., & Schuller, H. M. (2015)., Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides., International Journal of Cancer, 137(12), 2815-2824. doi:10.1002/ijc.29646 [doi]
Jimenez-Valerio, G., Martinez-Lozano, M., Bassani, N., Vidal, A., Ochoa-de-Olza, M., Suarez, C., . . . Casanovas, O. (2016), Resistance to antiangiogenic therapies by metabolic symbiosis in renal cell carcinoma PDX models and patients, Cell Reports, 15(6), 1134-1143. doi:10.1016/j.celrep.2016.04.015 [doi]
De Cian MC, Gregoire EP, Le Rolle M, Lachambre S, Mondin M, Bell S, Guigon CJ, Chassot AA, Chaboissier MC., R-spondin2 signaling is required for oocyte-driven intercellular communication and follicular growth, Cell Death Differ. 2020 Oct;27(10):2856-2871. doi: 10.1038/s41418-020-0547-7. Epub 2020 Apr 27.
Collins KB, Kang H, Matsche J, Klomp JE, Rehman J, Malik AB, Karginov AV., Septin2 mediates podosome maturation and endothelial cell invasion associated with angiogenesis, J Cell Biol. 2020 Feb 3;219(2):e201903023. doi: 10.1083/jcb.201903023.
Rohira, A. D., Yan, F., Wang, L., Wang, J., Zhou, S., Lu, A., . . . O'Malley, B. W. (2017)., Targeting SRC coactivators blocks the tumor-initiating capacity of cancer stem-like cells, . Cancer Research, 77(16), 4293-4304. doi:10.1158/0008-5472.CAN-16-2982 [doi]
Naftali-Shani, N., Itzhaki-Alfia, A., Landa-Rouben, N., Kain, D., Holbova, R., Adutler-Lieber, S., . . . Leor, J. (2013)., The origin of human mesenchymal stromal cells dictates their reparative properties, Journal of the American Heart Association, 2(5), e000253. doi:10.1161/JAHA.113.000253 [doi]
Schultz, M. J., Holdbrooks, A. T., Chakraborty, A., Grizzle, W. E., Landen, C. N., Buchsbaum, D. J., . . . Bellis, S. L. (2016)., The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype., Cancer Research, 76(13), 3978-3988. doi:10.1158/0008-5472.CAN-15-2834 [doi]
Thoma, D. S., Villar, C. C., Cochran, D. L., Hammerle, C. H., & Jung, R. E. (2012)., Tissue integration of collagen-based matrices: An experimental study in mice, Clinical Oral Implants Research, 23(12), 1333-1339. doi:10.1111/j.1600-0501.2011.02356.x [doi]
Qiao JX, Williams D, Gill P, Li L, Norris D, Tokarski JS, Wong J, Qi H, Hafeji Y, Downes DP, Degnen B, Wang YK, Locke G, Fang H, Yu F, Xu S, Naglich J, Zhang J, Nanjappa P, Dai C, Chourb L, Napoline J, Tester R, Jorge C, Li YX, Mathur A, Barbieri C, Soars MG, Venkatanarayan A, Lees E, Borzilleri RM, Gavai AV, Wichroski M, Dhar TGM., Discovery and Synthesis of Heterobifunctional Degraders of Rearranged during Transfection (RET) Kinase, J Med Chem - 10.1021/acs.jmedchem.4c02083
Kośnik W, Sikorska H, Kiciak A, Ciach T., Nanoparticle-Encapsulated Epirubicin Efficacy in the Inhibition of Growth of Orthotopic Ovarian Patient-Derived Xenograft in Immunocompromised Mice, Int J Mol Sci - 10.3390/ijms25010645
Tumor cell growth
Giesen D, Hooge MNL, Nijland M, Heyerdahl H, Dahle J, de Vries EGE, Pool M., (89)Zr-PET imaging to predict tumor uptake of (177)Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma, Sci Rep. 2022 Apr 15;12(1):6286. doi: 10.1038/s41598-022-10139-6.
Capozza M, Stefania R, Dinatale V, Bitonto V, Conti L, Grange C, Skovronova R, Terreno E., A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation, Int J Mol Sci. 2022 Oct 25;23(21):12878. doi: 10.3390/ijms232112878.
Zalles M, Smith N, Saunders D, Lerner M, Fung KM, Battiste J, Towner RA., A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007, J Cell Mol Med. 2022 Jan;26(2):570-582. doi: 10.1111/jcmm.17133. Epub 2021 Dec 14.
Meier JP, Zhang HJ, Freifelder R, Bhuiyan M, Selman P, Mendez M, Kankanamalage PHA, Brossard T, Pusateri A, Tsai HM, Leoni L, Penano S, Ghosh K, Broder BA, Markiewicz E, Renne A, Stadler W, Weichselbaum R, Nolen J, Kao CM, Chitneni SK, Rotsch DA, et al., Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics., Molecules. 2023 Aug 13;28(16). pii: 6041. doi: 10.3390/molecules28166041.
Ciccone V, Terzuoli E, Ristori E, Filippelli A, Ziche M, Morbidelli L, Donnini S., ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade, Int J Mol Med. 2022 Jul;50(1):99. doi: 10.3892/ijmm.2022.5155. Epub 2022 Jun 3.
Harris Y, Sason H, Niezni D, Shamay Y., Automated discovery of nanomaterials via drug aggregation induced emission, Biomaterials. 2022 Oct;289:121800. doi: 10.1016/j.biomaterials.2022.121800. Epub 2022 Sep 16.
Te Boekhorst V, Jiang L, Mählen M, Meerlo M, Dunkel G, Durst FC, Yang Y, Levine H, Burgering BMT, Friedl P., Calpain-2 regulates hypoxia/HIF-induced plasticity toward amoeboid cancer cell migration and metastasis, Curr Biol. 2022 Jan 24;32(2):412-427.e8. doi: 10.1016/j.cub.2021.11.040. Epub 2021 Dec 8.
Hsu MA, Okamura SM, De Magalhaes Filho CD, Bergeron DM, Rodriguez A, West M, Yadav D, Heim R, Fong JJ, Garcia-Guzman M., Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model, Cancer Immunol Immunother. 2023 Jan;72(1):151-168. doi: 10.1007/s00262-022-03239-9. Epub 2022 Jul 1.
Hsu MA, Okamura SM, De Magalhaes Filho CD, Bergeron DM, Rodriguez A, West M, Yadav D, Heim R, Fong JJ, Garcia-Guzman M., Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model., Cancer Immunol Immunother. 2023 Jan;72(1):151-168. doi: 10.1007/s00262-022-03239-9. Epub 2022 Jul 1.
Quandt E, Masip N, Hernández-Ortega S, Sánchez-Botet A, Gasa L, Fernández-Elorduy A, Plutta S, MartÃnez-Láinez JM, Bru S, Munoz-Torres PM, Floor M, Villà -Freixa J, Morris MC, Vidal A, Villanueva A, Clotet J, Ribeiro MPC., CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation., Mol Oncol. 2023 Jul;17(7):1228-1245. doi: 10.1002/1878-0261.13438. Epub 2023 May 31.
Kim K, Huang H, Parida PK, He L, Marquez-Palencia M, Reese TC, Kapur P, Brugarolas J, Brekken RA, Malladi S., Cell Competition Shapes Metastatic Latency and Relapse, Cancer Discov. 2023 Jan 9;13(1):85-97. doi: 10.1158/2159-8290.CD-22-0236.
Kim K, Huang H, Parida PK, He L, Marquez-Palencia M, Reese TC, Kapur P, Brugarolas J, Brekken RA, Malladi S., Cell Competition Shapes Metastatic Latency and Relapse., Cancer Discov. 2023 Jan 9;13(1):85-97. doi: 10.1158/2159-8290.CD-22-0236.
Talele S, Zhang W, Oh JH, Burgenske DM, Mladek AC, Dragojevic S, Sarkaria JN, Elmquist WF., Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases, J Pharmacol Exp Ther. 2022 Jun;381(3):217-228. doi: 10.1124/jpet.121.001069. Epub 2022 Apr 3.
Nikesitch N, Beraldi E, Zhang F, Adomat H, Bell R, Suzuki K, Fazli L, Hy Kung S, Wells C, Pinette N, Saxena N, Wang Y, Gleave M., Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling, Oncogene. 2023 Jan 7. doi: 10.1038/s41388-022-02573-7. Online ahead of print.
Nikesitch N, Beraldi E, Zhang F, Adomat H, Bell R, Suzuki K, Fazli L, Hy Kung S, Wells C, Pinette N, Saxena N, Wang Y, Gleave M., Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling., Oncogene. 2023 Mar;42(10):748-758. doi: 10.1038/s41388-022-02573-7. Epub 2023 Jan 7.
Choi SI, Lee YS, Lee YM, Kim HJ, Kim WJ, Jung S, Im JE, Lee MR, Kim JK, Jeon AR, Woo SM, Oh GT, Heo K, Kim YH, Kim IH., Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment., J Control Release. 2023 Aug;360:940-952. doi: 10.1016/j.jconrel.2023.03.048. Epub 2023 Apr 6.
Allouche-Arnon H, Khersonsky O, Tirukoti ND, Peleg Y, Dym O, Albeck S, Brandis A, Mehlman T, Avram L, Harris T, Yadav NN, Fleishman SJ, Bar-Shir A., Computationally designed dual-color MRI reporters for noninvasive imaging of transgene expression, Nat Biotechnol. 2022 Jul;40(7):1143-1149. doi: 10.1038/s41587-021-01162-5. Epub 2022 Jan 31.
Frontiñán-Rubio J, Llanos-González E, García-Carpintero S, Peinado JR, Ballesteros-Yáñez I, Rayo MV, de la Fuente J, Pérez-García VM, Perez-Romasanta LA, Malumbres M, Alcaín FJ, Durán-Prado M., CoQ(10) reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation, Cell Oncol (Dordr). 2022 Nov 2. doi: 10.1007/s13402-022-00734-0. Online ahead of print.
Frontiñán-Rubio, J., Llanos-González, E., García-Carpintero, S., Peinado, J. R., Ballesteros-Yáñez, I., Rayo, M. V., de la Fuente, J., Pérez-García, V. M., Perez-Romasanta, L. A., Malumbres, M., Alcaín, F. J., & Durán-Prado, M., CoQ(10) reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation., Cell Oncol (Dordr). 2023 Feb;46(1):65-77. doi: 10.1007/s13402-022-00734-0. Epub 2022 Nov 2. Erratum in: Cell Oncol (Dordr). 2023 Oct;46(5):1543.
Patel SS, Hoogenboezem EN, Yu F, DeJulius CR, Fletcher RB, Sorets AG, Cherry FK, Lo JH, Bezold MG, Francini N, d'Arcy R, Brasuell JE, Cook RS, Duvall CL., Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing., Biomaterials. 2023 Jun;297:122098. doi: 10.1016/j.biomaterials.2023.122098. Epub 2023 Mar 28.
Marayati R, Stafman LL, Williams AP, Bownes LV, Quinn CH, Markert HR, Easlick JL, Stewart JE, Crossman DK, Mroczek-Musulman E, Beierle EA., CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells, Cancer Gene Ther. 2022 May;29(5):558-572. doi: 10.1038/s41417-021-00334-4. Epub 2021 Apr 16.
Baeza-Kallee N, Bergès R, Hein V, Cabaret S, Garcia J, Gros A, Tabouret E, Tchoghandjian A, Colin C, Figarella-Branger D., Deciphering the Action of Neuraminidase in Glioblastoma Models., Int J Mol Sci. 2023 Jul 19;24(14). pii: 11645. doi: 10.3390/ijms241411645.
Espinoza I, Kurapaty C, Park CH, Vander Steen T, Kleer CG, Wiley E, Rademaker A, Cuyàs E, Verdura S, Buxó M, Reynolds C, Menendez JA, Lupu R., Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness, Am J Cancer Res. 2022 Feb 15;12(2):839-851. eCollection 2022.
Li J, Valkenburgh JV, Fang J, Zhang D, Chen Y, Chen Q, Jia G, Chen AZ, Zhang X, Chen K., Development of a novel radiofluorinated riboflavin probe for riboflavin receptor-targeting PET imaging, Pharmacol Res. 2022 Sep;183:106395. doi: 10.1016/j.phrs.2022.106395. Epub 2022 Aug 13.
Taffoni C, Marines J, Chamma H, Guha S, Saccas M, Bouzid A, Valadao AC, Maghe C, Jardine J, Park MK, Polak K, De Martino M, Vanpouille-Box C, Del Rio M, Gongora C, Gavard J, Bidère N, Song MS, Pineau D, Hugnot JP, Kissa K, Fontenille L, et al., DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma, EMBO J. 2023 Apr 3;42(7):e111961. doi: 10.15252/embj.2022111961. Epub 2022 Dec 27.
Taffoni C, Marines J, Chamma H, Guha S, Saccas M, Bouzid A, Valadao AC, Maghe C, Jardine J, Park MK, Polak K, De Martino M, Vanpouille-Box C, Del Rio M, Gongora C, Gavard J, Bidère N, Song MS, Pineau D, Hugnot JP, Kissa K, Fontenille L, Blanchet FP, Vila IK, Laguette N., DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma, EMBO J. 2022 Dec 27:e111961. doi: 10.15252/embj.2022111961. Online ahead of print.
Borgenvik A, Holmberg KO, Bolin S, Zhao M, Savov V, Rosén G, Hutter S, Garancher A, Rahmanto AS, Bergström T, Olsen TK, Mainwaring OJ, Sattanino D, Verbaan AD, Rusert JM, Sundström A, Bravo MB, Dang Y, Wenz AS, Richardson S, Fotaki G, Hill RM, Dubuc AM, Kalushkova A, Remke M, Čančer M, Jernberg-Wiklund H, Giraud G, Chen X, Taylor MD, Sangfelt O, Clifford SC, Schüller U, Wechsler-Reya RJ, Weishaupt H, Swartling FJ., Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma, Cancer Res. 2022 Dec 16;82(24):4586-4603. doi: 10.1158/0008-5472.CAN-22-2108.
Zhang Y, Wang Y, Valdivia A, Huang H, Matei D., DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling., Mol Cancer Res. 2023 Feb 1;21(2):140-154. doi: 10.1158/1541-7786.MCR-22-0418.
Sandhu HS, Portman KL, Zhou X, Zhao J, Rialdi A, Sfakianos JP, Guccione E, Kyprianou N, Zhang B, Mulholland DJ., Dynamic plasticity of prostate cancer intermediate cells during androgen receptor-targeted therapy, Cell Rep. 2022 Jul 26;40(4):111123. doi: 10.1016/j.celrep.2022.111123.
Pradhan AK, Bhoopathi P, Maji S, Kumar A, Guo C, Mannangatti P, Li J, Wang XY, Sarkar D, Emdad L, Das SK, Fisher PB., Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor, Front Oncol. 2022 Mar 24;12:812560. doi: 10.3389/fonc.2022.812560. eCollection 2022.
Naimo GD, Forestiero M, Paolì A, Malivindi R, Gelsomino L, GyÅ‘rffy B, Leonetti AE, Giordano F, Panza S, Conforti FL, Ruffo P, Panno ML, Mauro L, Andò S., ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure., Int J Cancer. 2023 Sep 15;153(6):1257-1272. doi: 10.1002/ijc.34626. Epub 2023 Jun 16.
Lehmann J, Caduff N, Krzywińska E, Stierli S, Salas-Bastos A, Loos B, Levesque MP, Dummer R, Stockmann C, Münz C, Diener J, Sommer L., Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma, Sci Adv. 2023 Jan 13;9(2):eadc8825. doi: 10.1126/sciadv.adc8825. Epub 2023 Jan 13.
Lehmann J, Caduff N, Krzywińska E, Stierli S, Salas-Bastos A, Loos B, Levesque MP, Dummer R, Stockmann C, Münz C, Diener J, Sommer L., Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma., Sci Adv. 2023 Jan 13;9(2):eadc8825. doi: 10.1126/sciadv.adc8825. Epub 2023 Jan 13.
Creus-Bachiller E, Fernández-RodrÃguez J, Magallón-Lorenz M, Ortega-Bertran S, Navas-Rutete S, Romagosa C, Silva TM, Pané M, Estival A, Perez Sidelnikova D, Morell M, Mazuelas H, Carrió M, Lausová T, Reuss D, Gel B, Villanueva A, Serra E, Lázaro C., Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities., Mol Oncol. 2023 Oct 5. doi: 10.1002/1878-0261.13534. [Epub ahead of print]
Moleirinho S, Kitamura Y, Borges PSGN, Auduong S, Kilic S, Deng D, Kanaya N, Kozono D, Zhou J, Gray JJ, Revai-Lechtich E, Zhu Y, Shah K., Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer., Stem Cells Transl Med. 2023 Jul 14;12(7):444-458. doi: 10.1093/stcltm/szad033.
Resovi A, Persichitti P, Brunelli L, Minoli L, Borsotti P, Garattini G, Tironi M, Dugnani E, Redegalli M, De Simone G, Pastorelli R, Bani MR, Piemonti L, Mosher DF, Giavazzi R, Taraboletti G, Belotti D., Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth., J Exp Clin Cancer Res. 2023 Aug 9;42(1):201. doi: 10.1186/s13046-023-02778-y.
Kuravi S, Baker RW, Mushtaq MU, Saadi I, Lin TL, Vivian CJ, Valluripalli A, Abhyankar S, Ganguly S, Cui W, Elenitoba-Johnson KSJ, Welch DR, Jensen RA, Saunthararajah Y, McGuirk JP, Balusu R., Functional characterization of NPM1-TYK2 fusion oncogene, NPJ Precis Oncol. 2022 Jan 18;6(1):3. doi: 10.1038/s41698-021-00246-4.
Burleson M, Deng JJ, Qin T, Duong TM, Yan Y, Gu X, Das D, Easley A, Liss MA, Yew PR, Bedolla R, Kumar AP, Huang TH, Zou Y, Chen Y, Chen CL, Huang H, Sun LZ, Boyer TG., GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer, Mol Cancer Res. 2022 Jan;20(1):62-76. doi: 10.1158/1541-7786.MCR-21-0108. Epub 2021 Oct 5.
Zlotver I, Sosnik A., Glucosylated Hybrid TiO(2) /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer., Small. 2023 Sep 15:e2305475. doi: 10.1002/smll.202305475. [Epub ahead of print]
Cirillo F, Talia M, Santolla MF, Pellegrino M, Scordamaglia D, Spinelli A, De Rosis S, Giordano F, Muglia L, Zicarelli A, Di Dio M, Rigiracciolo DC, Miglietta AM, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M., GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway., Cell Death Discov. 2023 Sep 26;9(1):353. doi: 10.1038/s41420-023-01654-0.
Millul J, Koepke L, Haridas GR, Sparrer KMJ, Mansi R, Fani M., Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides., Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3050-3061. doi: 10.1007/s00259-023-06272-7. Epub 2023 Jun 1.
O'Neill E, Mosley M, Cornelissen B., Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome., Theranostics. 2023 Feb 21;13(4):1302-1310. doi: 10.7150/thno.82101. eCollection 2023.
Ahmed MSU, Lord BD, Adu Addai B, Singhal SK, Gardner K, Salam AB, Ghebremedhin A, White J, Mahmud I, Martini R, Bedi D, Lin H, Jones JD, Karanam B, Dean-Colomb W, Grizzle W, Wang H, Davis M, Yates CC., Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling., Cancers (Basel). 2023 Apr 13;15(8). pii: 2282. doi: 10.3390/cancers15082282.
Yu L, Toriseva M, Afshan S, Cangiano M, Fey V, Erickson A, Seikkula H, Alanen K, Taimen P, Ettala O, Nurmi M, Boström PJ, Kallajoki M, Tuomela J, Mirtti T, Beumer IJ, Nees M, Härkönen P., Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression, Cancers (Basel). 2022 Jan 7;14(2):278. doi: 10.3390/cancers14020278.
Kleinberger I, Sanders E, Staes K, Van Troys M, Hirano S, Hochepied T, Lemeire K, Martens L, Ampe C, van Roy F., Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms, BMC Cancer. 2022 Apr 25;22(1):451. doi: 10.1186/s12885-022-09381-y.
Lupia M, Melocchi V, Bizzaro F, Lo Riso P, Dama E, Baronio M, Ranghiero A, Barberis M, Bernard L, Bertalot G, Giavazzi R, Testa G, Bianchi F, Cavallaro U., Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities, Int J Cancer. 2022 Jul 15;151(2):240-254. doi: 10.1002/ijc.33983. Epub 2022 Mar 14.
Sánchez-Velázquez P, Castellví Q, Villanueva A, Quesada R, Pañella C, Cáceres M, Dorcaratto D, Andaluz A, Moll X, Trujillo M, Burdío JM, Berjano E, Grande L, Ivorra A, Burdío F., Irreversible electroporation of the liver: is there a safe limit to the ablation volume?, Sci Rep. 2016 Apr 1;6:23781. doi: 10.1038/srep23781.
Ozturk H, Cingoz H, Tufan T, Yang J, Adair SJ, Tummala KS, Kuscu C, Kinali M, Comertpay G, Nagdas S, Goudreau BJ, Luleyap HU, Bingul Y, Ware TB, Hwang WL, Hsu KL, Kashatus DF, Ting DT, Chandel NS, Bardeesy N, Bauer TW, Adli M., ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer, Dev Cell. 2022 Jun 6;57(11):1331-1346.e9. doi: 10.1016/j.devcel.2022.04.014. Epub 2022 May 3.
Shindo M, Maeda M, Myat K, Mane MM, Cohen IJ, Vemuri K, Albeg AS, Serganova I, Blasberg R., LDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses, Cancers (Basel). 2022 May 6;14(9):2303. doi: 10.3390/cancers14092303.
Remsik J, Chi Y, Tong X, Sener U, Derderian C, Park A, Saadeh F, Bale T, Boire A., Leptomeningeal metastatic cells adopt two phenotypic states, Cancer Rep (Hoboken). 2022 Apr;5(4):e1236. doi: 10.1002/cnr2.1236. Epub 2020 Jan 29.
Parida PK, Marquez-Palencia M, Ghosh S, Khandelwal N, Kim K, Nair V, Liu XZ, Vu HS, Zacharias LG, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, McDonald JG, Lemoff A, Peng Y, Lewis C, Vale G, Halberg N, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S., Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases., Nat Cancer. 2023 Jun;4(6):893-907. doi: 10.1038/s43018-023-00563-6. Epub 2023 May 29.
Choi BH, Rawat V, Högström J, Burns PA, Conger KO, Ozgurses ME, Patel JM, Mehta TS, Warren A, Selfors LM, Muranen T, Coloff JL., Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors, Cell Rep. 2022 Jan 18;38(3):110278. doi: 10.1016/j.celrep.2021.110278.
Yuan M, Barefoot ME, Peterson K, Campbell MJ, Blancato JK, Chen M, Schmidt MO, Kiliti AJ, Fang HB, Wellstein A, Riegel AT, Sharif GM., Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer., Int J Mol Sci. 2023 Jul 15;24(14). pii: 11505. doi: 10.3390/ijms241411505.
Guendisch U, Loos B, Cheng PF, Dummer R, Levesque MP, Varum S, Sommer L., Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation, Front Cell Dev Biol. 2022 May 26;10:916033. doi: 10.3389/fcell.2022.916033. eCollection 2022.
Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S, Eedunuri VK, Gupta Y, Zheng S, Abdelfattah N, Huang Y, Vadlamudi R, Hromas R, Meltzer P, Houghton P, Chen Y, Rao MK., M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression, Cancer Res. 2022 May 16;82(10):1872-1889. doi: 10.1158/0008-5472.CAN-21-2106.
Parida PK, Marquez-Palencia M, Nair V, Kaushik AK, Kim K, Sudderth J, Quesada-Diaz E, Cajigas A, Vemireddy V, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Huffman K, Sahoo S, Alluri P, Lewis C, Peng Y, Bachoo RM, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S., Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness, Cell Metab. 2022 Jan 4;34(1):90-105.e7. doi: 10.1016/j.cmet.2021.12.001.
Al-Jamal WT, Kostarelos K., Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes, Nanotheranostics. 2022 Jan 1;6(3):230-242. doi: 10.7150/ntno.61280. eCollection 2022.
Dinami R, Pompili L, Petti E, Porru M, D'Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, Serra V, Mano M, Giacca M, Leonetti C, Ciliberto G, Tarsounas M, Stoppacciaro A, Schoeftner S, Biroccio A., MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer., EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25.
Nilsen A, Hillestad T, Skingen VE, Aarnes EK, Fjeldbo CS, Hompland T, Evensen TS, Stokke T, Kristensen GB, Grallert B, Lyng H., miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer, Mol Oncol. 2022 Mar;16(6):1402-1419. doi: 10.1002/1878-0261.13184. Epub 2022 Feb 15.
Bastiancich C, Fernandez S, Correard F, Novell A, Larrat B, Guillet B, Estève MA., Molecular Imaging of Ultrasound-Mediated Blood-Brain Barrier Disruption in a Mouse Orthotopic Glioblastoma Model, Pharmaceutics. 2022 Oct 19;14(10):2227. doi: 10.3390/pharmaceutics14102227.
Ruiz-López E, Jovčevska I, González-Gómez R, Tejero H, Al-Shahrour F, Muyldermans S, Schuhmacher AJ., Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma, Sci Rep. 2022 Dec 30;12(1):22581. doi: 10.1038/s41598-022-27161-3.
Yang Z, Wilkinson E, Cui YH, Li H, He YY., NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity., Toxicol Appl Pharmacol. 2023 Oct 15;477:116688. doi: 10.1016/j.taap.2023.116688. Epub 2023 Sep 14.
Boscolo E, Pastura P, Schrenk S, Goines J, Kang R, Pillis D, Malik P, Le Cras TD., NRAS(Q61R) mutation in human endothelial cells causes vascular malformations, Angiogenesis. 2022 Aug;25(3):331-342. doi: 10.1007/s10456-022-09836-7. Epub 2022 Apr 7.
Yang L, Vander Steen T, Espinoza I, Cuyàs E, Verdura S, Menendez JA, Lupu R., Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling, Am J Cancer Res. 2022 May 15;12(5):2173-2188. eCollection 2022.
Lecointre C, Fourgous E, Montarras I, Kerneur C, Simon V, Boublik Y, Bonenfant D, Robert B, Martineau P, Roche S., Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer, Cancers (Basel). 2022 Jun 16;14(12):2981. doi: 10.3390/cancers14122981.
Hedberg J, Studebaker A, Smith L, Chen CY, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE., Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution., Mol Ther Oncolytics. 2023 Jul 19;30:39-55. doi: 10.1016/j.omto.2023.07.006. eCollection 2023 Sep 21.
Di Maira G, Foglia B, Napione L, Turato C, Maggiora M, Sutti S, Novo E, Alvaro M, Autelli R, Colombatto S, Bussolino F, Carucci P, Gaia S, Rosso C, Biasiolo A, Pontisso P, Bugianesi E, Albano E, Marra F, Parola M, Cannito S., Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis, J Pathol. 2022 May;257(1):82-95. doi: 10.1002/path.5871. Epub 2022 Mar 7.
Wu YH, Gugala Z, Barry MM, Shen Y, Dasgupta S, Wang H., Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis, Mol Cancer Ther. 2022 Aug 2;21(8):1360-1368. doi: 10.1158/1535-7163.MCT-21-0684.
Parida PK, Marquez-Palencia M, Kaushik AK, Kim K, Nair V, Sudderth J, Vu H, Zacharias L, DeBerardinis R, Malladi S., Optimized protocol for stable isotope tracing and steady-state metabolomics in mouse HER2+ breast cancer brain metastasis, STAR Protoc. 2022 Apr 22;3(2):101345. doi: 10.1016/j.xpro.2022.101345. eCollection 2022 Jun 17.
Baslan T, Morris JP 4th, Zhao Z, Reyes J, Ho YJ, Tsanov KM, Bermeo J, Tian S, Zhang S, Askan G, Yavas A, Lecomte N, Erakky A, Varghese AM, Zhang A, Kendall J, Ghiban E, Chorbadjiev L, Wu J, Dimitrova N, Chadalavada K, Nanjangud GJ, Bandlamudi C, Gong Y, Donoghue MTA, Socci ND, Krasnitz A, Notta F, Leach SD, Iacobuzio-Donahue CA, Lowe SW., Ordered and deterministic cancer genome evolution after p53 loss, Nature. 2022 Aug;608(7924):795-802. doi: 10.1038/s41586-022-05082-5. Epub 2022 Aug 17.
Gendrau-Sanclemente N, Figueras A, Gracova K, Lahiguera Ã, Alsina-SanchÃs E, MarÃn-Jiménez JA, Vidal A, Matias-Guiu X, Fernandez-Gonzalez S, Barahona M, Martà L, Ponce J, Viñals F., Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread., Mol Oncol. 2024 Jan;18(1):136-155. doi: 10.1002/1878-0261.13556. Epub 2023 Dec 1.
Kagalwala HN, Bueno L, Wanniarachchi H, Unruh DK, Hamal KB, Pavlich CI, Carlson GJ, Pinney KG, Mason RP, Lippert AR., Oxygen-Sensing Chemiluminescent Iridium(III) 1,2-Dioxetanes: Unusual Coordination and Activity., Anal Sens. 2023 Jan;3(1). pii: e202200085. doi: 10.1002/anse.202200085. Epub 2022 Oct 25.
Miller P, Akama-Garren EH, Owen RP, Demetriou C, Carroll TM, Slee E, Al Moussawi K, Ellis M, Goldin R, O'Neill E, Lu X., p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer., Cell Death Differ. 2023 Jul;30(7):1619-1635. doi: 10.1038/s41418-023-01168-3. Epub 2023 Jun 3.
Hernández Guerrero T, Baños N, Del Puerto Nevado L, Mahillo-Fernandez I, Doger De-Speville B, Calvo E, Wick M, GarcÃa-Foncillas J, Moreno V., Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)., Cancers (Basel). 2023 Nov 14;15(22). pii: 5402. doi: 10.3390/cancers15225402.
Demétrio de Souza França P, Viray T, Roberts S, Michel A, Abrahão M, Patel SG, Ganly I, Schöder H, Brand C, Reiner T, Pillarsetty NVK., Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use, Mol Imaging Biol. 2022 Jul 26. doi: 10.1007/s11307-022-01756-8. Online ahead of print.
Demétrio de Souza França, P., Viray, T., Roberts, S., Michel, A., Abrahão, M., Patel, S. G., Ganly, I., Schöder, H., Brand, C., Reiner, T., & Pillarsetty, N. V. K., Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use., Mol Imaging Biol. 2023 Apr;25(2):294-302. doi: 10.1007/s11307-022-01756-8. Epub 2022 Jul 26.
Staniszewska AD, Pilger D, Gill SJ, Jamal K, Bohin N, Guzzetti S, Gordon J, Hamm G, Mundin G, Illuzzi G, Pike A, McWilliams L, Maglennon G, Rose J, Hawthorne G, Cortes Gonzalez M, Halldin C, Johnström P, Schou M, Critchlow SE, Fawell S, Johannes JW, et al., Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1., Clin Cancer Res. 2023 Nov 15. doi: 10.1158/1078-0432.CCR-23-2094. [Epub ahead of print]
Li M, Baumhover NJ, Liu D, Cagle BS, Boschetti F, Paulin G, Lee D, Dai Z, Obot ER, Marks BM, Okeil I, Sagastume EA, Gabr M, Pigge FC, Johnson FL, Schultz MK., Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for (203)Pb and (212)Pb-Based Theranostics., Pharmaceutics. 2023 Jan 26;15(2). pii: 414. doi: 10.3390/pharmaceutics15020414.
Aschero R, Castillo-Ecija H, Baulenas-Farres M, Resa-Pares C, Jimenez-Cabaco A, Rodriguez E, Monterrubio C, Perez-Jaume S, Suñol M, Chantada GL, Lavarino C, Mora J, Carcaboso AM., Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma., Pediatr Blood Cancer. 2023 Jun;70(6):e30318. doi: 10.1002/pbc.30318. Epub 2023 Mar 27.
Lelong EIJ, Khelifi G, Adjibade P, Joncas FH, Grenier St-Sauveur V, Paquette V, Gris T, Zoubeidi A, Audet-Walsh E, Lambert JP, Toren P, Mazroui R, Hussein SMI., Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation, NAR Cancer. 2022 Nov 4;4(4):zcac034. doi: 10.1093/narcan/zcac034. eCollection 2022 Dec.
Morosi L, Matteo C, Meroni M, Ceruti T, Fuso Nerini I, Bello E, Frapolli R, D'Incalci M, Zucchetti M, Davoli E., Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging, Talanta. 2022 Jan 15;237:122918. doi: 10.1016/j.talanta.2021.122918. Epub 2021 Oct 2.
Di Pompo G, Kusuzaki K, Ponzetti M, Leone VF, Baldini N, Avnet S., Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases, Biomedicines. 2022 Aug 5;10(8):1904. doi: 10.3390/biomedicines10081904.
White JM, Ramos N, Saliganan AD, Chung JY, Bell M, Lindquist J, Conner K, Wiesend WN, Schopperle M, Patrick SM, Kim S, Heath EI, Escorcia FE, Viola NT., Selective ablation of TRA-1-60(+) pluripotent stem cells suppresses tumor growth of prostate cancer., Theranostics. 2023 Mar 27;13(7):2057-2071. doi: 10.7150/thno.78915. eCollection 2023.
Ferré S, González-Ruiz V, Zangari J, Girel S, Martinou JC, Sardella R, Rudaz S., Separation and determination of cysteine enantiomers in plasma after derivatization with 4-fluoro-7-nitrobenzofurazan, J Pharm Biomed Anal. 2022 Feb 5;209:114539. doi: 10.1016/j.jpba.2021.114539. Epub 2021 Dec 18.
Sananes A, Cohen I, Allon I, Ben-David O, Abu Shareb R, Yegodayev KM, Stepensky D, Elkabets M, Papo N., Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers., Mol Oncol. 2023 Nov;17(11):2337-2355. doi: 10.1002/1878-0261.13513. Epub 2023 Sep 25.
Motta A, Barone R, Macaluso F, Giambalvo F, Pecoraro F, Di Marco P, Cassata G, Puleio R, Migliaresi C, Guercio A, Di Felice V., Silk-Based Matrices and c-Kit-Positive Cardiac Progenitor Cells for a Cellularized Silk Fibroin Scaffold: Study of an in vivo Model., Cells Tissues Organs. 2023;212(3):258-271. doi: 10.1159/000522568. Epub 2022 Feb 14.
Kalva SK, Deán-Ben XL, Reiss M, Razansky D., Spiral volumetric optoacoustic tomography for imaging whole-body biodynamics in small animals., Nat Protoc. 2023 Jul;18(7):2124-2142. doi: 10.1038/s41596-023-00834-7. Epub 2023 May 19. Review.
Hu J, Sánchez-Rivera FJ, Wang Z, Johnson GN, Ho YJ, Ganesh K, Umeda S, Gan S, Mujal AM, Delconte RB, Hampton JP, Zhao H, Kottapalli S, de Stanchina E, Iacobuzio-Donahue CA, Pe'er D, Lowe SW, Sun JC, Massagué J., STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma., Nature. 2023 Apr;616(7958):806-813. doi: 10.1038/s41586-023-05880-5. Epub 2023 Mar 29.
Pavic K, Gupta N, Omella JD, Derua R, Aakula A, Huhtaniemi R, Määttä JA, Höfflin N, Okkeri J, Wang Z, Kauko O, Varjus R, Honkanen H, Abankwa D, Köhn M, Hytönen VP, Xu W, Nilsson J, Page R, Janssens V, Leitner A, Westermarck J., Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A, Nat Commun. 2023 Feb 28;14(1):1143. doi: 10.1038/s41467-023-36693-9.
Buikhuisen JY, Gomez Barila PM, Cameron K, Suijkerbuijk SJE, Lieftink C, di Franco S, Krotenberg Garcia A, Uceda Castro R, Lenos KJ, Nijman LE, Torang A, Longobardi C, de Jong JH, Dekker D, Stassi G, Vermeulen L, Beijersbergen RL, van Rheenen J, Huveneers S, Medema JP., Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer., J Exp Clin Cancer Res. 2023 Mar 3;42(1):56. doi: 10.1186/s13046-023-02600-9.
Boese AC, Kang J, Hwang JS, Kim J, Eun K, Malin CM, Magliocca KR, Pan C, Jin L, Kang S., Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis., Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2217332120. doi: 10.1073/pnas.2217332120. Epub 2023 May 30.
Mukherjee D, Previs RA, Haines C, Al Abo M, Juras PK, Strickland KC, Chakraborty B, Artham S, Whitaker RS, Hebert K, Fontenot J, Patierno SR, Freedman JA, Lau FH, Burow ME, Chang CY, McDonnell DP., Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis., Cancer Res. 2023 Sep 1;83(17):2889-2907. doi: 10.1158/0008-5472.CAN-22-1622.
Hou R, Yu Y, Sluter MN, Li L, Hao J, Fang J, Yang J, Jiang J., Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma, Cell Rep. 2022 Jun 21;39(12):111000. doi: 10.1016/j.celrep.2022.111000.
Marsh IR, Li C, Grudzinski J, Jeffery J, Longhurst C, Adam DP, Hernandez R, Weichert JP, Harari PM, Bednarz BP., Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry., Cancer Biother Radiopharm. 2023 Sep;38(7):458-467. doi: 10.1089/cbr.2022.0084. Epub 2023 Apr 5.
Granda-DÃaz R, Manterola L, Hermida-Prado F, RodrÃguez R, Santos L, GarcÃa-de-la-Fuente V, Fernández MT, Corte-Torres MD, Rodrigo JP, Ãlvarez-Teijeiro S, Lawrie CH, Garcia-Pedrero JM., Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways., Biomed Pharmacother. 2023 May;161:114512. doi: 10.1016/j.biopha.2023.114512. Epub 2023 Mar 16.
Larrea E, Fernández-Rubio C, Peña-Guerrero J, Guruceaga E, Nguewa PA., The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells, Int J Mol Sci. 2022 Oct 30;23(21):13203. doi: 10.3390/ijms232113203.
Roshini A, Goparaju C, Kundu S, Nandhu MS, Longo SL, Longo JA, Chou J, Middleton FA, Pass HI, Viapiano MS., The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling, Front Oncol. 2022 Oct 11;12:1014749. doi: 10.3389/fonc.2022.1014749. eCollection 2022.
Peñuelas-Haro I, Espinosa-Sotelo R, Crosas-Molist E, Herranz-Itúrbide M, Caballero-Díaz D, Alay A, Solé X, Ramos E, Serrano T, Martínez-Chantar ML, Knaus UG, Cuezva JM, Zorzano A, Bertran E, Fabregat I., The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression, Hepatology. 2022 Aug 3. doi: 10.1002/hep.32702. Online ahead of print.
Peñuelas-Haro, I., Espinosa-Sotelo, R., Crosas-Molist, E., Herranz-Itúrbide, M., Caballero-Díaz, D., Alay, A., Solé, X., Ramos, E., Serrano, T., Martínez-Chantar, M. L., Knaus, U. G., Cuezva, J. M., Zorzano, A., Bertran, E., & Fabregat, I., The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression., Hepatology. 2023 Aug 1;78(2):416-433. doi: 10.1002/hep.32702. Epub 2022 Sep 17.
Rango E, Pastorino F, Brignole C, Mancini A, Poggialini F, Di Maria S, Zamperini C, Iovenitti G, Fallacara AL, Sabetta S, Clementi L, Valoti M, Schenone S, Angelucci A, Ponzoni M, Dreassi E, Botta M., The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma, Biomedicines. 2022 Mar 12;10(3):659. doi: 10.3390/biomedicines10030659.
Chatterjee S, Naidu GS, Hazan-Halevy I, Grobe H, Ezra A, Sharma P, Goldsmith M, Ramishetti S, Sprinzak D, Zaidel-Bar R, Peer D., Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells., Sci Adv. 2023 Apr 5;9(14):eade4800. doi: 10.1126/sciadv.ade4800. Epub 2023 Apr 5.
't Hart E, Bianco J, Besse HC, Chin Joe Kie LA, Cornet L, Eikelenboom KL, van den Broek TJM, Derieppe M, Su Y, Hoving EW, Ries MG, van Vuurden DG., Towards Standardisation of a Diffuse Midline Glioma Patient-Derived Xenograft Mouse Model Based on Suspension Matrices for Preclinical Research., Biomedicines. 2023 Feb 11;11(2). pii: 527. doi: 10.3390/biomedicines11020527.
Jadvar H, Park R, Vorobyova I, Chen K., Tracking Docetaxel-Induced Cellular Proliferation Changes in Prostate Tumor-Bearing Mice with (18)F-FMAU PET., Acad Radiol. 2023 Aug;30(8):1721-1726. doi: 10.1016/j.acra.2022.09.005. Epub 2022 Sep 30.
Conti G, Calderan L, Quintero Sierra LA, Conti A, Ossanna R, Boschi F, Marzola P, Ferrarini F, Governa M, Lievens PM, Sbarbati A., Tumor and peritumoral adipose tissue crosstalk: De-differentiated adipocytes influence spread of colon carcinoma cells, Tissue Cell. 2023 Feb;80:101990. doi: 10.1016/j.tice.2022.101990. Epub 2022 Dec 1.
Conti G, Calderan L, Quintero Sierra LA, Conti A, Ossanna R, Boschi F, Marzola P, Ferrarini F, Governa M, Lievens PM, Sbarbati A., Tumor and peritumoral adipose tissue crosstalk: De-differentiated adipocytes influence spread of colon carcinoma cells., Tissue Cell. 2023 Feb;80:101990. doi: 10.1016/j.tice.2022.101990. Epub 2022 Dec 1.
Muhammad M, Prakash J, Liapis E, Ntziachristos V, Jüstel D., Weighted model-based optoacoustic reconstruction for partial-view geometries, J Biophotonics. 2022 Jun;15(6):e202100334. doi: 10.1002/jbio.202100334. Epub 2022 Mar 6.
Dang TT, Lerner M, Saunders D, Smith N, Gulej R, Zalles M, Towner RA, Morales JC., XRN2 Is Required for Cell Motility and Invasion in Glioblastomas, Cells. 2022 Apr 28;11(9):1481. doi: 10.3390/cells11091481.
Tumor growth
Miner MW, Liljenbäck H, Virta J, Merisaari J, Oikonen V, Westermarck J, Li XG, Roivainen A., (2S, 4R)-4-[(18)F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models, Mol Imaging Biol. 2020 Aug;22(4):969-978. doi: 10.1007/s11307-020-01472-1.
Dadwal UC, Merkel AR, Page JM, Kwakwa KA, Kessler M, Rhoades JA., 3D Bone Morphology Alters Gene Expression, Motility, and Drug Responses in Bone Metastatic Tumor Cells, Int J Mol Sci. 2020 Sep 21;21(18):6913. doi: 10.3390/ijms21186913.
Bilger A, King RE, Schroeder JP, Piette JT, Hinshaw LA, Kurth AD, AlRamahi RW, Barthel MV, Ward-Shaw ET, Buehler D, Masters KS, Thibeault SL, Lambert PF., A Mouse Model of Oropharyngeal Papillomavirus-Induced Neoplasia Using Novel Tools for Infection and Nasal Anesthesia, Viruses. 2020 Apr 16;12(4):450. doi: 10.3390/v12040450.
Mansi R, Abid K, Nicolas GP, Del Pozzo L, Grouzmann E, Fani M., A new (68)Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting, EJNMMI Res. 2020 Aug 5;10(1):90. doi: 10.1186/s13550-020-00677-3.
Beer, M., Kuppalu, N., Stefanini, M., Becker, H., Schulz, I., Manoli, S., . . . Arcangeli, A. (2017), A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: Comparison with in vitro cultures and in vivo xenografts, Scientific Reports, 7(1), 1325-017-01256-8. doi:10.1038/s41598-017-01256-8 [doi]
Xiao, Z., Carrasco, R. A., Schifferli, K., Kinneer, K., Tammali, R., Chen, H., . . . Tice, D. A. (2016)., A potent HER3 monoclonal antibody that blocks both ligand-dependent and -independent activities: Differential impacts of PTEN status on tumor response., Molecular Cancer Therapeutics, 15(4), 689-701. doi:10.1158/1535-7163.MCT-15-0555 [doi]
O'Kelly D, Campbell J 3rd, Gerberich JL, Karbasi P, Malladi V, Jamieson A, Wang L, Mason RP., A scalable open-source MATLAB toolbox for reconstruction and analysis of multispectral optoacoustic tomography data, Sci Rep. 2021 Oct 6;11(1):19872. doi: 10.1038/s41598-021-97726-1.
Atkinson, J. M., Rank, K. B., Zeng, Y., Capen, A., Yadav, V., Manro, J. R., . . . Chedid, M. (2015)., Activating the Wnt/beta-catenin pathway for the treatment of melanoma--application of LY2090314, a novel selective inhibitor of glycogen synthase kinase-3, PloS One, 10(4), e0125028. doi:10.1371/journal.pone.0125028 [doi]
Johnson, J. J., Petiwala, S. M., Syed, D. N., Rasmussen, J. T., Adhami, V. M., Siddiqui, I. A., . . . Mukhtar, H. (2012)., Alpha-mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth., Carcinogenesis, 33(2), 413-419. doi:10.1093/carcin/bgr291 [doi]
Wei T, Buehler D, Ward-Shaw E, Lambert PF., An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer, mBio. 2020 May 12;11(3):e00908-20. doi: 10.1128/mBio.00908-20.
Shivange G, Mondal T, Lyerly E, Gatesman J, Tushir-Singh J., Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody, J Vis Exp. 2020 May 16;(159). doi: 10.3791/60727.
Pitts, T. M., Bradshaw-Pierce, E. L., Bagby, S. M., Hyatt, S. L., Selby, H. M., Spreafico, A., . . . Eckhardt, S. G. (2016), Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer., Oncotarget, 7(31), 50290-50301. doi:10.18632/oncotarget.10366 [doi]
Masannat, J., Purayil, H. T., Zhang, Y., Russin, M., Mahmud, I., Kim, W., . . . Daaka, Y. (2018)., betaArrestin2 mediates renal cell carcinoma tumor growth., Scientific Reports, 8(1), 4879-018-23212-w. doi:10.1038/s41598-018-23212-w [doi]
Kanojia, D., Morshed, R. A., Zhang, L., Miska, J. M., Qiao, J., Kim, J. W., . . . Ahmed, A. U. (2015)., betaIII-tubulin regulates breast cancer metastases to the brain, Molecular Cancer Therapeutics, 14(5), 1152-1161. doi:10.1158/1535-7163.MCT-14-0950 [doi]
Ory, B., Baud'huin, M., Verrecchia, F., Royer, B. B., Quillard, T., Amiaud, J., . . . Lamoureux, F. (2016)., Blocking HSP90 addiction inhibits tumor cell proliferation, metastasis development, and synergistically acts with zoledronic acid to delay osteosarcoma progression., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(10), 2520-2533. doi:10.1158/1078-0432.CCR-15-1925 [doi]
Tiwari A, Iida M, Kosnopfel C, Abbariki M, Menegakis A, Fehrenbacher B, Maier J, Schaller M, Brucker SY, Wheeler DL, Harari PM, Rothbauer U, Schittek B, Zips D, Toulany M., Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers, Cancers (Basel). 2020 Sep 29;12(10):2795. doi: 10.3390/cancers12102795.
Higgins, D. M., Wang, R., Milligan, B., Schroeder, M., Carlson, B., Pokorny, J., . . . Henley, J. R. (2013)., Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts., Oncotarget, 4(5), 792-801. doi:1059 [pii]
Toren, P., Kim, S., Johnson, F., & Zoubeidi, A. (2016), Combined AKT and MEK pathway blockade in pre-clinical models of enzalutamide-resistant prostate cancer., PloS One, 11(4), e0152861. doi:10.1371/journal.pone.0152861 [doi]
Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, Singh A, Hoque MO., Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy, Mol Cancer Ther. 2020 Oct;19(10):2175-2185. doi: 10.1158/1535-7163.MCT-20-0024. Epub 2020 Aug 26.
Williams, Adele P; Stewart, Jerry E; Stafman, Laura L; Aye, Jamie M; Mroczek-Musulman, Elizabeth; Ren, Changchun; Yoon, Karina; Whelan, Kimberly; Beierle, Elizabeth A;, Corruption of neuroblastoma patient derived xenografts with human T cell lymphoma., surgery Vol.54, 2019
Gonzales, C. B., De La Chapa, J. J., Saikumar, P., Singha, P. K., Dybdal-Hargreaves, N. F., Chavez, J., . . . Kirma, N. B. (2016), Co-targeting ALK and EGFR parallel signaling in oral squamous cell carcinoma, Oral Oncology, 59, 12-19. doi:S1368-8375(16)30053-7 [pii]
Rosenblum D, Gutkin A, Kedmi R, Ramishetti S, Veiga N, Jacobi AM, Schubert MS, Friedmann-Morvinski D, Cohen ZR, Behlke MA, Lieberman J, Peer D., CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy, Sci Adv. 2020 Nov 18;6(47):eabc9450. doi: 10.1126/sciadv.abc9450. Print 2020 Nov.
Morales X, Peláez R, Garasa S, Ortiz de Solórzano C, Rouzaut A., CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration, Biomolecules. 2021 Oct 18;11(10):1533. doi: 10.3390/biom11101533.
Huang, Y. H., Peng, W., Furuuchi, N., Gerhart, J., Rhodes, K., Mukherjee, N., . . . Sawicki, J. A. (2016), Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth, Cancer Research, 76(6), 1549-1559. doi:10.1158/0008-5472.CAN-15-2073 [doi]
Ferrauto G, Tripepi M, Di Gregorio E, Bitonto V, Aime S, Delli Castelli D., Detection of U-87 Tumor Cells by RGD-Functionalized/Gd-Containing Giant Unilamellar Vesicles in Magnetization Transfer Contrast Magnetic Resonance Images, Invest Radiol. 2021 May 1;56(5):301-312. doi: 10.1097/RLI.0000000000000742.
Baschnagel AM, Kaushik S, Durmaz A, Goldstein S, Ong IM, Abel L, Clark PA, Gurel Z, Leal T, Buehler D, Iyer G, Scott JG, Kimple RJ., Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases, Sci Rep. 2021 Jan 28;11(1):2520. doi: 10.1038/s41598-021-81832-1.
Lesma, E., Eloisa, C., Isaia, E., Grande, V., Ancona, S., Orpianesi, E., . . . Gorio, A. (2012)., Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice., The American Journal of Pathology, 181(3), 947-960. doi:10.1016/j.ajpath.2012.05.017 [doi]
Marcazzan S, Dadbin A, Brachi G, Blanco E, Varoni EM, Lodi G, Ferrari M., Development of lung metastases in mouse models of tongue squamous cell carcinoma, Oral Dis. 2021 Apr;27(3):494-505. doi: 10.1111/odi.13592. Epub 2020 Aug 20.
Jiang, X., Li, H., Zhao, P., Xie, J., Khabele, D., Xu, J., & Gore, J. C. (2016), Early detection of treatment-induced mitotic arrest using temporal diffusion magnetic resonance spectroscopy., Neoplasia (New York, N.Y.), 18(6), 387-397. doi:10.1016/j.neo.2016.04.006 [doi]
Tang, J., Kuai, R., Yuan, W., Drake, L., Moon, J. J., & Schwendeman, A. (2017), Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting, Nanomedicine : Nanotechnology, Biology, and Medicine, 13(6), 1869-1878. doi:S1549-9634(17)30070-9 [pii]
Schweppe, Rebecca E; Pozdeyev, Nikita; Pike, Laura A; Korch, Christopher; Zhou, Qiong; Sams, Sharon B; Sharma, Vibha; Pugazhenthi, Umarani; Raeburn, Christopher; Albuja-Cruz, Maria B; Reigan, Philip; LaBarbera, Daniel V; Landa, Iñigo; Knauf, Jeffrey A; Fagin, James A; Haugen, Bryan R;, Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers., Molecular cancer research : MCR Vol.17, 2019
Verma B, Wesa A., Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents, Curr Protoc Pharmacol. 2020 Jun;89(1):e77. doi: 10.1002/cpph.77.
Mansi R, Nicolas GP, Del Pozzo L, Abid KA, Grouzmann E, Fani M., Evaluation of a New (177)Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5, Molecules. 2020 Sep 11;25(18):4155. doi: 10.3390/molecules25184155.
Hernandez, R., Czerwinski, A., Chakravarty, R., Graves, S. A., Yang, Y., England, C. G., . . . Cai, W. (2015)., Evaluation of two novel (6)(4)cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin alphavbeta(3)., European Journal of Nuclear Medicine and Molecular Imaging, 42(12), 1859-1868. doi:10.1007/s00259-015-3085-7 [doi]
Valle S, Alcalá S, Martin-Hijano L, Cabezas-Sáinz P, Navarro D, Muñoz ER, Yuste L, Tiwary K, Walter K, Ruiz-Cañas L, Alonso-Nocelo M, Rubiolo JA, González-Arnay E, Heeschen C, Garcia-Bermejo L, Hermann PC, Sánchez L, Sancho P, Fernández-Moreno MÁ, Sainz B Jr., Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells, Nat Commun. 2020 Oct 16;11(1):5265. doi: 10.1038/s41467-020-18954-z.
Shen JZ, Qiu Z, Wu Q, Finlay D, Garcia G, Sun D, Rantala J, Barshop W, Hope JL, Gimple RC, Sangfelt O, Bradley LM, Wohlschlegel J, Rich JN, Spruck C., FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells, Cell. 2020 Dec 18:S0092-8674(20)31614-7. doi: 10.1016/j.cell.2020.11.042. Online ahead of print.
Souris, J. S., Hickson, J. A., Msezane, L., Rinker-Schaeffer, C. W., & Chen, C. T. (2013)., Flexible peritoneal windows for quantitative fluorescence and bioluminescence preclinical imaging., Molecular Imaging, 12(1), 28-38.
Schaff DL, Singh S, Kim KB, Sutcliffe MD, Park KS, Janes KA., Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments, Cancer Res. 2021 Apr 1;81(7):1853-1867. doi: 10.1158/0008-5472.CAN-20-1036. Epub 2021 Feb 2.
Polosukhina, D., Love, H. D., Correa, H., Su, Z., Dahlman, K. B., Pao, W., . . . Clark, P. E. (2017)., Functional KRAS mutations and a potential role for PI3K/AKT activation in wilms tumors., Molecular Oncology, 11(4), 405-421. doi:10.1002/1878-0261.12044 [doi]
Chomet M, Schreurs M, Bolijn MJ, Verlaan M, Beaino W, Brown K, Poot AJ, Windhorst AD, Gill H, Marik J, Williams S, Cowell J, Gasser G, Mindt TL, van Dongen GAMS, Vugts DJ., Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical (89)Zr-immuno-PET, Eur J Nucl Med Mol Imaging. 2020 Sep 5. doi: 10.1007/s00259-020-05002-7. Online ahead of print.
Santini, R., Vinci, M. C., Pandolfi, S., Penachioni, J. Y., Montagnani, V., Olivito, B., . . . Stecca, B. (2012)., Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells., Stem Cells (Dayton, Ohio), 30(9), 1808-1818. doi:10.1002/stem.1160 [doi]
Zhang H, Maeda M, Shindo M, Ko M, Mane M, Grommes C, Weber W, Blasberg R., Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives, Mol Imaging Biol. 2020 Oct;22(5):1184-1196. doi: 10.1007/s11307-020-01480-1.
Walsh JJ, Parent M, Akif A, Adam LC, Maritim S, Mishra SK, Khan MH, Coman D, Hyder F., Imaging Hallmarks of the Tumor Microenvironment in Glioblastoma Progression, Front Oncol. 2021 Aug 26;11:692650. doi: 10.3389/fonc.2021.692650. eCollection 2021.
Oshima, G., Wightman, S. C., Uppal, A., Stack, M. E., Pitroda, S. P., Oskvarek, J. J., . . . Khodarev, N. N. (2015)., Imaging of tumor clones with differential liver colonization., Scientific Reports, 5, 10946. doi:10.1038/srep10946 [doi]
Ferreira CA, Kang L, Li C, Kamkaew A, Barrett KE, Aluicio-Sarduy E, Yang Y, Engle JW, Jiang D, Cai W., ImmunoPET of the differential expression of CD146 in breast cancer, Am J Cancer Res. 2021 Apr 15;11(4):1586-1599. eCollection 2021.
Melsens, E., De Vlieghere, E., Descamps, B., Vanhove, C., De Wever, O., Ceelen, W., & Pattyn, P. (2017)., Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection, Oncology Reports, 38(1), 71-81. doi:10.3892/or.2017.5640 [doi]
Li M, Ehlerding EB, Jiang D, Barnhart TE, Chen W, Cao T, Engle JW, Cai W., In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with (89)Zr-labeled avelumab, Am J Transl Res. 2020 May 15;12(5):1862-1872. eCollection 2020.
Jiang, X., Li, H., Xie, J., McKinley, E. T., Zhao, P., Gore, J. C., & Xu, J. (2017)., In vivo imaging of cancer cell size and cellularity using temporal diffusion spectroscopy., Magnetic Resonance in Medicine, 78(1), 156-164. doi:10.1002/mrm.26356 [doi]
Lanigan LG, Hildreth BE 3rd, Dirksen WP, Simmons JK, Martin CK, Werbeck JL, Thudi NK, Papenfuss TL, Boyaka PN, Toribio RE, Ward JM, Weilbaecher KN, Rosol TJ., In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene, Am J Pathol. 2021 Feb;191(2):335-352. doi: 10.1016/j.ajpath.2020.10.014. Epub 2020 Nov 9.
Benabou, Eva; Salamé, Zeina; Wendum, Dominique; Lequoy, Marie; Tahraoui, Sylvana; Merabtene, Fatiha; Chrétien, Yves; Scatton, Olivier; Rosmorduc, Olivier; Fouassier, Laura; Fartoux, Laetitia; Praz, Françoise; Desbois-Mouthon, Christèle;, Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features., Cancer letters Vol.450, 2019
Ryu, Jin-Sun; Sim, Sung Hoon; Park, In Hae; Lee, Eun Gyeong; Lee, Eun Sook; Kim, Yun-Hee; Kwon, Youngmee; Kong, Sun-Young; Lee, Keun Seok;, Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer, Cancers Vol.11, 2019
Williams, A. P., Garner, E. F., Waters, A. M., Stafman, L. L., Aye, J. M., Markert, H., . . . Beierle, E. A. (2018)., Investigation of PP2A and its endogenous inhibitors in neuroblastoma cell survival and tumor growth., Translational Oncology, 12(1), 84-95. doi:S1936-5233(18)30371-1 [pii]
Zhou, Q., Chen, T., Ibe, J. C., Raj, J. U., & Zhou, G. (2012)., Knockdown of von hippel-lindau protein decreases lung cancer cell proliferation and colonization., FEBS Letters, 586(10), 1510-1515. doi:10.1016/j.febslet.2012.04.009 [doi]
Al-Azayzih, A., Missaoui, W. N., Cummings, B. S., & Somanath, P. R. (2016), Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo., Nanomedicine : Nanotechnology, Biology, and Medicine, 12(5), 1231-1239. doi:10.1016/j.nano.2016.01.003 [doi]
Battaglia, S., Karasik, E., Gillard, B., Williams, J., Winchester, T., Moser, M. T., . . . Foster, B. A. (2017)., LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer., Clinical Epigenetics, 9, 82-017-0382-y. eCollection 2017. doi:10.1186/s13148-017-0382-y [doi]
Lodestijn SC, Miedema DM, Lenos KJ, Nijman LE, Belt SC, El Makrini K, Lecca MC, Waasdorp C, van den Bosch T, Bijlsma MF, Vermeulen L., Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer, Cell Rep. 2021 Oct 19;37(3):109852. doi: 10.1016/j.celrep.2021.109852.
Gorka J, Marona P, Kwapisz O, Waligórska A, Pospiech E, Dobrucki JW, Rys J, Jura J, Miekus K., MCPIP1 inhibits Wnt/?-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs, Oncogene. 2021 Oct 16. doi: 10.1038/s41388-021-02062-3. Online ahead of print.
VanOpstall C, Perike S, Brechka H, Gillard M, Lamperis S, Zhu B, Brown R, Bhanvadia R, Vander Griend DJ., MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans, Elife. 2020 Jun 18;9:e53600. doi: 10.7554/eLife.53600.
Huang, X., Taeb, S., Jahangiri, S., Korpela, E., Cadonic, I., Yu, N., . . . Liu, S. K. (2015)., miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD)., Oncotarget, 6(26), 22439-22451. doi:4210 [pii]
Fanfone D, Stanicki D, Nonclercq D, Port M, Vander Elst L, Laurent S, Muller RN, Saussez S, Burtea C., Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes, Biology (Basel). 2020 Mar 14;9(3):53. doi: 10.3390/biology9030053.
Roy J, White ME, Basuli F, Opina ACL, Wong K, Riba M, Ton AT, Zhang X, Jansson KH, Edmondson E, Butcher D, Lin FI, Choyke PL, Kelly K, Jagoda EM., Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [(18)F]DCFPyL PET Imaging, Mol Imaging Biol. 2021 Oct;23(5):745-755. doi: 10.1007/s11307-021-01605-0. Epub 2021 Apr 23.
Cladel, N. M., Budgeon, L. R., Cooper, T. K., Balogh, K. K., Christensen, N. D., Myers, R., . . . Hu, J. (2017), Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy., The Journal of General Virology, doi:10.1099/jgv.0.000926 [doi]
Wei SJ, Nguyen TH, Yang IH, Mook DG, Makena MR, Verlekar D, Hindle A, Martinez GM, Yang S, Shimada H, Reynolds CP, Kang MH., MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma, Cell Death Dis. 2020 May 14;11(5):368. doi: 10.1038/s41419-020-2563-4.
Serrano-Heras, G., Dominguez-Berzosa, C., Collantes, E., Guadalajara, H., Garcia-Olmo, D., & Garcia-Olmo, D. C. (2012)., NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice., Cancer Letters, 316(1), 85-90. doi:10.1016/j.canlet.2011.10.028 [doi]
Park J, Tacam MJ, Chauhan G, Cohen EN, Gagliardi M, Iles LR, Ueno NT, Battula VL, Sohn YK, Wang X, Kim HS, Krishnamurthy S, Fowlkes NW, Green MM, Bartholomeusz GA, Tripathy D, Reuben JM, Bartholomeusz C., Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression, Breast Cancer Res Treat. 2021 Sep;189(2):333-345. doi: 10.1007/s10549-021-06316-2. Epub 2021 Jul 9.
Trotta AM, Aurilio M, D'Alterio C, Ieranò C, Di Martino D, Barbieri A, Luciano A, Gaballo P, Santagata S, Portella L, Tomassi S, Marinelli L, Sementa D, Novellino E, Lastoria S, Scala S, Schottelius M, Di Maro S., Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors, J Med Chem. 2021 Mar 25;64(6):3449-3461. doi: 10.1021/acs.jmedchem.1c00066. Epub 2021 Mar 4.
Chomet M, Schreurs M, Vos R, Verlaan M, Kooijman EJ, Poot AJ, Boellaard R, Windhorst AD, van Dongen GA, Vugts DJ, Huisman MC, Beaino W., Performance of nanoScan PET/CT and PET/MR for quantitative imaging of (18)F and (89)Zr as compared with ex vivo biodistribution in tumor-bearing mice, EJNMMI Res. 2021 Jun 12;11(1):57. doi: 10.1186/s13550-021-00799-2.
Polosukhina, D., Love, H. D., Moses, H. L., Lee, E., Zent, R., & Clark, P. E. (2017)., Pharmacologic inhibition of beta-catenin with pyrvinium inhibits murine and human models of wilms tumor, Oncology Research, 25(9), 1653-1664. doi:10.3727/096504017X14992942781895 [doi]
Castillo-Ecija H, Pascual-Pasto G, Perez-Jaume S, Resa-Pares C, Vila-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farres M, Muńoz-Aznar O, Salvador N, Cuadrado-Vilanova M, Olaciregui NG, Balaguer-Lluna L, Burgueńo V, Vicario FJ, Manzanares A, Castańeda A, Santa-Maria V, Cruz O, Celis V, Morales La Madrid A, Garraus M, Gorostegui M, Vancells M, Carrasco R, Krauel L, Torner F, Suńol M, Lavarino C, Mora J, Carcaboso AM., Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas, J Pathol Clin Res. 2021 Jul;7(4):338-349. doi: 10.1002/cjp2.210. Epub 2021 Apr 9.
Gupta K, Vuckovic I, Zhang S, Xiong Y, Carlson BL, Jacobs J, Olson I, Petterson XM, Macura SI, Sarkaria J, Burns TC., Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma, Front Oncol. 2020 May 5;10:535. doi: 10.3389/fonc.2020.00535. eCollection 2020.
Benítez S, Cordero A, Santamaría PG, Redondo-Pedraza J, Rocha AS, Collado-Solé A, Jimenez M, Sanz-Moreno A, Yoldi G, Santos JC, De Benedictis I, Gómez-Aleza C, Da Silva-Álvarez S, Troulé K, Gómez-López G, Alcazar N, Palmero I, Collado M, Serrano M, Gonzalez-Suarez E., RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness, Dev Cell. 2021 Jun 21;56(12):1727-1741.e7. doi: 10.1016/j.devcel.2021.04.022. Epub 2021 May 17.
Labay, E., Mauceri, H. J., Efimova, E. V., Flor, A. C., Sutton, H. G., Kron, S. J., & Weichselbaum, R. R. (2016), Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers., Oncotarget, 7(23), 33919-33933. doi:10.18632/oncotarget.8984 [doi]
Li T, Wang X, Ju E, da Silva SR, Chen L, Zhang X, Wei S, Gao SJ., RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation, Nat Commun. 2021 Feb 16;12(1):1055. doi: 10.1038/s41467-021-21206-3.
Merckx G, Lo Monaco M, Lambrichts I, Himmelreich U, Bronckaers A, Wolfs E., Safety and Homing of Human Dental Pulp Stromal Cells in Head and Neck Cancer, Stem Cell Rev Rep. 2021 Oct;17(5):1619-1634. doi: 10.1007/s12015-021-10159-1. Epub 2021 Apr 6.
Chlenski, A., Dobratic, M., Salwen, H. R., Applebaum, M., Guerrero, L. J., Miller, R., . . . Cohn, S. L. (2016)., Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids, Oncotarget, 7(47), 77696-77706. doi:10.18632/oncotarget.12773 [doi]
Sharma, S., Xing, F., Liu, Y., Wu, K., Said, N., Pochampally, R., . . . Watabe, K. (2016)., Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone, The Journal of Biological Chemistry, 291(37), 19351-19363. doi:10.1074/jbc.M116.737379 [doi]
Maloney R, Buuh ZY, Zhao Y, Wang RE., Site-specific antibody fragment conjugates for targeted imaging, Methods Enzymol. 2020;638:295-320. doi: 10.1016/bs.mie.2020.02.023. Epub 2020 Mar 31.
Li J, Chekkoury A, Prakash J, Glasl S, Vetschera P, Koberstein-Schwarz B, Olefir I, Gujrati V, Omar M, Ntziachristos V., Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy, Light Sci Appl. 2020 Apr 13;9:57. doi: 10.1038/s41377-020-0295-y. eCollection 2020.
Gaonkar RH, Wiesmann F, Del Pozzo L, McDougall L, Zanger S, Miko?ajczak R, Mansi R, Fani M., SPECT Imaging of SST2-Expressing Tumors with (99m)Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers, Pharmaceuticals (Basel). 2021 Mar 28;14(4):300. doi: 10.3390/ph14040300.
Sayyad, Megan R; Puchalapalli, Madhavi; Vergara, Natasha G; Wangensteen, Sierra Mosticone; Moore, Melvin; Mu, Liang; Edwards, Chevaunne; Anderson, Aubree; Kall, Stefanie; Sullivan, Megan; Dozmorov, Mikhail; Singh, Jaime; Idowu, Michael O; Koblinski, Jennifer E;, Syndecan-1 facilitates breast cancer metastasis to the brain., Breast cancer research and treatment Vol.178, 2019
Zhu, S., Moore, T. W., Lin, X., Morii, N., Mancini, A., Howard, R. B., . . . Shoji, M. (2012)., Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts, Integrative Biology : Quantitative Biosciences from Nano to Macro, 4(6), 633-640. doi:10.1039/c2ib20007d [doi]
Steins, A., Ebbing, E. A., Pistorius, M. C. M., Waasdorp, C., Krishnadath, K. K., Medema, J. P., . . . van Laarhoven, H. W. M. (2017)., Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel., Drug Delivery, 24(1), 1801-1810. doi:10.1080/10717544.2017.1406559 [doi]
Waters, A. M., Stafman, L. L., Garner, E. F., Mruthyunjayappa, S., Stewart, J. E., Mroczek-Musulman, E., & Beierle, E. A. (2016)., Targeting focal adhesion kinase suppresses the malignant phenotype in rhabdomyosarcoma cells., Translational Oncology, 9(4), 263-273. doi:10.1016/j.tranon.2016.06.001 [doi]
Alcalá S, Mayoral-Varo V, Ruiz-Cañas L, López-Gil JC, Heeschen C, Martín-Pérez J, Sainz B Jr., Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells, Int J Mol Sci. 2020 Oct 9;21(20):7437. doi: 10.3390/ijms21207437.
Bado IL, Zhang W, Hu J, Xu Z, Wang H, Sarkar P, Li L, Wan YW, Liu J, Wu W, Lo HC, Kim IS, Singh S, Janghorban M, Muscarella AM, Goldstein A, Singh P, Jeong HH, Liu C, Schiff R, Huang S, Ellis MJ, Gaber MW, Gugala Z, Liu Z, Zhang XH., The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells, Dev Cell. 2021 Apr 19;56(8):1100-1117.e9. doi: 10.1016/j.devcel.2021.03.008.
Kaliszczak, M., van Hechanova, E., Li, Y., Alsadah, H., Parzych, K., Auner, H. W., & Aboagye, E. O. (2018), The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death., British Journal of Cancer, doi:10.1038/s41416-018-0232-5 [doi]
van Senten, Jeffrey R; Bebelman, Maarten P; Fan, Tian Shu; Heukers, Raimond; Bergkamp, Nick D; van Gasselt, Puck; Langemeijer, Ellen V; Slinger, Erik; Lagerweij, Tonny; Rahbar, Afsar; Stigter-van Walsum, Marijke; Maussang, David; Leurs, Rob; Musters, RenĂŠ J P; van Dongen, Guus A M S; SĂśderberg-NauclĂŠr, Cecilia; WĂźrdinger, Thomas; Siderius, Marco; Smit, Martine J;, The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties, The Journal of biological chemistry Vol.294, 2019
Sami E, Bogan D, Molinolo A, Koziol J, ElShamy WM., The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs, Cancer Gene Ther. 2021 Mar 15. doi: 10.1038/s41417-021-00311-x. Online ahead of print.
Arsic, N., Gadea, G., Lagerqvist, E. L., Busson, M., Cahuzac, N., Brock, C., . . . Roux, P. (2015)., The p53 isoform Delta133p53beta promotes cancer stem cell potential., Stem Cell Reports, 4(4), 531-540. doi:10.1016/j.stemcr.2015.02.001 [doi]
Caria, P., Pillai, R., Dettori, T., Frau, D. V., Zavattari, P., Riva, G., . . . Vanni, R. (2017)., Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells., Journal of Cancer, 8(9), 1629-1639. doi:10.7150/jca.18855 [doi]
Medeiros B, Goodale D, Postenka C, Lowes LE, Kiser P, Hearn S, Salmond N, Williams KC, Allan AL., Triple-Negative Primary Breast Tumors Induce Supportive Premetastatic Changes in the Extracellular Matrix and Soluble Components of the Lung Microenvironment, Cancers (Basel). 2020 Jan 10;12(1):172. doi: 10.3390/cancers12010172.
Marti, P., Stein, C., Blumer, T., Abraham, Y., Dill, M. T., Pikiolek, M., . . . Tchorz, J. S. (2015)., YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors., Hepatology (Baltimore, Md.), 62(5), 1497-1510. doi:10.1002/hep.27992 [doi]
Mahmud MA, Siddique AB, Tajmim A, King JA, El Sayed KA., The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway, Molecules - 10.3390/molecules30010139
Kubaichuk K, Seitz T, Bergmann U, Glumoff V, Mennerich D, Kietzmann T., Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type IIB, Oncogenesis - 10.1038/s41389-024-00538-x
Ishida CT, Myers SL, Kubota CS, Shao W, McGuire MR, Liu C, Ewachiw TE, Mukhopadhyay D, Ke S, Wang H, Rasheed ZA, Anders RA, Espenshade PJ., SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma, Cancer Res Commun - 10.1158/2767-9764.CRC-24-0120
Alfandari A, Moskovich D, Weisz A, Katzav A, Kidron D, Beiner M, Josephy D, Asali A, Hants Y, Yagur Y, Weitzner O, Ellis M, Itchaki G, Ashur-Fabian O., The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer, Mol Oncol - 10.1002/1878-0261.13612
Hartl L, Ten Brink MS, Aberson HL, Koster J, Zwijnenburg DA, Duitman J, Bijlsma MF, Spek CA., Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer, Int J Mol Sci - 10.3390/ijms25179449
Fox A, Leonard GD, Adzibolosu N, Wong T, Tedja R, Sharma S, Gogoi R, Morris R, Mor G, Fehl C, Alvero AB., Adipose microenvironment promotes hypersialylation of ovarian cancer cells, Front Oncol - 10.3389/fonc.2024.1432333
Kubota CS, Myers SL, Seppälä TT, Burkhart RA, Espenshade PJ., In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency, Mol Metab - 10.1016/j.molmet.2024.101964
Rupert PB, Buerger M, Girard EJ, Frutoso M, Parrilla D, Ng K, Gooley T, Groh V, Strong RK., Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys, Heliyon - 10.1016/j.heliyon.2024.e28583
Szczepanski A, Tsuboyama N, Lyu H, Wang P, Beytullahoglu O, Zhang T, Singer BD, Yue F, Zhao Z, Wang L., A SWI/SNF-dependent transcriptional regulation mediated by POU2AF2/C11orf53 at enhancer, Nat Commun - 10.1038/s41467-024-46492-5
Smoots SG, Schreiber AR, Jackson MM, Bagby SM, Dominguez ATA, Dus ED, Binns CA, MacBeth M, Whitty PA, Diamond JR, Pitts TM., Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis, Breast Cancer Res - 10.1186/s13058-024-01799-5
Subscribe to updates from Inotiv
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
